Resistant Methylation Motifs

Motif ID	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_h9laurent_promoter_n_RM_14_205_15	4	0.5	3.49E-04	RASGRP1, HRAS, ABCA2, MED16, CRK, SOX21	Ras protein signal transduction [BP], regulation of Rac protein signal transduction [BP], regulation of Rho GTPase activity [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_28_14	1	0.25	2.76E-04	EZH2, CDK5, CRK	ephrin receptor binding [MF], cerebellar cortex development [BP], acetylcholine receptor activator activity [MF]
CG_h9laurent_promoter_n_RM_14_242_13	3	0.5	3.76E-04	BAD, CDC37, PARP1, GSK3B, VIMP	protein kinase B binding [MF], base-excision repair [BP], pore complex assembly [BP], ER overload response [BP], negative regulation of glycogen biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_472_10	5	0.75	3.05E-04	SERINC5, PDIA6, GLRX2, NUP153, MPDZ, ATXN1, CHCHD4	myelination [BP], nuclear inclusion body [CC], protein disulfide oxidoreductase activity [MF]
CG_h9laurent_promoter_n_RM_14_162_6	2	0.25	2.36E-04	NOP14, GJC1, DBN1	Noc4p-Nop14p complex [CC], gap junction [CC]
CG_h9laurent_promoter_n_RM_12_403_12	2	0.25	2.11E-04	DDB1, PAF1, JUP	gastrulation [BP], Wnt receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_439_21	5	0.75	3.07E-04	ELAVL1, PAXBP1, CPSF3L, TLE2, PDS5A, ADI1, TTF1, FBXO5, PHLDA1, SOX18, ZNF746, MLF2, YPEL1, CEBPD, CHD8, AFF4, DVL2, ZNF784, CRMP1, IRX4, ZNF516, IRX3, ZNF641, C2CD2, SIRT6, KIAA0368, NR4A2, PAF1, ALYREF, VCP, NR2C1, EBF3, LUZP1, CFL1, FLNA, PHLPP2, LEF1, NTHL1, TJP1, ETV5, UCKL1, DNPH1, H2AFX, NRIP1, ZSCAN10, ZNF467, PRDM4, CBS, CINP, NKX3-1, HUS1, ANKRD23, TUBGCP2, ZBTB21, ZNF395, CREBBP, RECQL4	steroid hormone receptor activity [MF], intracellular membrane-bounded organelle [CC], negative regulation of estrogen receptor binding [BP], estrogen receptor activity [MF], nucleus [CC]
CG_h9laurent_promoter_n_RM_14_236_14	3	0.25	3.07E-04	RNF168, UBR1	ubiquitin ligase complex [CC]
CG_h9laurent_promoter_n_RM_12_282_16	3	0.5	3.11E-04	HMGB2, THRB, IRS1, FOXS1, FOXA1, RUNX3, PAX6, RBP4, SORT1, STRA13, SOX21	response to peptide hormone stimulus [BP], response to insulin stimulus [BP], organ morphogenesis [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], pattern specification process [BP], double-stranded DNA binding [MF]
CG_h9laurent_promoter_n_RM_16_47_4	3	0.5	4.99E-04	GNB1, GNAQ, GNG4	extrinsic to internal side of plasma membrane [CC], cellular response to glucagon stimulus [BP], heterotrimeric G-protein complex [CC], protein ADP-ribosylation [BP]
CG_h9laurent_promoter_n_RM_12_362_7	2	0.25	2.33E-04	MSI1, MGEA5	positive regulation of protein complex disassembly [BP], polysome [CC]
CG_h9laurent_promoter_n_RM_12_110_11	2	0.25	3.16E-04	GPR143, TFAP2A, MUC1, PASK, AP3D1, ADI1	eye pigment biosynthetic process [BP], negative regulation of transcription by competitive promoter binding [BP], Golgi apparatus [CC]
CG_h9laurent_promoter_n_RM_12_79_27	3	0.5	3.71E-04	RBP4, IRS2, SMAD2, DOC2B	positive regulation of insulin secretion [BP], insulin secretion [BP]
CG_h9laurent_promoter_n_RM_12_563_8	3	0.5	2.80E-04	USP2, CUL3, SAR1B	COPII vesicle coating [BP], cyclin binding [MF]
CG_h9laurent_promoter_n_RM_14_202_7	2	0.25	3.28E-04	KIF17	protein complex localization [BP]
CG_h9laurent_promoter_n_RM_12_54_13	2	0.5	2.25E-04	LMO2, SOX18	mRNA transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_16_32_5	3	0.5	3.88E-04	HEY1, CRAT	anterior/posterior axis specification [BP], carnitine O-acetyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_12_347_18	3	0.75	2.36E-04	CCNL2, CDKN2A, PTK2, ELAVL1, CDKN2B	cyclin-dependent protein kinase inhibitor activity [MF], protein kinase binding [MF], positive regulation of smooth muscle cell migration [BP]
CG_h9laurent_promoter_n_RM_14_199_18	4	0.5	4.15E-04	RGPD8, RGPD1, DCXR	NADP metabolic process [BP], protein targeting to Golgi [BP]
CG_h9laurent_promoter_n_RM_12_43_44	3	0.75	2.93E-04	ANXA2, STAT5B	body fluid secretion [BP], taurine metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_548_18	2	0.25	2.81E-04	SPTBN2, CDK5, MYO1C	adult behavior [BP], positive regulation of protein targeting to membrane [BP]
CG_h9laurent_promoter_n_RM_12_220_13	4	0.75	2.25E-04	FOXA2, PHOX2B, PITX3	cell differentiation in hindbrain [BP], dopaminergic neuron differentiation [BP]
CG_h9laurent_promoter_n_RM_12_209_11	3	0.5	3.42E-04	ADRA2B, INSR	activation of protein kinase B activity [BP]
CG_h9laurent_promoter_n_RM_12_569_14	3	0.5	2.19E-04	MAD1L1, CHD8, BARX1, FBXO5, LEF1, TOP3B, MKI67	condensed chromosome [CC], armadillo repeat domain binding [MF], mitotic metaphase [BP], nuclear chromosome [CC]
CG_h9laurent_promoter_n_RM_12_202_11	6	0.75	3.39E-04	FOXP1, HDAC4, ZCCHC14, TCEB2, KCTD8, GTF2A1, NKX2-2, MNX1, GNG12, RGS7, JAKMIP1, PRKAR1B, FLNA, KCTD12, IRF1, RGS11, LITAF, EZR, GNG4, WDFY3, CTBP1, HES4, KCTD1	regulation of G-protein coupled receptor protein signaling pathway [BP], extrinsic to membrane [CC], transcription factor binding [MF], ventral spinal cord development [BP], heterotrimeric G-protein complex [CC], cellular response to glucagon stimulus [BP], cell communication [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_338_10	3	0.25	4.36E-04	PARD3, BCL11B, KIF16B	epithelial cell morphogenesis [BP], phosphatidylinositol-3-phosphate binding [MF], phosphatidylinositol-3,4,5-trisphosphate binding [MF]
CG_h9laurent_promoter_n_RM_12_417_9	3	0.5	2.45E-04	STMN1, SOS2, TBC1D2B, PLXNA2, EZR, SPTBN2, RRAS, RAPH1, CADPS2, PITPNA, SEMA6C, FEZF1, ARHGEF11	axonogenesis [BP], axon guidance [BP], phospholipid binding [MF]
CG_h9laurent_promoter_n_RM_12_341_10	3	0.5	3.11E-04	HOXB2	neural nucleus development [BP]
CG_h9laurent_promoter_n_RM_16_31_11	2	0.25	4.72E-04	SOS1, MKI67, PABPC1, IRS1, AKT1, FLNA, CTBP1, MGEA5, CITED1, NFIB	positive regulation of glycogen biosynthetic process [BP], spongiotrophoblast layer development [BP], phospholipid binding [MF], positive regulation of glucose import [BP], protein kinase C binding [MF], protein C-terminus binding [MF], RNA polymerase II transcription corepressor activity [MF]
CG_h9laurent_promoter_n_RM_12_391_18	3	0.5	2.26E-04	MLXIPL, SIX2, SALL1, RELN, OXCT1, ANAPC2, TADA3, WNT7B, IRF1	mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], positive regulation of synapse maturation [BP], positive regulation of cellular metabolic process [BP], protein phosphorylation [BP], metanephros morphogenesis [BP], cellular response to glucose stimulus [BP], regulation of protein phosphorylation [BP]
CG_h9laurent_promoter_n_RM_12_78_25	3	0.5	3.65E-04	RORC	T-helper 17 cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_429_21	3	0.5	1.18E-04	NSMCE4A, NDNL2, HUS1	response to DNA damage stimulus [BP], Smc5-Smc6 complex [CC], DNA repair [BP]
CG_h9laurent_promoter_n_RM_12_49_22	2	0.25	3.66E-04	EFNB2, FOXP1, SIAH1, BID, SORT1, BAD, ABCB10, CCDC90A, BBC3, BCAP31	elevation of mitochondrial calcium ion concentration [BP], integral to mitochondrial membrane [CC], apoptotic signaling pathway [BP], positive regulation of release of cytochrome c from mitochondria [BP], positive regulation of cardiac muscle cell differentiation [BP], reduction of endoplasmic reticulum calcium ion concentration [BP], positive regulation of protein homooligomerization [BP], positive regulation of intrinsic apoptotic signaling pathway [BP], regulation of mitochondrial membrane permeability [BP]
CG_h9laurent_promoter_n_RM_14_54_10	2	0.25	3.44E-04	NCOA6, HDAC4, AXIN1, PREX1, AKT1, CFL1, ANAPC2, FNBP1	neural fold formation [BP], cell cortex [CC], enzyme binding [MF], labyrinthine layer blood vessel development [BP], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_345_17	5	0.75	2.16E-04	HOXA5	cell-cell signaling involved in mammary gland development [BP]
CG_h9laurent_promoter_n_RM_12_152_10	2	0.25	2.67E-04	ARHGEF9, VAV2, GNB1, GDI2, DLC1, RHOF, RALGAPA2, IQGAP3, ARHGEF11	regulation of small GTPase mediated signal transduction [BP], Ras protein signal transduction [BP], GTPase activator activity [MF]
CG_h9laurent_promoter_n_RM_12_299_19	5	0.75	3.46E-04	RHOA, LARP4B, UCN	positive regulation of translation [BP]
CG_h9laurent_promoter_n_RM_12_128_16	3	0.5	3.20E-04	ELAVL3, LDB1	neuron differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_16_24_5	1	0.25	4.56E-04	GNG12, RGS11, GNG4	heterotrimeric G-protein complex [CC]
CG_h9laurent_promoter_n_RM_12_405_22	3	0.5	1.17E-04	ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_h9laurent_promoter_n_RM_14_292_14	3	0.5	3.26E-04	USP22	SAGA-type complex [CC]
CG_h9laurent_promoter_n_RM_12_249_12	4	0.5	2.75E-04	SEMA6A, PLXNA2	centrosome localization [BP]
CG_h9laurent_promoter_n_RM_12_112_10	3	0.5	3.23E-04	FOXS1, FGF8, HOXA3	blood vessel remodeling [BP], organ formation [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_12_382_17	3	0.25	2.74E-04	FLNA, SMARCD3, ACTG1, PKM, GLI3	extracellular vesicular exosome [CC], positive regulation of neuroblast proliferation [BP]
CG_h9laurent_promoter_n_RM_12_284_13	4	0.5	3.14E-04	PAK1, NOTCH1	branching morphogenesis of an epithelial tube [BP]
CG_h9laurent_promoter_n_RM_12_380_23	2	0.25	3.25E-04	DGKQ, HIPK2, PREX1, HMGB2, PCID2, TIA1, MYO18A, CTGF, BRAF, ARHGDIA, FLT4, KRAS, ARRB1	protein kinase C signaling cascade [BP], positive regulation of ERK1 and ERK2 cascade [BP], apoptotic process [BP], positive regulation of JNK cascade [BP], negative regulation of apoptotic process [BP], positive regulation of MAPK cascade [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_14_347_6	2	0.25	2.23E-04	ALYREF, ELL, HMGN1	positive regulation of DNA-dependent transcription, elongation [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_12_13	3	0.5	2.43E-04	INTS1	U2 snRNA 3'-end processing [BP]
CG_h9laurent_promoter_n_RM_14_185_6	2	0.25	2.56E-04	HR, TONSL, CSDA, FBXW4, FGFR1, ELAVL1	3'-UTR-mediated mRNA stabilization [BP], mRNA stabilization [BP], positive regulation of mesenchymal cell proliferation [BP], transcription corepressor activity [MF], positive regulation of cytoplasmic translation [BP]
CG_h9laurent_promoter_n_RM_12_581_17	4	0.5	3.79E-04	HUWE1, TRAPPC2P1, CUL3, SPRY2	ER to Golgi vesicle-mediated transport [BP], protein monoubiquitination [BP], negative regulation of Ras protein signal transduction [BP]
CG_h9laurent_promoter_n_RM_14_213_10	3	0.5	3.80E-04	CCNL2, NCOA6, NR3C1, BHLHE23, TCF15, FOXL2, FOXN4, ZNF503, PITX1, PRDM14	transcription, DNA-dependent [BP], organ development [BP], anatomical structure morphogenesis [BP], estrogen receptor binding [MF], transcription factor complex [CC]
CG_h9laurent_promoter_n_RM_16_26_3	1	0.25	1.59E-04	TOLLIP, TDP2	nuclear body [CC], interleukin-18 receptor complex [CC], tyrosyl-RNA phosphodiesterase activity [MF], 5'-tyrosyl-DNA phosphodiesterase activity [MF]
CG_h9laurent_promoter_n_RM_14_147_7	2	0.25	4.68E-04	CDC42BPA, EPB41L4B	actomyosin structure organization [BP]
CG_h9laurent_promoter_n_RM_12_225_14	2	0.25	2.55E-04	NRARP, VCP, AKT1, CSNK1E, LEF1, EFNA5	regulation of cell-cell adhesion [BP], tongue development [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_600_4	4	0.5	2.75E-04	HOXA11, HOXA9	proximal/distal pattern formation [BP]
CG_h9laurent_promoter_n_RM_14_86_33	5	0.5	4.12E-04	RYK, CKB, FBXO11, SBF1, NKX2-8, SMAD9, CDYL2, LHX5, SIX4, BHLHE41, ZCCHC14, CIAPIN1, CBFA2T3, IRF2BP2, ESRP2, CUL7, CUL3, EXT1, ZNF367, EVX2, REV3L, CHFR, SETD3, CENPT, NKX6-2, BRD1, BRD3, REXO1, STRBP, PCGF6, HCN1, MBTD1, AKT2, PID1, YBX2, NUP88, ZNF217, SLBP, ADNP, ELAVL2, RRP9, GLIS1, PHF21A, KLLN, SSU72, PHLDA1, SAP130, DHX37, SRSF4, GTF2E2, MAML3, PDE4DIP, CSRNP1, ZIC5, ZNF768, PKM, ALYREF, ASIC2, PAX3, HOXB5, FGF3, THOC7, IRF2, RPS6KA3, PSMD12, TRIM9, TOX3, NFE2L2, ZNF503, LIN54, LCORL, HDAC5, HDAC4, FILIP1L, CLOCK, SRXN1, ZFHX3, TAF11, SHROOM4, ATXN7L3, NCOR2, IKZF2, TNPO2, WDR26, MLF2, HOXA10, ETF1, RANBP9, CITED4, ASH1L, ZBED5, MECP2, CELSR1, TCEA1, BARX1, BCOR, HEY1, APBA1, SOS2, PKD1, HOXA6, CDK5, SMEK2, GATAD2B, ZNF18, PATL1, PREP, GTF2A1, MAD2L2, KCTD1, JHDM1D, ANKH, FIZ1, WASL, CPSF7, ODC1, PDZD7, LPIN2, CGGBP1, UBQLN1, MLLT3, GLI3, DGKI, NCKAP1, ZNF644, NR3C2, ZBTB7A, ZC3H7A, TXNL1, TRIP12, RAB3A, TTBK2, MEX3D, AGTPBP1, SOX21, NOTCH3, SCRIB, ZBTB45, ZBTB46, BCL6, C17orf70	central nervous system development [BP], apical protein localization [BP], gene expression [BP], asymmetric protein localization [BP], nucleic acid binding [MF], RNA metabolic process [BP], negative regulation of myotube differentiation [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], nucleoplasm [CC], regulation of gene expression [BP], zeta DNA polymerase complex [CC], nucleus [CC], anatomical structure morphogenesis [BP], skeletal system development [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], synaptic vesicle exocytosis [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_414_21	3	0.5	2.63E-04	AXIN2, SH3RF1, HOXB3, VGF, SP3, SIX2, DGKG, SLC23A1, SDC1, WNT9A, FGF8, DUSP1, DGKI, SFRP2	Wnt receptor signaling pathway involved in somitogenesis [BP], canonical Wnt receptor signaling pathway [BP], negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP], diacylglycerol kinase activity [MF], lung development [BP], cartilage development [BP], endoderm development [BP], chondrocyte differentiation [BP], anterior/posterior pattern specification [BP], embryonic skeletal system development [BP], gastrulation [BP], chondrocyte development [BP], embryo development [BP], response to cAMP [BP], mesodermal cell fate specification [BP]
CG_h9laurent_promoter_n_RM_12_603_32	4	0.75	3.30E-04	SLC4A11, SLC23A1	sodium ion transmembrane transport [BP]
CG_h9laurent_promoter_n_RM_12_434_19	2	0.25	3.32E-04	ATP5E, ATP5A1	mitochondrial ATP synthesis coupled proton transport [BP], proton-transporting ATP synthase complex, catalytic core F(1) [CC], mitochondrial proton-transporting ATP synthase complex [CC], proton-transporting ATP synthase activity, rotational mechanism [MF], proton-transporting ATPase activity, rotational mechanism [MF]
CG_h9laurent_promoter_n_RM_12_25_13	2	0.25	3.41E-04	DLL1, LBX1, FOXS1, TBX20, SLC27A5	embryonic heart tube morphogenesis [BP], embryonic heart tube development [BP], heart looping [BP], plasma membrane long-chain fatty acid transport [BP]
CG_h9laurent_promoter_n_RM_12_397_12	2	0.25	3.56E-04	ATXN2	neuromuscular process [BP]
CG_h9laurent_promoter_n_RM_12_490_15	3	0.75	3.27E-04	AQP4, FZD5, NCBP2, WIBG, TFAP2A, HYAL2, CLOCK, APBB2, BCL11B, POLDIP3, RUNX1, BCOR, MED16, FOXI3, HES4, CPSF1, RBL1, TGFB1	transcription factor binding [MF], hematopoietic progenitor cell differentiation [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF], odontogenesis [BP], exon-exon junction complex [CC], core promoter proximal region sequence-specific DNA binding [MF], post-embryonic camera-type eye development [BP], renal water absorption [BP], keratinocyte development [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_445_11	3	0.5	2.61E-04	TNK2	regulation of clathrin-mediated endocytosis [BP]
CG_h9laurent_promoter_n_RM_14_111_2	1	0.25	3.29E-04	FASN	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF]
CG_h9laurent_promoter_n_RM_12_528_19	4	0.75	3.37E-04	ZBTB14, MLXIPL, LITAF, AFF3, HOXB7, NAMPT, PRDM4, ZNF496, DDX6, RARS2, TOX3, GTF2A1, TLR5, HNRNPH1, ZNF503, MAPK9, ATXN7L3, TGFBRAP1, RAX, ZNF652, TLR9	positive regulation of fatty acid biosynthetic process [BP], positive regulation of lipid biosynthetic process [BP], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], toll-like receptor signaling pathway [BP], positive regulation of nitric-oxide synthase biosynthetic process [BP], gene expression [BP], RNA metabolic process [BP], positive regulation of toll-like receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_282_26	4	0.75	4.05E-04	ONECUT1, ZFHX3, MEIS2, CASK, MED16, JAG2, CITED1, SOD2, CALY, DNMT3L, DENND1A, ICMT, NFIB, STX2, PDE2A, TCF15, MAOB, RUNX1, GNA13, WNT11, WNT7B, MED20	negative regulation of mesenchymal cell proliferation [BP], response to selenium ion [BP], dopamine receptor binding [MF], oxygen homeostasis [BP], metanephros morphogenesis [BP], organ morphogenesis [BP], liver development [BP], presynaptic membrane [CC], in utero embryonic development [BP], epithelial cell development [BP], establishment of endothelial barrier [BP], lung-associated mesenchyme development [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_145_12	3	0.5	3.07E-04	CTSL2	Sertoli cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_242_12	3	0.5	2.91E-04	KIF27, MYH10	cerebellar Purkinje cell layer development [BP], ventricular system development [BP]
CG_h9laurent_promoter_n_RM_12_29_16	2	0.25	3.40E-04	HLCS, LBX1, AKT1	biotin-protein ligase activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], glycogen cell differentiation involved in embryonic placenta development [BP], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], histone biotinylation [BP]
CG_h9laurent_promoter_n_RM_12_16_7	2	0.5	2.98E-04	FGF4, SCRIB	apoptotic process involved in morphogenesis [BP]
CG_h9laurent_promoter_n_RM_16_28_5	2	0.5	3.99E-04	HMGCS1	organic acid binding [MF], response to tellurium ion [BP], response to low light intensity stimulus [BP]
CG_h9laurent_promoter_n_RM_14_264_6	1	0.25	1.63E-04	SIAH1, TCF3, NOTCH1, TTC21B, APBB1, TLN1, RANBP9, SALL1, BBC3, CREBBP, DPYSL3, MYH10	protein complex [CC], axonogenesis [BP], cell development [BP], cellular response to hypoxia [BP], growth cone [CC], axon guidance [BP], positive regulation of intrinsic apoptotic signaling pathway [BP], chromatin binding [MF], nuclear chromatin [CC], smoothened signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_52_10	2	0.25	2.46E-04	P4HB, TXN2	glycerol ether metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_596_12	3	0.25	2.32E-04	PEMT	phosphatidylethanolamine N-methyltransferase activity [MF], phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF], phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_12_365_14	3	0.5	4.93E-04	NLRP10, PRKCQ	positive regulation of T-helper 17 type immune response [BP]
CG_h9laurent_promoter_n_RM_20_11_2	1	0.25	2.37E-04	STX1A	myosin head/neck binding [MF], synaptic vesicle docking involved in exocytosis [BP], synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [CC], synaptobrevin 2-SNAP-25-syntaxin-1a complex [CC], positive regulation of neurotransmitter secretion [BP]
CG_h9laurent_promoter_n_RM_14_166_9	2	0.25	4.56E-04	FLT4, SALL1, CREBBP, GAS1	cellular response to vascular endothelial growth factor stimulus [BP], outer ear morphogenesis [BP], regulation of smoothened signaling pathway [BP], negative regulation of smoothened signaling pathway [BP], embryonic digit morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_101_18	2	0.25	3.46E-04	ACTG1, UBC, NKX2-5	endosomal transport [BP], sarcomere organization [BP]
CG_h9laurent_promoter_n_RM_12_367_9	3	0.5	3.45E-04	GFPT1, MYO1C, PLXNA2, MCM3	cerebellar granule cell precursor tangential migration [BP], helicase activity [MF], glucosamine biosynthetic process [BP], positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_218_17	4	0.75	2.46E-04	DLG4, KIF5B, NRXN1, CLIP3, APRT, CIB1, CHRNA3, KCNE1	positive regulation of potassium ion transport [BP], grooming behavior [BP], regulation of excitatory postsynaptic membrane potential [BP], membrane depolarization [BP], vocalization behavior [BP], protein localization to synapse [BP], positive regulation of establishment of protein localization to plasma membrane [BP], regulation of N-methyl-D-aspartate selective glutamate receptor activity [BP], positive regulation of excitatory postsynaptic membrane potential [BP], regulation of grooming behavior [BP], receptor localization to synapse [BP]
CG_h9laurent_promoter_n_RM_14_287_10	5	0.5	4.71E-04	TNK2, ARFGAP3, ACAP3, FAM189B	WW domain binding [MF], regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF]
CG_h9laurent_promoter_n_RM_14_379_20	3	0.5	4.23E-04	RYK, NCBP2, EPHA7, ENAH, ZNF598, MSC, TCF15, TWIST1, ZIC5, FASN, RELN, TBX18, CITED2, POU3F1, ASCL2, ALYREF, HSF2BP, FOXL2, PTPRS, FGFR2, LRP2, TRPS1, LRP6, LRP8, IRS2, NADKD1, SCRIB, FZD8, EXD3, GAS1, NADK	NAD+ kinase activity [MF], intracellular [CC], skeletal system morphogenesis [BP], neural tube closure [BP], reelin-mediated signaling pathway [BP], positive regulation of cellular metabolic process [BP], embryonic eye morphogenesis [BP], positive regulation of mesenchymal cell proliferation [BP], brain development [BP], morphogenesis of embryonic epithelium [BP], forebrain development [BP], central nervous system development [BP], bone morphogenesis [BP], NADP biosynthetic process [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], cerebellum development [BP]
CG_h9laurent_promoter_n_RM_12_264_15	2	0.25	3.26E-04	IRF1, TCF3, DVL2, RIPK3, HAND2, CBX8, CREBBP, TAF7	protein acetylation [BP], transcription coactivator activity [MF], histone acetylation [BP], transcription regulatory region DNA binding [MF], E-box binding [MF], nuclear chromatin [CC], bHLH transcription factor binding [MF], positive regulation of sequence-specific DNA binding transcription factor activity [BP]
CG_h9laurent_promoter_n_RM_12_421_20	3	0.5	3.95E-04	KAT6A, LEF1, BRD1, TAF12	MOZ/MORF histone acetyltransferase complex [CC], transcription factor binding [MF], histone H3 acetylation [BP], histone acetylation [BP]
CG_h9laurent_promoter_n_RM_14_244_21	4	0.5	3.71E-04	RRM2B, PTPN5, GRB2	phosphotyrosine binding [MF], deoxyribonucleoside diphosphate metabolic process [BP], deoxyribonucleotide biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_592_8	2	0.25	3.20E-04	DLG4, ATXN2	negative regulation of receptor internalization [BP]
CG_h9laurent_promoter_n_RM_12_286_13	3	0.5	4.18E-04	CSPG4, CSPG5, GXYLT1	lysosomal lumen [CC], chondroitin sulfate catabolic process [BP], dermatan sulfate biosynthetic process [BP], chondroitin sulfate metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_384_11	4	0.25	2.81E-04	PPAT	amidophosphoribosyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_16_48_6	3	0.5	3.99E-04	BMP4, NT5C2, SLC37A4, YBX2, GCNT4	BMP signaling pathway involved in renal system segmentation [BP], bud dilation involved in lung branching [BP], ureter epithelial cell differentiation [BP], specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP], negative regulation of glomerulus development [BP], inter-male aggressive behavior [BP], negative regulation of mesenchymal cell proliferation involved in ureter development [BP], negative regulation of metanephric comma-shaped body morphogenesis [BP], negative regulation of cell proliferation involved in heart morphogenesis [BP], negative regulation of metanephric S-shaped body morphogenesis [BP], pulmonary artery endothelial tube morphogenesis [BP], BMP signaling pathway involved in nephric duct formation [BP], glucose-6-phosphate transmembrane transporter activity [MF], negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP], nucleoside phosphotransferase activity [MF], intermediate mesodermal cell differentiation [BP], BMP signaling pathway involved in ureter morphogenesis [BP], translational attenuation [BP], positive regulation of cardiac muscle fiber development [BP]
CG_h9laurent_promoter_n_RM_14_175_10	3	0.5	3.00E-04	EEA1, RB1CC1, SREBF1, RAPGEF5, ULK2	pre-autophagosomal structure membrane [CC], cellular response to starvation [BP], GTP-dependent protein binding [MF], recycling endosome [CC], response to starvation [BP]
CG_h9laurent_promoter_n_RM_16_20_4	7	0.5	4.65E-04	PXN, TOLLIP, HID1	interleukin-18 receptor complex [CC], BH4 domain binding [MF], response to brefeldin A [BP], extrinsic to Golgi membrane [CC]
CG_h9laurent_promoter_n_RM_18_22_10	2	0.25	2.76E-04	FBXO43, RGS11, SMAD7, RGS19, GNG4, LAMA5	heterotrimeric G-protein complex [CC], meiosis [BP], morphogenesis of embryonic epithelium [BP], adherens junction assembly [BP]
CG_h9laurent_promoter_n_RM_12_45_17	3	0.5	3.36E-04	SIAH2, EFNA5, WNT4, MAPK9, SHPRH, CUL7	regulation of cell-cell adhesion [BP], protein ubiquitination [BP], regulation of protein ubiquitination [BP]
CG_h9laurent_promoter_n_RM_12_156_12	3	0.25	2.09E-04	DEK, ADAM17, AADAT, RPS29, DICER1	viral genome replication [BP], viral infectious cycle [BP], spleen development [BP], 2-aminoadipate transaminase activity [MF]
CG_h9laurent_promoter_n_RM_12_130_10	3	0.5	3.11E-04	TGFB1, ETV3, ZBTB17, STRN3, ATXN7L3, TWIST1, NKX6-2, NRIP1, ZFAND5, NR2C1, TP53INP1, NKX3-2, UBE2V1, FGFR2, DVL1, MAD2L2	skeletal system morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], negative regulation of transcription from RNA polymerase II promoter [BP], cranial suture morphogenesis [BP], negative regulation of skeletal muscle tissue development [BP], positive regulation of transcription regulatory region DNA binding [BP], regulation of striated muscle tissue development [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_14_38_6	1	0.25	5.23E-04	TCF3, TFAP2A, TSHZ3, DRD1, TERF2, NKX2-2, BMP4	lens induction in camera-type eye [BP], ureter smooth muscle cell differentiation [BP], regulation of smooth muscle cell differentiation [BP], peristalsis [BP], positive regulation of neuron differentiation [BP], positive regulation of muscle cell differentiation [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP], chromatin binding [MF], type B pancreatic cell development [BP]
CG_h9laurent_promoter_n_RM_12_272_22	1	0.25	2.65E-04	SALL1, ZC3H3	regulation of mRNA export from nucleus [BP], inductive cell-cell signaling [BP]
CG_h9laurent_promoter_n_RM_12_4_15	2	0.25	3.87E-04	SRCIN1, HYAL2	negative regulation of protein tyrosine kinase activity [BP]
CG_h9laurent_promoter_n_RM_14_245_27	6	1.0	2.73E-04	ACSL1, MYO1C, NOTCH1, STRA13, MYO9A, FANCC, WNT5A, PNPLA8, SP8	Fanconi anaemia nuclear complex [CC], unconventional myosin complex [CC], cardiac right atrium morphogenesis [BP], linoleic acid metabolic process [BP], pericardium morphogenesis [BP], embryonic limb morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_369_9	5	0.75	2.51E-04	ETHE1	sulfur dioxygenase activity [MF]
CG_h9laurent_promoter_n_RM_12_498_17	2	0.5	1.60E-04	HOXA2, DVL2	segment specification [BP]
CG_h9laurent_promoter_n_RM_12_223_16	3	0.25	3.29E-04	CSPG5, GNPTAB, MPPED2, NRIP1, SMAD2, STAT5B, SCRIB, AKT1, FGF8, IL15RA, HMGB1, NUMBL, FZD5	glucocorticoid receptor binding [MF], positive regulation of natural killer cell differentiation [BP], lung development [BP], neuron differentiation [BP], lung morphogenesis [BP], establishment of apical/basal cell polarity [BP], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_281_10	4	0.75	2.83E-04	CLOCK, SSX2IP, RAD1, USP28, FOXP3	DNA damage checkpoint [BP], protein complex [CC]
CG_h9laurent_promoter_n_RM_12_310_13	4	0.5	3.46E-04	SMAD7, NACC2	cellular protein complex localization [BP]
CG_h9laurent_promoter_n_RM_12_410_15	2	0.5	2.40E-04	JOSD1	omega peptidase activity [MF]
CG_h9laurent_promoter_n_RM_12_381_8	4	0.25	2.96E-04	NIN	centrosome-templated microtubule nucleation [BP]
CG_h9laurent_promoter_n_RM_14_184_7	2	0.25	3.56E-04	KLHL21, RFWD3, UBE2N, SCRIB, ATP1A3, CBX8, SYNJ1, BCL2, RNF130	ubiquitin-protein ligase activity [MF], response to radiation [BP], asymmetric protein localization [BP], myelin sheath [CC], synaptic vesicle endocytosis [BP]
CG_h9laurent_promoter_n_RM_12_177_11	3	0.5	3.83E-04	STRA13, TONSL	replication fork processing [BP]
CG_h9laurent_promoter_n_RM_12_428_21	3	0.5	3.49E-04	CNR1, AKT2, HDAC5, CDK5, CPT1A	regulation of fatty acid oxidation [BP], response to cocaine [BP], positive regulation of fatty acid beta-oxidation [BP], positive regulation of protein targeting to membrane [BP]
CG_h9laurent_promoter_n_RM_14_371_18	3	0.25	3.61E-04	PRKAA1, IMPAD1, CDK5, SALL1, LMBR1, ITPK1	catalytic activity [MF], embryo development [BP], embryonic digit morphogenesis [BP], tau-protein kinase activity [MF]
CG_h9laurent_promoter_n_RM_14_92_19	3	0.5	2.76E-04	DIAPH1, EEA1, ACSL1, BAD, CDC42BPB, FLNA, CTBP1, SHANK1, EPB41L3	Rho GTPase binding [MF], cytoskeletal anchoring at plasma membrane [BP], negative regulation of histone acetylation [BP], response to oleic acid [BP], early endosome to late endosome transport [BP]
CG_h9laurent_promoter_n_RM_14_278_13	3	0.5	2.73E-04	CLIP1, CERS5, CERS2, SPTSSA	sphingolipid biosynthetic process [BP], sphingosine N-acyltransferase activity [MF], tubulin binding [MF]
CG_h9laurent_promoter_n_RM_14_62_8	2	0.25	4.03E-04	UCN, KAT6A, CCDC90A	calcium ion import [BP], neuron projection development [BP], histone acetylation [BP]
CG_h9laurent_promoter_n_RM_14_145_6	2	0.25	2.35E-04	PDGFA, NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_h9laurent_promoter_n_RM_14_23_11	5	0.5	3.39E-04	HEY1, AKT1	labyrinthine layer blood vessel development [BP]
CG_h9laurent_promoter_n_RM_12_524_15	3	0.5	2.22E-04	PDE10A, HCN4, RAPGEF3	cAMP binding [MF]
CG_h9laurent_promoter_n_RM_12_309_24	3	0.5	3.08E-04	WDR35, GLI3, RPS2, CYS1, RBM28, MPHOSPH6	cilium [CC], RNA binding [MF], microtubule basal body [CC]
CG_h9laurent_promoter_n_RM_14_141_4	2	0.25	3.13E-04	MEX3D, PTCH1, FAM168B, FBXL5	mRNA localization resulting in posttranscriptional regulation of gene expression [BP], perinuclear region of cytoplasm [CC]
CG_h9laurent_promoter_n_RM_12_213_19	2	0.25	3.97E-04	RELN, SHANK1, E2F8, WNT7B	synapse maturation [BP], synapse organization [BP], protein localization to synapse [BP], placenta development [BP], positive regulation of dendritic spine development [BP], positive regulation of excitatory postsynaptic membrane potential [BP], anatomical structure regression [BP]
CG_h9laurent_promoter_n_RM_12_107_14	3	0.25	3.33E-04	HOXA5, SMEK1, SMEK2, LRP6	positive regulation of gluconeogenesis [BP], protein phosphatase 4 complex [CC], trachea cartilage morphogenesis [BP]
CG_h9laurent_promoter_n_RM_14_25_16	2	0.5	3.84E-04	SPG20, FITM2	lipid particle organization [BP]
CG_h9laurent_promoter_n_RM_12_251_11	2	0.25	3.09E-04	CBX4, CBX7	PRC1 complex [CC], PcG protein complex [CC]
CG_h9laurent_promoter_n_RM_12_98_7	2	0.25	3.09E-04	SMAD7, VCP	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_16_64_15	4	0.25	4.92E-04	CBX1, PAX3, JHDM1D, AHCTF1, TLE3, RORC, HNRPLL, SOX15, MLL3, CBFA2T3, CBX4, MNX1, NCOR1, XPO1, HOXA7, KLF10, SMG1, HECTD4, UBTD2, U2AF1, THOC7, AFF3, BHLHE23, WHSC1L1, ADAP1, CSNK1D, CSNK1E, RELN, ELL2, HNRNPD, POU3F1, WDR4, PRKRIR, LSM4, CAMK2B, POLR2E, HDGFRP3, EBF3, ZNF827, SATB1, YIF1A, DACH1, SSBP3, MEX3B, MEX3C, MEMO1, KIAA2022, STRBP, PTCH1, BARHL2, PPP1CA, SUGP2, LRP8, RFX7, ACSL6, CLIP1, PIAS2, PURB, GRB2, ADARB2, PPP3CA, ZNF503, BCL6, MORC2	reelin-mediated signaling pathway [BP], nucleic acid binding [MF], CD4-positive, alpha-beta T cell differentiation [BP], intracellular membrane-bounded organelle [CC], regulation of dendritic spine development [BP], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], regulation of skeletal muscle adaptation [BP], positive regulation of neuron projection development [BP], positive regulation of dendritic spine morphogenesis [BP], nucleoplasm [CC], gene expression [BP], RNA metabolic process [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_12_48_23	2	0.5	1.76E-04	CSDA, AKR7A3	positive regulation of cytoplasmic translation [BP], aflatoxin catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_447_13	3	0.5	2.83E-04	LAMA5, CRLF1, SMAD7, WNT4, CXCR4, SHH, PDGFB	ureteric bud development [BP], myelin maintenance [BP], renal system development [BP], immature T cell proliferation in thymus [BP], branching involved in salivary gland morphogenesis [BP], positive regulation of oligodendrocyte differentiation [BP], blood vessel morphogenesis [BP], branching involved in ureteric bud morphogenesis [BP], epithelial cell proliferation involved in salivary gland morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_363_15	3	0.5	2.60E-04	ARSB, GUSB, GPC4	lysosomal lumen [CC], glycosaminoglycan catabolic process [BP]
CG_h9laurent_promoter_n_RM_18_3_9	5	0.25	4.33E-04	HECTD4, AHCTF1, GNPTAB, SYMPK, EPB41L4B, BHLHE23, UFD1L, CLSTN1, SMG5, SMG1, DEAF1, CSNK1E, MYCBP2, LARP6, STK39, TONSL, BOLL, YIF1A, THOC7, BRD1, KRAS, PNCK, BARHL2, RFX7, ACSL6, GRB2, FRA10AC1, TAF5L, ST3GAL2, GLIS1, MLL3, RAD1, MNX1, CHD1, PIAS2, MAML3, SOX10, AFF3, SOX15, TOP2B, HOXA5, STK40, KIAA0368, ZNF827, PAX3, CNTFR, RPS6KA6, RPAP1, MOK, AURKAIP1, ASCC2, ZNF503, CREBBP, UBA3, TLE3, ONECUT1, CBLN1, THSD7A, SIK1, FZD8, HOXA10, AKAP8L, MAPK1, FOSL1, CITED2, CADM1, SIAH1, RXRG, SATB1, TAPT1, TAOK3, ZNF521, APBA1, SFRP5, LMO2, EIF2AK2, ADARB2, GJC1, HOXA7, STAT5B, SRP68, SMEK1, CDK5, CDK6, HIVEP3, MORC2, MAP4K3, MAP4K5, USP4, ADAM10, EZH2, HAND2, CEBPA, HDGFRP3, KLF14, CALCOCO1, MLLT1, AHDC1, TTLL11, GNA13, PDGFA, POU3F1, ZBTB4, ABR, EBF1, MLF1IP, DACH1, SSBP3, MEX3B, BAI2, PTPRS, OAZ2, NOTCH2, E2F8, PPP1R13B, ACTL6B, PPP3CA, PTCH1, DEDD2, ELL2, ZNF652, RYK	negative regulation of erythrocyte differentiation [BP], peripheral nervous system development [BP], protein serine/threonine kinase activity [MF], brain development [BP], liver development [BP], multicellular organismal development [BP], nervous system development [BP], intracellular membrane-bounded organelle [CC], transcription coactivator activity [MF], regulation of transcription, DNA-dependent [BP], cell development [BP], sequence-specific DNA binding transcription factor activity [MF], in utero embryonic development [BP], nucleus [CC], RNA metabolic process [BP], cell differentiation [BP], reflex [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], negative regulation of myeloid cell differentiation [BP], extrinsic to membrane [CC], central nervous system development [BP], corpus callosum development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], regulation of erythrocyte differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP], embryonic limb morphogenesis [BP], DNA binding [MF], RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription [MF], suckling behavior [BP], cellular protein modification process [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], regulation of gene expression [BP], embryo development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_14_332_14	3	0.5	3.32E-04	IGF2, SLTM, MED20, AFF4, AFF3, MKL1, NFYB, LDB1, GTF2A1, MBD3, TCEB2, MYBL1, POLR2L, KAT6A, CBX4, ZNF503, SMARCC2	transcription, DNA-dependent [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_n_RM_12_80_31	4	0.75	2.94E-04	DHCR24	plasminogen activation [BP]
CG_h9laurent_promoter_n_RM_14_285_15	5	0.5	3.25E-04	SERTAD2, SMARCC1, JHDM1D, CREB3L2, PYCR1, MAPK9, ELF4, SERTAD1	cellular nitrogen compound metabolic process [BP], positive regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_n_RM_14_340_13	3	0.5	3.21E-04	DGAT1	transferase activity, transferring acyl groups [MF]
CG_h9laurent_promoter_n_RM_12_207_10	2	0.25	2.76E-04	BAG1, TLE1, EIF2B3, SH3BP5, AKT2, ATR, DBN1, ICOSLG, PGF, MECOM, VOPP1, CBLN1, JAG2, ILDR2, SHB, PAX6, SALL1, PRKAR1B, ADA, LEF1, FGFR2, VAV2, ANGPTL6, LDB1, CASKIN1, OTP, EFNB2	neurogenesis [BP], angiogenesis [BP], anatomical structure morphogenesis [BP], cellular response to stimulus [BP], cell differentiation [BP], forebrain neuroblast division [BP], cell surface receptor signaling pathway [BP], embryonic digestive tract development [BP], lacrimal gland development [BP], neural precursor cell proliferation [BP], cell-cell signaling [BP], signal transduction [BP], negative regulation of apoptotic process in bone marrow [BP], multicellular organismal development [BP], forebrain neuron differentiation [BP], positive regulation of cell proliferation in bone marrow [BP], pituitary gland development [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_14_68_8	4	0.5	3.68E-04	COMMD7, FAF1	NF-kappaB binding [MF]
CG_h9laurent_promoter_n_RM_16_46_8	7	0.5	3.77E-04	POLR3K, PDE6D, POLR2E	transcription elongation from RNA polymerase III promoter [BP], termination of RNA polymerase III transcription [BP], regulation of GTP catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_555_12	1	0.25	2.78E-04	NR3C1, HSPG2, PDGFRB	mammary gland duct morphogenesis [BP], glycosaminoglycan biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_10_23	2	0.25	3.35E-04	NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_425_13	4	0.75	3.07E-04	TJP1	cell-cell signaling involved in cell-cell junction organization [BP]
CG_h9laurent_promoter_n_RM_12_227_16	4	0.5	3.63E-04	TLE1, SMAD7, TEAD3, PITX1, HES6, MLXIPL	transcription factor complex [CC]
CG_h9laurent_promoter_n_RM_16_40_2	5	0.5	4.02E-04	KCNQ2, HMGB1, DRD2, BAZ1A, SEPT12, HCN1	ACF complex [CC], sperm annulus [CC], potassium ion transport [BP], negative regulation of apoptotic cell clearance [BP], regulation of potassium ion transport [BP]
CG_h9laurent_promoter_n_RM_14_112_12	1	0.25	2.22E-04	CASK, TFAP2A	regulation of neuron differentiation [BP], negative regulation of cellular response to growth factor stimulus [BP]
CG_h9laurent_promoter_n_RM_14_174_14	3	0.5	2.52E-04	STAT5B, BAD, ADA, JAG2, BRF1, FGFR2, ERRFI1	positive regulation of B cell differentiation [BP], lung alveolus development [BP], positive regulation of T cell differentiation [BP], Peyer's patch development [BP], regulation of mRNA stability [BP], gamma-delta T cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_306_20	3	0.75	3.06E-04	DVL2	cell migration in hindbrain [BP]
CG_h9laurent_promoter_n_RM_14_171_9	3	0.5	3.93E-04	COL2A1, CTNND2, CDK6, CDK5, MAPK9	central nervous system development [BP], cyclin-dependent protein kinase activity [MF], cyclin-dependent protein kinase holoenzyme complex [CC], regulation of synaptic plasticity [BP]
CG_h9laurent_promoter_n_RM_12_289_6	3	0.5	3.45E-04	FLT4, PDGFA	regulation of smooth muscle cell migration [BP], growth factor binding [MF]
CG_h9laurent_promoter_n_RM_18_13_5	2	0.25	4.07E-04	ASH1L, SOS2, KLLN, PHF21A, STRBP, TAF11, GTF2A1, PAX3, MAFA, LCORL, SMAD9, IRF2	DNA binding [MF], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_16_44_11	7	0.5	4.92E-04	CFL1, APBA3, VAV2, CAMSAP1, IRS1, AKT1, CDC42BPB, ARHGAP4, FLNA, PYGO1, FOXP1	cytoskeleton organization [BP], positive regulation of glycogen biosynthetic process [BP], neural fold formation [BP], positive regulation of phosphatidylinositol 3-kinase activity [BP], platelet activation [BP], intracellular signal transduction [BP], protein kinase C binding [MF], nerve growth factor receptor signaling pathway [BP], embryo development [BP], protein localization to nucleus [BP]
CG_h9laurent_promoter_n_RM_14_252_8	2	0.25	3.66E-04	DLG5, HDAC4, EIF2AK1	negative regulation of cell proliferation [BP]
CG_h9laurent_promoter_n_RM_14_250_4	3	0.25	3.21E-04	HOXA13	branching involved in prostate gland morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_250_33	4	0.5	2.98E-04	MECP2, TONSL, STAT5B, FOXO1, PURB, JAG2, JAG1, RAB14, FGFR1, WNT7B, GATM	loop of Henle development [BP], regulation of cell differentiation [BP], neuron differentiation [BP], auditory receptor cell differentiation [BP], gamma-delta T cell differentiation [BP], lung-associated mesenchyme development [BP], embryo development [BP], DNA replication factor A complex [CC], creatine metabolic process [BP]
CG_h9laurent_promoter_n_RM_18_15_4	1	0.25	3.26E-04	HDAC4	response to denervation involved in regulation of muscle adaptation [BP]
CG_h9laurent_promoter_n_RM_12_99_25	3	0.5	2.88E-04	BMP4, AXIN2, SMAD7, FOXS1, OVOL2, MNX1, TGFBR3	negative regulation of epithelial to mesenchymal transition [BP], epithelial to mesenchymal transition [BP], pathway-restricted SMAD protein phosphorylation [BP], SMAD binding [MF], negative regulation of transcription by competitive promoter binding [BP], activin binding [MF], heart morphogenesis [BP], ventricular cardiac muscle tissue morphogenesis [BP], artery morphogenesis [BP], dorsal/ventral neural tube patterning [BP], dorsal/ventral pattern formation [BP], heart trabecula formation [BP], I-SMAD binding [MF]
CG_h9laurent_promoter_n_RM_12_419_10	2	0.25	3.73E-04	OTOP1	detection of gravity [BP]
CG_h9laurent_promoter_n_RM_14_106_3	2	0.25	2.77E-04	ZNF425, NACC2, FOXN3, FGFR2, AGO2, EXOSC10	endoribonuclease activity, cleaving siRNA-paired mRNA [MF], fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], negative regulation of transcription, DNA-dependent [BP], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP], nuclear retention of unspliced pre-mRNA at the site of transcription [BP], coronal suture morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_479_28	3	0.75	3.70E-04	DICER1, HDAC4, FEZF2, BCL11B, NPPC	negative regulation of cell proliferation [BP], post-embryonic development [BP]
CG_h9laurent_promoter_n_RM_12_214_15	2	0.25	2.47E-04	HOXB1, PRKAR1B, MAFB	rhombomere 5 development [BP], learning or memory [BP]
CG_h9laurent_promoter_n_RM_14_66_6	2	0.25	3.83E-04	RAP1GAP, RGS19, RELN, MDGA1, APBB1	GTP catabolic process [BP], positive regulation of GTPase activity [BP], neuron migration [BP], regulation of Ras GTPase activity [BP]
CG_h9laurent_promoter_n_RM_14_186_23	2	0.5	4.03E-04	EHD4, SGK1, ZDHHC9, ERMP1, CYP26B1, EDEM3, IQSEC1, MESDC2	endoplasmic reticulum [CC], endoplasmic reticulum membrane [CC], intracellular membrane-bounded organelle [CC]
CG_h9laurent_promoter_n_RM_18_9_2	2	0.25	1.28E-04	IDH3B	isocitrate dehydrogenase (NAD+) activity [MF]
CG_h9laurent_promoter_n_RM_14_44_4	1	0.25	2.80E-04	EGR2	rhombomere 3 formation [BP], rhombomere 5 formation [BP]
CG_h9laurent_promoter_n_RM_12_350_7	2	0.5	2.12E-04	TBX20, HEY1, HMGB2	pulmonary valve morphogenesis [BP], response to steroid hormone stimulus [BP], endocardial cushion formation [BP], endocardial cushion morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_190_40	6	0.75	3.27E-04	PRDM14, RPS6KA3, DLG4, STAT5B, EGR2, GPRIN1, LPHN1, TNK2, GRIN2B, GLI3, CDK5, SLIT1, OPRK1, GABRB2, PTCH1, ADCY10, DENND1A, WNT7B, JAK3	response to interleukin-2 [BP], synaptic transmission [BP], negative regulation of smoothened signaling pathway [BP], synaptic vesicle endocytosis [BP], growth cone [CC], cell morphogenesis [BP], motor neuron axon guidance [BP]
CG_h9laurent_promoter_n_RM_12_105_13	3	0.75	3.52E-04	SOD2	detection of oxygen [BP]
CG_h9laurent_promoter_n_RM_12_543_4	2	0.25	2.69E-04	LEF1, FOXP1, SLC27A5	cholate-CoA ligase activity [MF], DNA binding, bending [MF]
CG_h9laurent_promoter_n_RM_18_11_1	1	0.25	4.12E-04	NOTCH1, PXN, FLNA	cell migration involved in endocardial cushion formation [BP], mesenchymal cell development [BP], mitral valve formation [BP], cell junction assembly [BP], Myb complex [CC], Fc-gamma receptor I complex binding [MF], vasculogenesis involved in coronary vascular morphogenesis [BP], arterial endothelial cell differentiation [BP], cardiac right atrium morphogenesis [BP], coronary vein morphogenesis [BP], negative regulation of pro-B cell differentiation [BP], positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP], branching morphogenesis of an epithelial tube [BP], atrioventricular node development [BP], epithelial to mesenchymal transition [BP], BH4 domain binding [MF], MAML1-RBP-Jkappa- ICN1 complex [CC], regulation of extracellular matrix assembly [BP], venous endothelial cell differentiation [BP], growth involved in heart morphogenesis [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], regulation of somitogenesis [BP], cardiac vascular smooth muscle cell development [BP]
CG_h9laurent_promoter_n_RM_12_324_7	3	0.5	1.49E-04	DTYMK	nucleoside monophosphate phosphorylation [BP], nucleoside phosphate kinase activity [MF]
CG_h9laurent_promoter_n_RM_12_175_9	2	0.25	3.34E-04	SOCS1, GSK3A, CACNA2D2, KY, RELA, SNTA1	negative regulation of insulin receptor signaling pathway [BP], neuromuscular junction development [BP]
CG_h9laurent_promoter_n_RM_20_2_38	2	0.25	4.33E-04	SNX5, ONECUT1, PHF21A, EZH2, IMPAD1, HAND2, CBX4, CEBPA, SOX10, CALCOCO1, AFF3, MLLT1, FOSL1, MYCBP2, CDK5, PDGFA, SIAH1, ZBTB4, EPB41L4B, RXRG, BOLL, ABR, EBF3, TAPT1, DACH1, PTPRS, SHANK1, ICMT, ZNF521, APBA1, GNAQ, RPS6KA6, SFRP5, LMO2, RFX7, NOTCH2, GJC1, FZD8, CDK6, GNA13, ACTL6B, ASCC2, ZNF503, PTCH1, CREBBP, RYK	embryonic limb morphogenesis [BP], extrinsic to internal side of plasma membrane [CC], limb morphogenesis [BP], embryonic digit morphogenesis [BP], dendritic spine morphogenesis [BP], transcription regulatory region DNA binding [MF], peripheral nervous system development [BP], extrinsic to membrane [CC], suckling behavior [BP], regulation of transcription, DNA-dependent [BP], hippocampus development [BP], brain development [BP], central nervous system development [BP], corpus callosum development [BP], in utero embryonic development [BP], cell development [BP], Wnt-activated receptor activity [MF], regulation of gene expression [BP], multicellular organismal development [BP], embryo development [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_199_11	2	0.25	4.40E-04	FLT3, IRS1, PLXNB1, GDPD5, GPLD1	phosphatidylinositol-mediated signaling [BP], phosphatidylinositol 3-kinase binding [MF], GPI anchor release [BP], lipid metabolic process [BP], positive regulation of phosphatidylinositol 3-kinase activity [BP], phosphatidylinositol 3-kinase cascade [BP], positive regulation of phosphatidylinositol 3-kinase cascade [BP], glycosylphosphatidylinositol phospholipase D activity [MF], positive regulation of glucose metabolic process [BP], regulation of cellular response to insulin stimulus [BP], cellular response to triglyceride [BP]
CG_h9laurent_promoter_n_RM_14_309_11	4	0.5	2.55E-04	EEA1, SCRIB	serine-pyruvate aminotransferase complex [CC], synaptic vesicle endocytosis [BP]
CG_h9laurent_promoter_n_RM_12_154_16	3	0.5	3.15E-04	ANKLE2, STRN, SIN3A, CTBP1	negative regulation of histone acetylation [BP], RNA polymerase II transcription corepressor activity [MF], protein phosphatase 2A binding [MF]
CG_h9laurent_promoter_n_RM_12_68_10	4	0.75	3.28E-04	BMP4, RAP1GAP, MYH9, SBF2, GIPC1, CTBP1, CRH, DSCAML1, FGFR1, PDGFA	epithelial-mesenchymal cell signaling [BP], protein homodimerization activity [MF], lung development [BP]
CG_h9laurent_promoter_n_RM_12_453_9	2	0.25	2.74E-04	NCBP2	positive regulation of RNA export from nucleus [BP], snRNA export from nucleus [BP]
CG_h9laurent_promoter_n_RM_12_427_18	3	0.5	3.18E-04	DTYMK, UBE2G2, AMFR, KIAA0368, CMPK2	ER-associated protein catabolic process [BP], thymidylate kinase activity [MF], dTDP biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_290_23	4	0.75	4.20E-04	UBP1, SESTD1, PTPN21, SNX13, PHF12, SOX10, PPP2CB, STAT5B, COL4A3BP, DEK, DUSP8, DUSP4, SH3PXD2B, PPP3CA, EZH2, PHLDA3, PTPRT, CHD1	protein dephosphorylation [BP], phosphatidylinositol-3,5-bisphosphate binding [MF], negative regulation of epidermal cell differentiation [BP], phosphatidylinositol binding [MF], phosphatidylinositol-3-phosphate binding [MF], phosphatidylinositol-5-phosphate binding [MF], phosphatidylinositol-4-phosphate binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_14_48_3	2	0.25	1.88E-04	SLC7A10	D-alanine transport [BP]
CG_h9laurent_promoter_n_RM_12_443_20	3	0.5	3.05E-04	HCN1, ATP1A3, NAPA, BCL2, SCRIB	apical protein localization [BP], response to radiation [BP], asymmetric protein localization [BP], myelin sheath [CC]
CG_h9laurent_promoter_n_RM_12_318_16	3	0.5	4.45E-04	SNAP91, BRD7, CLINT1, TNIP2	positive regulation of B cell activation [BP], clathrin binding [MF], negative regulation of G1/S transition of mitotic cell cycle [BP]
CG_h9laurent_promoter_n_RM_14_314_20	3	0.5	3.03E-04	KCNMA1, NOTCH1, NPC2, DLL1	left/right axis specification [BP], neuronal stem cell maintenance [BP], intracellular sterol transport [BP], intracellular cholesterol transport [BP], compartment pattern specification [BP], auditory receptor cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_183_16	4	0.75	3.26E-04	CDX2, APBA3, SMAD7, SPRY2, DGKI, PDE6G, CDC42BPB, NACC2, CORO2A, SMARCC2	transcriptional repressor complex [CC], intracellular signal transduction [BP], negative regulation of catalytic activity [BP], enzyme inhibitor activity [MF], protein serine/threonine kinase inhibitor activity [MF], negative regulation of peptidyl-threonine phosphorylation [BP], cellular protein complex localization [BP]
CG_h9laurent_promoter_n_RM_12_483_21	3	0.5	3.47E-04	SMAD7, MAMSTR, LRRC26, CTNND2, CBX8, NKX2-2, NCOA2, NHLRC1, KLF10, NR2F6, HOXA10, ARHGDIA, JAG1, NECAB3, CDAN1, C17orf62, GIPC1, HEY1, NFIB, TARBP1, RUNX1, WDFY3, CIZ1, ERRFI1	protein binding [MF], cardiac ventricle morphogenesis [BP], cardiac septum morphogenesis [BP], negative regulation of transcription from RNA polymerase II promoter [BP], extrinsic to membrane [CC], aorta morphogenesis [BP], pulmonary valve morphogenesis [BP], artery morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], positive regulation of myeloid cell differentiation [BP], Notch signaling involved in heart development [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_102_10	3	0.5	3.13E-04	GPR143, AP3D1	eye pigment biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_406_33	4	0.75	3.84E-04	CSPG5, TFAP2A, SDC1, SMAD2, DVL2, ROCK2, RNASET2, NCKAP1, GNS	embryonic body morphogenesis [BP], lysosomal lumen [CC], embryonic foregut morphogenesis [BP], neural tube closure [BP], paraxial mesoderm morphogenesis [BP]
CG_h9laurent_promoter_n_RM_18_5_3	5	0.25	5.03E-04	TRPS1, TWIST1, AFF3, BHLHE23, RORA, NAMPT, TCF15, FGFR2, POU3F1	positive regulation of transcription, DNA-dependent [BP], regulation of transcription, DNA-dependent [BP], cranial suture morphogenesis [BP], transcription, DNA-dependent [BP], positive regulation of transcription from RNA polymerase II promoter [BP], embryonic hindlimb morphogenesis [BP], skeletal system development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_65_25	4	1.0	3.38E-04	EGR2, FBXO2, SLIT1, SHH, FLNA, FOXP1	telencephalon regionalization [BP], motor neuron axon guidance [BP], glycoprotein binding [MF]
CG_h9laurent_promoter_n_RM_12_236_10	4	0.75	3.44E-04	HDAC7, SMAD7, SAV1, ADAM10, TBX3, ADAM17, DBN1, CBX4, SAP130, RERE, MAP3K9, NCOA6, THRB, CBFA2T3, HOXA10, JAG2, DAPK3, DIAPH1, ZNF41, ZNF367, THAP7, SCRIB, ZBTB46, PBRM1, TLR9, FRYL	negative regulation of interleukin-8 production [BP], positive regulation of T cell chemotaxis [BP], profilin binding [MF], regulation of cell motility [BP], Notch signaling pathway [BP], transcription, DNA-dependent [BP], PMA-inducible membrane protein ectodomain proteolysis [BP], chromatin binding [MF], mammary gland duct morphogenesis [BP], ventricular septum morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_536_27	3	0.5	3.56E-04	PDGFB, LAMA5, BRD1, WNT4, MEAF6	MOZ/MORF histone acetyltransferase complex [CC], branching involved in salivary gland morphogenesis [BP], female gonad development [BP]
CG_h9laurent_promoter_n_RM_14_143_12	2	0.25	3.52E-04	GSK3B, ARC	regulation of cell morphogenesis [BP], regulation of neuronal synaptic plasticity [BP]
CG_h9laurent_promoter_n_RM_12_540_18	3	0.5	1.69E-04	B4GALT6, ACVR1	UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [MF], endocardial cushion cell fate commitment [BP], activin receptor complex [CC]
CG_h9laurent_promoter_n_RM_12_30_13	1	0.25	4.00E-04	CDKN2A, C2CD5, CASK, IGF2	insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade [BP], negative regulation of cell-matrix adhesion [BP]
CG_h9laurent_promoter_n_RM_12_303_6	4	0.75	2.81E-04	OIP5, GTF3C2, NOC2L, WDR12, TEAD2, ATXN3, CD2BP2	nucleoplasm [CC], nucleosome binding [MF]
CG_h9laurent_promoter_n_RM_14_124_9	2	0.25	3.92E-04	C2CD5, GPR179	protein localization to plasma membrane [BP]
CG_h9laurent_promoter_n_RM_12_32_16	3	0.5	2.17E-04	CXCL12, CD24, IL2RA	regulation of actin polymerization or depolymerization [BP], positive regulation of activated T cell proliferation [BP]
CG_h9laurent_promoter_n_RM_12_115_21	3	0.75	3.33E-04	SNTA1, BNC1, SLC9A1, NT5C, CASK, MESP1, POLR2L, MYO10, EDF1	regulation of transcription from RNA polymerase I promoter [BP], calmodulin binding [MF], nucleotidase activity [MF], endothelial cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_456_15	2	0.25	3.34E-04	ABR, DUSP16, SALL1, PYCARD	MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], positive regulation of antigen processing and presentation of peptide antigen via MHC class II [BP], MAPK export from nucleus [BP], inductive cell-cell signaling [BP], positive regulation of phagocytosis [BP]
CG_h9laurent_promoter_n_RM_12_506_19	3	0.75	3.06E-04	AMOTL2, CERS2, DLG4, LRP4, CERS1, FZD8, GSK3A, DEGS2, DVL2, CERS5, CAPRIN2, GDNF, SGMS1, CNTFR, PLXND1, SPTSSA, RELN, TAX1BP3	receptor localization to synapse [BP], Wnt receptor signaling pathway [BP], sphingosine N-acyltransferase activity [MF], extrinsic to membrane [CC], postsynaptic membrane organization [BP], ceramide biosynthetic process [BP], positive regulation of dendritic spine morphogenesis [BP], sphingolipid biosynthetic process [BP], negative regulation of Wnt receptor signaling pathway [BP], canonical Wnt receptor signaling pathway [BP], synapse assembly [BP]
CG_h9laurent_promoter_n_RM_14_237_4	3	0.25	2.78E-04	CTBP1, CRLF1, BNIP3, DCXR	L-xylulose reductase (NADP+) activity [MF], negative regulation of membrane potential [BP], negative regulation of motor neuron apoptotic process [BP], regulation of transcription by chromatin organization [BP], cellular response to cobalt ion [BP]
CG_h9laurent_promoter_n_RM_12_85_11	2	0.25	3.30E-04	OMA1, LONP1	misfolded or incompletely synthesized protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_18_18_1	1	0.25	1.53E-04	DAPK2	autophagic vacuole lumen [CC]
CG_h9laurent_promoter_n_RM_12_320_21	3	0.5	4.20E-04	FOXN4, RAPH1, PLXNA2, KDELR2, SMAD7, AKAP8, NOTCH1, DLL1, TBX20, NKX3-2, FKBP1A, JAG2, WNT5A, KDELR1, DLC1, FOXI3, PJA2	cardiac septum morphogenesis [BP], auditory receptor cell fate commitment [BP], protein kinase A regulatory subunit binding [MF], compartment pattern specification [BP], axon extension [BP], ventricular septum morphogenesis [BP], cardiac atrium morphogenesis [BP], pattern specification process [BP], embryonic heart tube morphogenesis [BP], cardiac ventricle morphogenesis [BP], aortic valve morphogenesis [BP], Notch receptor processing [BP], pericardium morphogenesis [BP], somitogenesis [BP], type I transforming growth factor beta receptor binding [MF], cardiac muscle tissue morphogenesis [BP], heart morphogenesis [BP], cardiac right atrium morphogenesis [BP], cardiac septum development [BP], KDEL sequence binding [MF], determination of left/right symmetry [BP], heart looping [BP], positive regulation of meiosis [BP]
CG_h9laurent_promoter_n_RM_12_418_8	2	0.25	2.72E-04	TAX1BP3	Rho protein signal transduction [BP]
CG_h9laurent_promoter_n_RM_12_8_23	4	0.75	3.13E-04	PLXNB1, KCNMA1, ANKS1B, CHRNA2, CTNNBIP1, NETO1, GABBR1, SRCIN1, SEMA3C	negative regulation of mesenchymal cell proliferation [BP], semaphorin receptor binding [MF], postsynaptic membrane [CC]
CG_h9laurent_promoter_n_RM_14_231_6	2	0.25	2.14E-04	RAP1GAP, EEA1	vesicle fusion [BP], Ras GTPase binding [MF]
CG_h9laurent_promoter_n_RM_12_231_8	2	0.25	2.89E-04	NAMPT	nicotinamide metabolic process [BP], nicotinamide phosphoribosyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_12_329_6	2	0.5	2.40E-04	SULF2, GFRA1	glial cell-derived neurotrophic factor receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_85_9	2	0.25	2.28E-04	SMURF2, ZFHX3, CSNK1D, ANKLE2, FBXO31, CBX8, CUL3, CDK5, TGFB1	cyclin binding [MF], ubiquitin-dependent protein catabolic process [BP], protein ubiquitination [BP], receptor catabolic process [BP], mitotic cell cycle G1/S transition checkpoint [BP], proteasomal ubiquitin-dependent protein catabolic process [BP], tau-protein kinase activity [MF], cyclin catabolic process [BP], positive regulation of protein dephosphorylation [BP], negative regulation of myoblast differentiation [BP], ubiquitin ligase complex [CC]
CG_h9laurent_promoter_n_RM_12_203_10	2	0.25	2.43E-04	NHEJ1, LIG4	double-strand break repair via nonhomologous end joining [BP], nonhomologous end joining complex [CC]
CG_h9laurent_promoter_n_RM_14_40_7	2	0.25	2.21E-04	SIN3A	DNA replication [BP]
CG_h9laurent_promoter_n_RM_14_89_20	7	0.75	4.70E-04	HECTD4, AHCTF1, AFF3, HNRPLL, SFMBT1, SBF2, SPG20, THOC7, ZNF706, WHSC1L1, ARHGAP21, CSNK1E, RELN, FBXL14, TONSL, BOLL, CAMK2B, KLHL3, RNF19B, H2AFV, INPP5K, FGF12, C17orf62, RUNX1, CHTF8, KPNA1, SNX3, KLLN, SNX4, RAB6A, SSU72, CRK, MNX1, NCKAP1, XPO1, HOXA7, RFX7, AMER2, MEIS3, CHMP2A, CBX1, ZNF281, LNX2, FOXS1, POLR2E, ICMT, ELOVL2, GAS1, ZNF428, VPS54, ONECUT1, RORA, CBX4, NCOR1, ZNF746, FZD8, ADAP1, TBX18, VGLL3, DHCR24, SUGP2, TMEM30A, AMFR, PARD3, ELL2, MEMO1, KIAA2022, ZNF521, MAPK9, LYST, HN1, SREBF1, CDK5, TADA1, MAP4K3, MAP4K5, JHDM1D, HMGB1, EZH1, LATS1, KLF10, RAP1GAP, KLF14, NAP1L4, MLLT1, RPS19BP1, CLIP1, DGKI, TTLL11, PXN, TOX3, N4BP1, POU3F1, CD47, HDGFRP3, EBF3, SSBP2, MEX3C, FAM53A, BCL6, PURB, ACBD5, MBD2, PPP3CA, PTCH1, UBE2Q1	protein binding [MF], intracellular [CC], negative regulation of transcription, DNA-dependent [BP], nucleus [CC], enzyme binding [MF], intracellular membrane-bounded organelle [CC], regulation of signal transduction [BP], cellular protein modification process [BP], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], regulation of skeletal muscle adaptation [BP], dorsal/ventral neural tube patterning [BP], negative regulation of gene expression [BP], protein localization [BP], positive regulation of dendritic spine morphogenesis [BP], regulation of dendritic spine morphogenesis [BP]
CG_h9laurent_promoter_n_RM_14_35_5	2	0.25	3.75E-04	MYO1C, ACTG1, PODXL	microvillus membrane [CC], filamentous actin [CC]
CG_h9laurent_promoter_n_RM_14_294_13	2	0.25	3.61E-04	GNAQ, DLG4, CNR1	behavior [BP], learning [BP]
CG_h9laurent_promoter_n_RM_12_465_4	1	0.25	1.84E-04	ST3GAL5	neolactotetraosylceramide alpha-2,3-sialyltransferase activity [MF], lactosylceramide alpha-2,3-sialyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_18_16_4	1	0.25	5.13E-04	MEX3D	mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_14_194_11	2	0.5	3.50E-04	PAK1, SNAP91, STX10, HIP1, RAB14, FERMT2	Golgi vesicle transport [BP], clathrin binding [MF], clathrin coat assembly [BP], filamentous actin [CC], vesicle-mediated transport [BP]
CG_h9laurent_promoter_n_RM_12_495_11	4	0.75	2.61E-04	SFRP1, SATB1, FOXN3, STAT5B, HOOK2, ZNF148, MYO1E, KLF4, GSK3B, FEV, DLL1, CDON, LHX3, STRA13, CDK6, JAG2, FLNA, HEYL, PAFAH1B3, WNT7B, AES	regulation of cell adhesion [BP], epithelial to mesenchymal transition [BP], negative regulation of myeloid cell differentiation [BP], organ morphogenesis [BP], brain development [BP], early endosome to late endosome transport [BP], generation of neurons [BP], neuron differentiation [BP], forebrain regionalization [BP], anterior/posterior pattern specification [BP], post-embryonic hemopoiesis [BP], proximal tubule development [BP], positive regulation of cell-matrix adhesion [BP], axis specification [BP], double-stranded DNA binding [MF]
CG_h9laurent_promoter_n_RM_12_452_11	1	0.25	3.97E-04	SOX10	extrinsic to mitochondrial outer membrane [CC]
CG_h9laurent_promoter_n_RM_14_317_17	2	0.25	3.87E-04	LOXL2, E2F8, PGF	sprouting angiogenesis [BP]
CG_h9laurent_promoter_n_RM_12_538_20	2	0.25	3.63E-04	KLF10, TRAF6, ZBTB14, LMO1, NR2F6, TFCP2L1, CDC37, ABCA2, TBX20, TEAD3, RYBP, CBX4, SOX7, FOXN3, MAD2L2	negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transcription, DNA-dependent [BP], positive regulation of osteoclast differentiation [BP], protein kinase B binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_14_57_7	2	0.25	3.98E-04	JAG2	respiratory system process [BP]
CG_h9laurent_promoter_n_RM_12_56_13	2	0.25	2.31E-04	RRP8, CASK, TIGD7, CBX4, CDK2AP1, ANKRD11, SCRIB, LPHN1, YPEL1, SIX2, PHC2, ELMSAN1, FAM53A, TOP2A, C2CD2, PSMA5, ZNF367, CRMP1, EBF3, TRIM47, AKR1B1, BRD1, FGFR1, UBE2N, ARX, FAM107A, ZNF91, AGO2, RYK	presynaptic membrane [CC], PcG protein complex [CC], intracellular membrane-bounded organelle [CC], PRC1 complex [CC], nucleus [CC]
CG_h9laurent_promoter_n_RM_12_392_8	2	0.25	2.73E-04	ABCF2, ABCA2	ATP-binding cassette (ABC) transporter complex [CC]
CG_h9laurent_promoter_n_RM_14_277_9	2	0.5	3.44E-04	AKT1, BID, PTCH1, CYTH3, IGF2	mammary gland epithelial cell differentiation [BP], establishment of protein localization to membrane [BP], positive regulation of glycogen biosynthetic process [BP], phosphatidylinositol-3,4,5-trisphosphate binding [MF]
CG_h9laurent_promoter_n_RM_14_42_4	2	0.25	4.09E-04	GAS1	anchored to plasma membrane [CC]
CG_h9laurent_promoter_n_RM_12_193_10	1	0.25	2.65E-04	CELSR1, MDGA1, SATB2	neuron migration [BP]
CG_h9laurent_promoter_n_RM_14_59_6	2	0.25	2.63E-04	ZIC5, PCGF6, ZNF573, DEK, KAT6A, WDHD1, PRDM15	DNA binding [MF]
CG_h9laurent_promoter_n_RM_12_551_22	2	0.25	3.36E-04	PAWR, CBX4, KDM5B, HR	transcription corepressor activity [MF]
CG_h9laurent_promoter_n_RM_12_411_23	3	0.5	2.74E-04	ICMT, HEG1	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], lymph circulation [BP]
CG_h9laurent_promoter_n_RM_14_122_4	1	0.25	4.57E-04	TLN1, ACTG1, ANXA2, TOP2A, ARPP19	extracellular vesicular exosome [CC], G2/M transition of mitotic cell cycle [BP], viral integration complex [CC], DNA topoisomerase complex (ATP-hydrolyzing) [CC], positive regulation of retroviral genome replication [BP]
CG_h9laurent_promoter_n_RM_12_455_24	3	0.5	3.10E-04	SHPK, TFEB, ENG, NRARP, SPRY2, LEF1, TTPA, GBX2	embryonic placenta development [BP], cellular response to interleukin-4 [BP], patterning of blood vessels [BP], branching morphogenesis of an epithelial tube [BP]
CG_h9laurent_promoter_n_RM_12_92_11	2	0.25	2.27E-04	NAMPT, NADK	NAD metabolic process [BP]
CG_h9laurent_promoter_n_RM_14_210_9	3	0.5	2.83E-04	FOXP1, EFNB2	positive regulation of cardiac muscle cell differentiation [BP]
CG_h9laurent_promoter_n_RM_20_10_2	1	0.25	1.83E-04	NMRK1, MYO5A	ribosylnicotinamide kinase activity [MF], secretory granule localization [BP], regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP], endoplasmic reticulum localization [BP]
CG_h9laurent_promoter_n_RM_12_195_14	3	0.5	2.98E-04	ARSD, ALK, PRKAA1, BAD, CXCR4, DBN1, RB1CC1, DAPK3, PLXNB2	cellular protein metabolic process [BP], protein phosphorylation [BP], phosphorylation [BP], neural precursor cell proliferation [BP], pore complex assembly [BP], regulation of autophagy [BP], regulation of protein phosphorylation [BP]
CG_h9laurent_promoter_n_RM_12_95_7	1	0.25	3.12E-04	TBX20, SEMA3C, OSR1, TFAP2A	cardiac right ventricle morphogenesis [BP], embryonic forelimb morphogenesis [BP], positive regulation of bone mineralization [BP], RNA polymerase II transcription coactivator activity [MF], outflow tract morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_90_11	2	0.25	2.11E-04	PYY, DRD2, C1QTNF2, CNTFR	feeding behavior [BP], receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_415_17	1	0.25	3.30E-04	PYCRL, TWIST1, SMAD7, EPHA7, OAT, HEY1, PDGFA	L-proline biosynthetic process [BP], endocardial cushion morphogenesis [BP], cardiac epithelial to mesenchymal transition [BP], endocardial cushion to mesenchymal transition involved in heart valve formation [BP], negative chemotaxis [BP], cellular protein complex localization [BP]
CG_h9laurent_promoter_n_RM_12_196_9	3	0.75	3.92E-04	PAX6, TOP2B, TOP2A, CEBPA	DNA topoisomerase type II (ATP-hydrolyzing) activity [MF], DNA topological change [BP], resolution of meiotic recombination intermediates [BP], HMG box domain binding [MF], mitotic cell cycle G2/M transition decatenation checkpoint [BP]
CG_h9laurent_promoter_n_RM_12_451_8	2	0.25	3.65E-04	SMAD7, FGFBP3, MBD2, UCN, LEF1, CDH2, CALCOCO1	gamma-catenin binding [MF], catenin complex [CC], beta-catenin binding [MF], armadillo repeat domain binding [MF], positive regulation of vascular permeability [BP], C2H2 zinc finger domain binding [MF]
CG_h9laurent_promoter_n_RM_14_362_11	3	0.5	3.06E-04	PIP4K2A, FZD5, WNT9A, PIP5K1C	neuron differentiation [BP], 1-phosphatidylinositol-4-phosphate 5-kinase activity [MF]
CG_h9laurent_promoter_n_RM_12_504_10	2	0.5	2.70E-04	PDGFA, BAD, DENND6A, FOXA1	positive regulation of cell-cell adhesion mediated by cadherin [BP], response to estradiol stimulus [BP]
CG_h9laurent_promoter_n_RM_12_232_19	3	0.5	3.13E-04	ERI3, PIK3C2B, MAP3K14, RAD1, IQSEC1, PRUNE2, GNB1	intracellular [CC], intracellular membrane-bounded organelle [CC]
CG_h9laurent_promoter_n_RM_12_143_24	2	0.25	3.05E-04	TOX3, FGR, MAPK1	phosphotyrosine binding [MF], phosphoprotein binding [MF]
CG_h9laurent_promoter_n_RM_14_300_12	6	0.5	2.86E-04	CITED2, SIN3A, SIX1, TCEB2, GAS1	cranial nerve morphogenesis [BP], RNA polymerase II transcription corepressor activity [MF], middle ear morphogenesis [BP], regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP]
CG_h9laurent_promoter_n_RM_14_165_2	2	0.25	4.19E-04	PRDX3, AKR7A3	alkyl hydroperoxide reductase activity [MF], aflatoxin catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_63_19	3	0.5	2.18E-04	SEMA5A, EPHA7	axon guidance receptor activity [MF]
CG_h9laurent_promoter_n_RM_14_310_6	1	0.25	2.11E-04	CDON, CELF4, ACTL6B, DPF3	chromatin organization [BP], positive regulation of small GTPase mediated signal transduction [BP], nBAF complex [CC], chromatin modification [BP], mRNA splice site selection [BP]
CG_h9laurent_promoter_n_RM_14_336_3	1	0.25	9.55E-05	SLC30A3, SLC40A1	zinc transporting ATPase activity [MF], spleen trabecula formation [BP]
CG_h9laurent_promoter_n_RM_16_73_14	5	0.5	4.69E-04	SATB1, RORC, RAB6A, ADAM10, LIFR, HAND2, EID2B, MNX1, NCOR1, HOXA7, THSD7A, KLF14, TWIST1, CALCOCO1, AFF3, SOX15, WHSC1L1, FOSL1, NCKAP1, ELL2, PDGFA, POU3F1, RXRG, SIAH1, ZBTB4, SP3, BOLL, ZNF827, PAX3, TAPT1, CNTFR, PBX4, BICD2, MLL3, BCL6, APBA1, SIX5, HIRA, SFRP5, E2F8, SCRIB, SIX4, GNA13, MBD2, ASCC2, PTCH1, CREBBP, FOXP3	cardiac neural crest cell development involved in outflow tract morphogenesis [BP], nuclear chromatin [CC], chromatin binding [MF], cardiac neural crest cell migration involved in outflow tract morphogenesis [BP], multicellular organismal development [BP], ciliary neurotrophic factor receptor activity [MF], embryonic skeletal system development [BP], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], in utero embryonic development [BP], CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [BP], cell differentiation [BP], reflex [BP], anatomical structure morphogenesis [BP], CD4-positive, alpha-beta T cell differentiation [BP], minus-end-directed organelle transport along microtubule [BP], negative regulation of isotype switching to IgE isotypes [BP], vasculature development [BP], regulation of transcription from RNA polymerase II promoter [BP], regulation of protein localization [BP], neural tube closure [BP], sequence-specific DNA binding [MF], regulation of gene expression [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], ciliary neurotrophic factor-mediated signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_334_11	2	0.25	3.83E-04	WNT11, HEY1, PTCH1	cardiac septum morphogenesis [BP], artery morphogenesis [BP], osteoblast differentiation [BP], heart morphogenesis [BP], atrioventricular valve formation [BP], axis specification [BP], ventricular septum morphogenesis [BP]
CG_h9laurent_promoter_n_RM_14_321_15	4	0.5	3.09E-04	RELN, DVL2	positive regulation of protein tyrosine kinase activity [BP]
CG_h9laurent_promoter_n_RM_14_120_7	3	0.5	3.22E-04	PGM3	glucosamine metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_93_30	4	0.75	2.92E-04	LBX1, ZNF3, HR, SMAD7, HOXA13, SIX1, ZFHX3, OTX2, BARX1, CBFA2T3, SCML2, ZNF132, GBX1, PCGF2, YWHAG, ZNF70	transcription regulatory region DNA binding [MF], regulation of neuron differentiation [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_n_RM_12_9_22	3	0.25	2.92E-04	EPB41L3, CDKN2A, IFT20, HDAC4, AXIN1, CSPG5, BNIP3, USP7, GPR179, AKT1, GDNF, CFL1, ANAPC2, PKM, HES6, MOAP1, PCDH8	myelin maintenance [BP], neural fold formation [BP], positive regulation of protein sumoylation [BP], potassium ion binding [MF], dendrite [CC], apoptotic nuclear changes [BP], neuron projection morphogenesis [BP], dendrite terminus [CC], p53 binding [MF], cell projection organization [BP], nervous system development [BP], neuron projection development [BP]
CG_h9laurent_promoter_n_RM_14_30_9	3	0.75	3.87E-04	UBE2D3, SMAD2, DEK, TPR, NCOR2, SMURF1	R-SMAD binding [MF], transforming growth factor beta receptor signaling pathway [BP], cellular response to heat [BP], I-SMAD binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_464_16	2	0.5	2.09E-04	GJA5, DBN1	gap junction [CC], cell communication by electrical coupling [BP]
CG_h9laurent_promoter_n_RM_12_372_25	5	0.75	3.01E-04	BMP4, DICER1, NRL, FZD8, LMO1, PAF1, BCL11A, CEBPA, MAMSTR, BHLHE23, FOXA1, NR4A2, IRF7, SSBP3, PDGFB	positive regulation of transcription, DNA-dependent [BP], epithelial-mesenchymal cell signaling [BP], neuron differentiation [BP], positive regulation of transcription from RNA polymerase II promoter [BP], regulation of neuron differentiation [BP], MDA-5 signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_148_11	3	0.5	3.90E-04	LIFR	growth factor binding [MF]
CG_h9laurent_promoter_n_RM_14_180_12	3	0.5	2.08E-04	PTGR1	2-alkenal reductase [NAD(P)] activity [MF]
CG_h9laurent_promoter_n_RM_14_183_6	2	0.25	2.75E-04	STX2, ZBTB17, QDPR, HSPD1	ectoderm development [BP], positive regulation of T cell mediated immune response to tumor cell [BP], 6,7-dihydropteridine reductase activity [MF], NADH binding [MF]
CG_h9laurent_promoter_n_RM_12_166_19	2	0.25	3.50E-04	CDK5, LRRTM1	protein localization to synapse [BP]
CG_h9laurent_promoter_n_RM_12_297_17	3	0.75	3.55E-04	RCC2, SIK1, CDC23, MCM7, PID1, CLIP1, SMPD3, JAG2, BCL2L1	mitotic cell cycle [BP], negative regulation of establishment of protein localization to plasma membrane [BP], cell cycle [BP]
CG_h9laurent_promoter_n_RM_14_161_6	3	0.25	3.72E-04	EPHA2, DRD2	negative regulation of protein kinase B signaling cascade [BP]
CG_h9laurent_promoter_n_RM_12_511_7	3	0.25	3.05E-04	NTAN1, DOCK7, KEAP1, ATP1A3, AGPAT2, FLNA, TRMT1L, CDKN2B	regulation of epidermal cell differentiation [BP], Rac GTPase binding [MF], adult locomotory behavior [BP], cellular response to nutrient [BP], megakaryocyte differentiation [BP], positive regulation of cytokine-mediated signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_70_39	3	0.75	3.05E-04	PTK2, CLU	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_14_146_7	3	0.25	3.59E-04	IRS2, PYCARD, STAT5B	JAK-STAT cascade involved in growth hormone signaling pathway [BP], positive regulation of activated T cell proliferation [BP]
CG_h9laurent_promoter_n_RM_12_533_13	4	0.75	2.86E-04	IRS2, SNCA, FECH	ferrous iron binding [MF], positive regulation of glucose metabolic process [BP]
CG_h9laurent_promoter_n_RM_16_11_6	2	0.25	4.25E-04	USP7, AKT1, EZH2, CLU, RHOA, ANAPC2, GPR143	phosphatidylinositol-mediated signaling [BP], regulation of sequence-specific DNA binding transcription factor activity [BP], negative regulation of striated muscle cell differentiation [BP], ubiquitin protein ligase binding [MF], positive regulation of vasoconstriction [BP], cerebellar cortex development [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_442_27	4	0.5	3.20E-04	NDN, TWIST1, CERS1, AFF3, CRMP1, OBFC1, PITX2, MNX1, CERS5	cardiac neural crest cell migration involved in outflow tract morphogenesis [BP], embryonic hindlimb morphogenesis [BP], sphingosine N-acyltransferase activity [MF], neuron migration [BP], intracellular membrane-bounded organelle [CC]
CG_h9laurent_promoter_n_RM_14_144_3	2	0.25	3.02E-04	IMMP2L	mitochondrial inner membrane peptidase complex [CC]
CG_h9laurent_promoter_n_RM_16_17_3	2	0.25	4.87E-04	BRD3, PHIP	histone acetyl-lysine binding [MF]
CG_h9laurent_promoter_n_RM_14_61_7	2	0.25	3.04E-04	YBX2	translational attenuation [BP]
CG_h9laurent_promoter_n_RM_12_50_10	2	0.25	3.60E-04	EPB41L3	myelin maintenance [BP]
CG_h9laurent_promoter_n_RM_14_19_7	2	0.25	2.32E-04	ATE1	protein arginylation [BP], arginyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_163_6	2	0.25	3.14E-04	HECTD1, SGK1, HECW2, USP7, DBN1	regulation of dendrite development [BP], regulation of catalytic activity [BP], protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP], regulation of sequence-specific DNA binding transcription factor activity [BP]
CG_h9laurent_promoter_n_RM_12_46_11	3	0.5	4.13E-04	FOXO1, HES2, PURB, STAT5B	double-stranded DNA binding [MF]
CG_h9laurent_promoter_n_RM_12_291_14	3	0.5	3.22E-04	ALX4, ST3GAL5, HOXB2, ST8SIA6, HOXA10, IMPAD1, JAG1, RAB23	embryonic limb morphogenesis [BP], ganglioside biosynthetic process [BP], morphogenesis of an epithelial sheet [BP], embryonic digit morphogenesis [BP], skeletal system development [BP]
CG_h9laurent_promoter_n_RM_12_336_15	2	0.25	3.81E-04	GRIN3A, FOXO1, EFNB2	lymph vessel development [BP], protein phosphatase 2A binding [MF]
CG_h9laurent_promoter_n_RM_12_263_23	2	0.25	2.77E-04	SOX7	regulation of canonical Wnt receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_430_21	2	0.25	3.89E-04	FZD8, NOTCH1, MREG, GSK3B, BCL9L, MEX3D, CNOT6L, EPB41L3	canonical Wnt receptor signaling pathway [BP], mRNA destabilization [BP], anagen [BP], neuron projection morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_422_25	3	0.5	3.47E-04	ARHGEF11, ICK, SH3RF1, KCNG1, TFPT, TONSL, GNB1, TRADD, RFX3, ANKRD27, DLL1, PURB, FOXL2, PPP1R13B, BBC3, WNT7B, RASGEF1C	intracellular [CC], ciliary cell motility [BP], induction of apoptosis [BP], loop of Henle development [BP], guanyl-nucleotide exchange factor activity [MF], DNA replication factor A complex [CC], intracellular membrane-bounded organelle [CC]
CG_h9laurent_promoter_n_RM_12_288_17	3	0.5	3.04E-04	DLG4, AKT1, GRIK1, LRP8, GRIN2C, RELN, CXCR4, HSP90AA1, EPB41L3	myelin maintenance [BP], reelin-mediated signaling pathway [BP], regulation of excitatory postsynaptic membrane potential [BP], dendritic spine morphogenesis [BP], glutamate receptor signaling pathway [BP], ionotropic glutamate receptor complex [CC], positive regulation of dendritic spine morphogenesis [BP], nitric-oxide synthase regulator activity [MF], receptor localization to synapse [BP]
CG_h9laurent_promoter_n_RM_14_330_10	4	0.5	1.75E-04	PTPN2, DUSP7, PTPRN2	protein dephosphorylation [BP], protein tyrosine phosphatase activity [MF]
CG_h9laurent_promoter_n_RM_12_239_22	4	0.75	2.80E-04	SMAD7, TRIM33	negative regulation of BMP signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_502_13	5	0.75	2.36E-04	ERO1L, TOR2A, PPP1R42	chaperone mediated protein folding requiring cofactor [BP], regulation of phosphatase activity [BP]
CG_h9laurent_promoter_n_RM_12_114_24	2	0.25	3.44E-04	AFF4, MED20, NFYB, DEK, GTF2A1, MYBL1, CBX4, SMURF1, PITX1, CHD8, NOC2L, AFF3, MKL1, POU6F1, POLD4, TCEB2, IGF2, NXF1, HOXB7, LDB1, SMARCD3, BCOR, POLR2L, CHMP1A, ZNF503, CASP3, KCNH2, SLTM, AKT1, MBD3, KAT6A, SMARCC2	chromatin modification [BP], protein binding transcription factor activity [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], histone binding [MF], nucleoplasm [CC], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_16_13_7	1	0.25	3.95E-04	RBKS, TSC1, NACC2	rRNA export from nucleus [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], ribokinase activity [MF]
CG_h9laurent_promoter_n_RM_14_259_9	3	0.5	3.31E-04	RPS6KA2	cellular response to carbohydrate stimulus [BP]
CG_h9laurent_promoter_n_RM_12_323_18	3	0.5	2.80E-04	NR3C1, FARSA, PSMB5, SUPT16H	gene expression [BP], cellular nitrogen compound metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_462_11	2	0.5	4.16E-04	DOCK7, IRS1, RHOG	insulin-like growth factor receptor signaling pathway [BP], activation of Rac GTPase activity [BP]
CG_h9laurent_promoter_n_RM_14_69_3	2	0.25	2.95E-04	BCL2, SMURF1	negative regulation of ossification [BP]
CG_h9laurent_promoter_n_RM_14_339_5	2	0.25	4.23E-04	SORT1, CDC42EP3	neurotensin receptor activity, non-G-protein coupled [MF], cytoskeletal regulatory protein binding [MF]
CG_h9laurent_promoter_n_RM_16_3_10	2	0.25	2.30E-04	NFIB, MEX3D, PCYT2, GPCPD1, CDC42EP3	negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], ethanolamine-phosphate cytidylyltransferase activity [MF], glycerophosphocholine phosphodiesterase activity [MF], cytoskeletal regulatory protein binding [MF]
CG_h9laurent_promoter_n_RM_14_96_16	3	0.25	3.64E-04	BMP4, GNAQ, ELL, SPG20, RP9, VAV2, RFX1, SERGEF, ZNF3, LEF1, PTCH1, SHANK1, BRD3, TNK2	trachea development [BP], mammary gland development [BP], protein binding [MF], osteoblast differentiation [BP], limb morphogenesis [BP], epidermal growth factor receptor binding [MF], BMP signaling pathway [BP], sprouting angiogenesis [BP], embryonic limb morphogenesis [BP], neural tube patterning [BP], negative regulation of striated muscle tissue development [BP], dorsal/ventral neural tube patterning [BP], regulation of striated muscle tissue development [BP], forebrain neuron differentiation [BP]
CG_h9laurent_promoter_n_RM_12_201_14	6	0.75	3.34E-04	NSUN2, SSBP3	prechordal plate formation [BP], tRNA (cytosine-5-)-methyltransferase activity [MF], midbrain-hindbrain boundary initiation [BP]
CG_h9laurent_promoter_n_RM_12_307_15	2	0.25	3.76E-04	TSC1, PPP6R1	regulation of phosphoprotein phosphatase activity [BP]
CG_h9laurent_promoter_n_RM_12_270_11	2	0.5	2.57E-04	TBX20, TRUB2, HSPG2, NOP10, HOXB3, PLXND1, SEMA5A	angiogenesis [BP], patterning of blood vessels [BP], pseudouridine synthesis [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_254_12	2	0.5	2.73E-04	KCNJ10	optic nerve development [BP]
CG_h9laurent_promoter_n_RM_12_57_26	2	0.5	2.97E-04	ICMT, SIK1, TCEB1, NELFE, EAPP	positive regulation of transcription elongation from RNA polymerase II promoter [BP], cAMP response element binding protein binding [MF], negative regulation of transcription elongation from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_82_26	2	0.5	4.11E-04	MAP3K9, NCBP2, CBX8, GRIN2B, AAK1, RBM22, CHRNA3, CBX7, PPP3CA, IRAK1, DAPK3, ERN1, CHD1	regulation of excitatory postsynaptic membrane potential [BP], mRNA cis splicing, via spliceosome [BP], protein autophosphorylation [BP], PRC1 complex [CC], methylated histone residue binding [MF]
CG_h9laurent_promoter_n_RM_12_459_24	3	0.25	2.85E-04	AASDH, PRKDC, CDKN2A	acid-thiol ligase activity [MF], protein destabilization [BP]
CG_h9laurent_promoter_n_RM_14_6_12	2	0.25	3.39E-04	DPYD, CRMP1	UMP biosynthetic process [BP], pyrimidine nucleobase catabolic process [BP]
CG_h9laurent_promoter_n_RM_18_12_2	1	0.25	7.09E-04	GSK3B, ODC1, USP7, OTUD5	canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], ornithine decarboxylase activity [MF], p53 binding [MF], ubiquitin-specific protease activity [MF], protein deubiquitination [BP], putrescine biosynthetic process from ornithine [BP]
CG_h9laurent_promoter_n_RM_12_75_10	3	0.5	4.61E-04	DLK2, HEY1	negative regulation of Notch signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_382_17	3	0.5	4.75E-04	STAT5B, TFAP2A, SAV1, POU4F1, HOXA5, CDK6, DICER1	negative regulation of erythrocyte differentiation [BP], intestinal epithelial cell development [BP], intestinal epithelial cell differentiation [BP], negative regulation of cell differentiation [BP], trigeminal nerve development [BP], central nervous system neuron differentiation [BP], regulation of erythrocyte differentiation [BP]
CG_h9laurent_promoter_n_RM_12_574_31	2	0.5	2.96E-04	ELAVL3, PDIA6, DLK2, GLT25D2, STAT5B, IMPAD1, CDK5, CDK6, COL1A1, NTF4, COL2A1, OVOL2, FZD4	endoplasmic reticulum lumen [CC], cyclin-dependent protein kinase holoenzyme complex [CC], generation of neurons [BP], luteinization [BP], platelet-derived growth factor binding [MF], neuron differentiation [BP], endochondral ossification [BP], nervous system development [BP], cell differentiation [BP], negative regulation of Notch signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_103_2	2	0.25	4.13E-04	ABCA3, GNE, LPHN1	latrotoxin receptor activity [MF], N-acylmannosamine kinase activity [MF], N-acetylglucosamine biosynthetic process [BP], N-acetylneuraminate biosynthetic process [BP], UDP-N-acetylglucosamine 2-epimerase activity [MF], alveolar lamellar body membrane [CC]
CG_h9laurent_promoter_n_RM_12_18_17	2	0.5	3.70E-04	MYO1C, SLC9A1, CASK, ADCY3, PDE1C	calmodulin binding [MF]
CG_h9laurent_promoter_n_RM_12_296_14	2	0.25	2.71E-04	SNAPC4, PSIP1	snRNA-activating protein complex [CC], supercoiled DNA binding [MF], snRNA transcription from RNA polymerase III promoter [BP], snRNA transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_321_13	3	0.5	3.72E-04	SERTAD2, ELAVL3, HMGB1, TIA1, PLEC, CDK5, CAPRIN2, THOC1, BCL7C, SGPP1, BCL2, SFRP2	AU-rich element binding [MF], negative regulation of cell growth [BP], positive regulation of peptidyl-serine phosphorylation [BP], cell growth [BP], peptidyl-serine phosphorylation [BP], apoptotic process [BP]
CG_h9laurent_promoter_n_RM_14_101_4	1	0.25	4.52E-04	FOXO1, ANKLE2, ACTG1, FERMT2	protein acetylation [BP], filamentous actin [CC], protein phosphatase 2A binding [MF]
CG_h9laurent_promoter_n_RM_14_83_18	2	0.25	3.68E-04	HDAC5, HDAC4, SPIRE1, DLL1, EZH2, COBL, RHOA, RHOF, PARD3	axonal growth cone [CC], negative regulation of striated muscle cell differentiation [BP], actin filament organization [BP], somite specification [BP], NAD-dependent histone deacetylase activity (H4-K16 specific) [MF], NAD-dependent histone deacetylase activity (H3-K14 specific) [MF], cleavage furrow formation [BP], negative regulation of myotube differentiation [BP]
CG_h9laurent_promoter_n_RM_12_217_9	4	0.75	2.70E-04	ATXN7L3	histone deubiquitination [BP]
CG_h9laurent_promoter_n_RM_12_328_18	2	0.25	2.50E-04	EGR3, RAB3A, TNIP2	positive regulation of B cell activation [BP], neuromuscular synaptic transmission [BP]
CG_h9laurent_promoter_n_RM_14_251_4	2	0.25	4.57E-04	TAF9, BCAR1	regulation of cell growth [BP], negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_438_15	5	0.75	1.49E-04	AHI1, ENOX2	pronephric nephron tubule morphogenesis [BP], Kupffer's vesicle development [BP], pronephric duct morphogenesis [BP], ultradian rhythm [BP], positive regulation of polarized epithelial cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_433_13	2	0.25	2.12E-04	TAL1, G6PD	erythrocyte maturation [BP]
CG_h9laurent_promoter_n_RM_14_335_6	4	0.5	4.44E-04	DNASE1L1, DPF1, SMARCD3, CCBL1, PLXNB2	neuroblast proliferation [BP], glutamine-phenylpyruvate transaminase activity [MF], L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], L-glutamine:pyruvate aminotransferase activity [MF], deoxyribonuclease activity [MF], nBAF complex [CC]
CG_h9laurent_promoter_n_RM_14_17_7	2	0.25	2.81E-04	RERE	poly-glutamine tract binding [MF]
CG_h9laurent_promoter_n_RM_14_1_10	1	0.25	4.03E-04	SMARCD3, DPF1	nBAF complex [CC]
CG_h9laurent_promoter_n_RM_14_49_4	2	0.25	5.53E-04	DBN1, A4GALT, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], lactosylceramide 4-alpha-galactosyltransferase activity [MF], cell communication by chemical coupling [BP], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_h9laurent_promoter_n_RM_12_176_29	2	0.25	3.60E-04	LRP6	midbrain-hindbrain boundary development [BP]
CG_h9laurent_promoter_n_RM_14_240_19	4	0.5	3.25E-04	TOP2A, IRS1, FLNA, AKT1	protein kinase C binding [MF], protein kinase B signaling cascade [BP], response to UV-A [BP]
CG_h9laurent_promoter_n_RM_12_484_19	5	0.75	4.18E-04	CAMK2B, SH3PXD2B, KLK8, ANAPC2, PHLDA3, NEUROD2	regulation of synapse organization [BP], phosphatidylinositol-5-phosphate binding [MF], positive regulation of synaptic plasticity [BP], positive regulation of synapse maturation [BP]
CG_h9laurent_promoter_n_RM_12_374_6	3	0.5	3.64E-04	NUMA1, WNT2, VAV2, PPTC7, TIAM1, NKX1-2, CDK5RAP2, SOS1	phosphoprotein phosphatase activity [MF], Rho guanyl-nucleotide exchange factor activity [MF], multicellular organismal development [BP], mammary gland epithelium development [BP], establishment of mitotic spindle orientation [BP]
CG_h9laurent_promoter_n_RM_12_497_22	2	0.25	3.03E-04	TGFB3, XBP1, CREG1, YWHAE, GLI3, TCEB2, HRAS, ALS2, POU3F1, IRS2, DLL1, AKT1, PAX3, NFIL3, DICER1, NEUROG1, BRWD1, CCDC85C, CEP120, BRD3, IRF1	positive regulation of Rac protein signal transduction [BP], negative regulation of plasma membrane long-chain fatty acid transport [BP], myelination in peripheral nervous system [BP], positive regulation of miRNA metabolic process [BP], cerebral cortex development [BP], proximal tubule development [BP], frontal suture morphogenesis [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_366_13	5	0.75	2.12E-04	MSRB1, SLC25A11, DNPH1	nucleoside deoxyribosyltransferase activity [MF], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF], methionine-R-sulfoxide reductase activity [MF], oxoglutarate:malate antiporter activity [MF]
CG_h9laurent_promoter_n_RM_12_535_26	2	0.5	3.24E-04	IRS2, AKT1, CYBA, NOX4, C5, TOLLIP	positive regulation of glycogen biosynthetic process [BP], superoxide anion generation [BP], superoxide-generating NADPH oxidase activity [MF], intracellular signal transduction [BP], glucose homeostasis [BP], negative regulation of plasma membrane long-chain fatty acid transport [BP], NADPH oxidase complex [CC], cellular response to gamma radiation [BP]
CG_h9laurent_promoter_n_RM_18_10_3	1	0.25	4.66E-04	ICMT	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], C-terminal protein methylation [BP], protein C-terminal carboxyl O-methyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_11_4	2	0.25	3.66E-04	SLC19A1, HDDC3	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], methotrexate transport [BP], methotrexate transporter activity [MF]
CG_h9laurent_promoter_n_RM_18_8_3	2	0.25	7.26E-04	REV1	deoxycytidyl transferase activity [MF], error-prone translesion synthesis [BP]
CG_h9laurent_promoter_n_RM_12_441_20	4	0.5	3.09E-04	ACVR1, TBX3	cardiac muscle cell fate commitment [BP]
CG_h9laurent_promoter_n_RM_14_361_23	2	0.5	2.93E-04	TUBGCP6	microtubule nucleation [BP]
CG_h9laurent_promoter_n_RM_14_299_13	2	0.5	2.54E-04	RELN, DLG4	protein localization to synapse [BP], dendritic spine morphogenesis [BP], positive regulation of excitatory postsynaptic membrane potential [BP], regulation of N-methyl-D-aspartate selective glutamate receptor activity [BP], receptor localization to synapse [BP]
CG_h9laurent_promoter_n_RM_12_469_6	2	0.5	3.87E-04	PLOD3	procollagen glucosyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_12_173_15	4	0.5	3.73E-04	CSPG5, ST8SIA6, B3GNT9, PARP10, CHST9, MTHFS, SORT1, AP3D1, CHPF, QDPR	neuron projection [CC], proteoglycan biosynthetic process [BP], chondroitin sulfate biosynthetic process [BP], glycoprotein metabolic process [BP], Golgi apparatus [CC], Golgi membrane [CC], chondroitin sulfate metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_579_6	2	0.5	8.99E-05	NCBP2, SNUPN	RNA cap binding [MF], spliceosomal snRNP assembly [BP]
CG_h9laurent_promoter_n_RM_16_15_3	1	0.25	7.15E-05	ZNF44, ZNF442, ZNF823, ZNF433, PSG9, PSG6, PSG2, PSG1, ZNF709	female pregnancy [BP], zinc ion binding [MF]
CG_h9laurent_promoter_n_RM_12_573_19	3	0.5	2.19E-04	GRIK3, ACAP3, SBF1, RAPH1, ARHGAP12, CDC42BPB, FGD6	phospholipid binding [MF], adenylate cyclase inhibiting G-protein coupled glutamate receptor activity [MF]
CG_h9laurent_promoter_n_RM_12_283_13	4	0.5	3.57E-04	RYK, TRAK2, PABPC1, SYMPK, LCAT, SMAD2, AFF3, CBX8, MNX1, CPSF1, CALCOCO1, TIMELESS, MLLT1, HMGB2, BRWD1, HSPG2, AADAT, PAF1, FOXS1, DLL1, PAX6, SMARCD3, SATB1, NFRKB, NFIB, FOXA1, RUNX3, MEF2D, GAS1, HES2, TAF5L, SLBP	mRNA polyadenylation [BP], cell fate commitment [BP], lipoprotein biosynthetic process [BP], biosynthetic process [BP], lipoprotein metabolic process [BP], commissural neuron axon guidance [BP], proximal tubule development [BP], nuclear chromatin [CC], transcription from RNA polymerase II promoter [BP], double-stranded DNA binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_14_63_3	1	0.25	1.18E-05	DEGS2, MAPK3	negative regulation of apolipoprotein binding [BP], sphingolipid delta-4 desaturase activity [MF], sphingosine hydroxylase activity [MF]
CG_h9laurent_promoter_n_RM_14_15_5	2	0.25	3.13E-04	FEV	neuron fate specification [BP]
CG_h9laurent_promoter_n_RM_14_273_3	2	0.5	2.67E-04	ELAVL1, MEX3D	AU-rich element binding [MF]
CG_h9laurent_promoter_n_RM_12_238_25	2	0.5	3.48E-04	LNX2, SNTB1, GRIN2C	PDZ domain binding [MF]
CG_h9laurent_promoter_n_RM_14_65_6	2	0.25	2.71E-04	PIDD, BID	death receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_489_9	3	0.75	3.32E-04	RPS6KA3	regulation of translation in response to stress [BP]
CG_h9laurent_promoter_n_RM_12_186_12	3	0.5	3.16E-04	FLOT2, DLG4	ionotropic glutamate receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_165_23	2	0.25	3.50E-04	GFRA2, SULF2	glial cell-derived neurotrophic factor receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_125_4	2	0.25	3.55E-04	TCF15, HSPG2, FOXN4	skeletal system morphogenesis [BP], cartilage development involved in endochondral bone morphogenesis [BP], tissue development [BP]
CG_h9laurent_promoter_n_RM_14_109_8	1	0.25	2.54E-04	MLL2, SOX15, DPF3, RRP8	chromatin organization [BP], chromatin silencing [BP], chromatin modification [BP]
CG_h9laurent_promoter_n_RM_14_297_8	4	0.5	2.95E-04	HOXA5, PARD3, WDR45B, WT1	epithelial cell differentiation [BP], respiratory system process [BP], phosphatidylinositol-3-phosphate binding [MF], anterior/posterior pattern specification [BP], cellular response to gonadotropin stimulus [BP]
CG_h9laurent_promoter_n_RM_14_258_2	3	0.5	4.28E-04	ACD, TRPV4	osmosensor activity [MF], cortical microtubule organization [BP], osmosensory signaling pathway [BP], positive regulation of single-stranded telomeric DNA binding [BP]
CG_h9laurent_promoter_n_RM_12_167_16	3	0.5	3.50E-04	NEUROD2, WT1, NRXN1, BAK1, ZXDC, MBD2, DACT2, BCAP31	epithelial cell morphogenesis [BP], reduction of endoplasmic reticulum calcium ion concentration [BP], C2H2 zinc finger domain binding [MF], positive regulation of synapse maturation [BP]
CG_h9laurent_promoter_n_RM_14_374_5	2	0.25	2.59E-04	CIZ1, HEG1, NFIB	lymph circulation [BP], negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP], maintenance of nucleus location [BP]
CG_h9laurent_promoter_n_RM_16_22_3	3	0.5	3.68E-04	SYT7	regulation of calcium ion-dependent exocytosis [BP]
CG_h9laurent_promoter_n_RM_12_476_15	2	0.25	3.24E-04	EGR2, SKIDA1, HNRNPR, ZGLP1, USP7, CBS, HOXA5, CSNK1E, PRUNE2, USP44, PATZ1, CBX4, EHHADH, FOXN3, CCNJL	negative regulation of transcription, DNA-dependent [BP], ubiquitin protein ligase binding [MF], protein sumoylation [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_14_90_23	7	0.75	4.58E-04	SLC6A3, SATB1, COL11A2, SMG5, GNPTAB, SHARPIN, SYMPK, EPB41L4B, MAMSTR, CSRNP1, SFMBT1, JPH1, LIFR, UBL3, MAFA, POU3F1, CLSTN1, DHX36, RYK, CREBZF, ASB3, MAP3K9, SMG1, NCBP2, SIX4, SIX5, CERS2, DEAF1, GALNT3, WHSC1L1, MAP3K5, IRF2BP2, CCDC47, LSG1, CSNK1E, RELN, PLXND1, FGFR1, TLE1, RALGAPA2, VPS54, WT1, JAKMIP1, FAM126B, SP3, BOLL, XYLT1, BAZ1A, PER2, GRSF1, REV3L, HNRPLL, APBA1, CHSY1, FGFR2, ROR2, UBR5, BRD3, STRBP, ERRFI1, ADRA1D, AKT1, HCN1, DAPK3, HYAL1, CSPG5, GSK3A, FGF12, SMEK2, TEX2, TCF15, EIF4G3, GNG5, FRA10AC1, PID1, MYO5A, TAF5L, LMO2, SAP25, WNT7B, SNX3, ZBTB3, AES, STMN1, ANKRD54, ZBTB2, TRIM33, ENAH, PDS5A, PLCB2, ANO2, MLL3, B4GALT5, SFXN4, GPLD1, ATP1A3, ZNF597, SULF2, ZNF598, MNX1, NPLOC4, NCKAP1, STK40, XPO1, HOXA7, KANSL1, MCIN, SOX10, KIAA0368, AFF3, SOX15, NAIF1, PAM16, GUCY1A2, ZNF764, TOP2B, RASGEF1C, TRAM1, ST3GAL2, WAPAL, TFEB, FAF1, MIER3, ASIC2, SHB, HSF2BP, TP53INP1, ZNF827, PAX3, DTNBP1, ITPR2, NUP62, CORO2A, BRF1, TUBGCP2, ICMT, MEX3D, ZC3H8, TBC1D7, GNAQ, RPS6KA6, GRB2, NCOA5, RPAP1, MOK, AURKAIP1, CAMKK1, SLC35B2, KCNMA1, DCUN1D3, GAS1, ASCC2, LUZP1, LIN54, HES4, CREBBP, UBA3, RAB11FIP5, RFWD2, MIS18A, FOXP3, MKNK2, RORC, ONECUT1, SMAD7, NAMPT, ZFHX3, COMMD7, PRKAR2A, CNTFR, VPS37C, CHD1, CTNND2, EID2B, TTBK2, FAM53A, CBLN1, ATXN7L3, NCOR2, NCOR1, RORA, TBC1D9, THSD7A, SIK1, SNX5, ZBTB14, FZD8, POLDIP2, TFPT, NR2F6, PGAP1, CDKL3, HOXA10, ADAP1, ELAVL3, SOS2, MAPK1, FOSL1, ATE1, PHIP, ELL2, CITED1, DUSP6, FBXW4, HNRNPF, MYCBP2, MAML3, SIAH1, PDAP1, SRP68, SEPHS1, RXRG, GNB1, ASB6, DLL1, APPL2, PTPRT, BCOR, TAPT1, SAV1, CHST15, PDE10A, MLF2, RRAS, ZNF521, TRPS1, LRP6, TOLLIP, HIRA, SFRP5, CAPZB, LRP8, SMURF1, ADARB2, GJC1, PIAS2, PNCK, HOXA5, SMEK1, CDK5, PITPNM3, ST8SIA6, SH3PXD2B, BARHL2, SLC35D1, WIZ, HIVEP3, BRD1, TOX, DBX2, ARHGEF11, ZNF251, ZNF704, USP7, ADAM10, FOXO1, EZH2, HAND2, ANKRD17, BCL9L, PITX1, MYO18A, BIN3, PYGO1, CEBPA, C1orf61, RAP1GAP, FEZF2, KLF14, TWIST1, CALCOCO1, ESCO1, DGKQ, BHLHE23, PBX4, IRAK1, KLF4, MMS19, MED16, TTLL12, JAG2, WDFY3, ZNF644, NRG2, RLIM, TBC1D2B, VPS13C, PPP1R13B, NKX6-2, PDGFA, KCND3, SNUPN, RRAGC, ZBTB4, GSPT1, CHRM4, RTN2, MGAT1, ABR, MTSS1, EBF3, EBF2, EBF1, STK39, DACH1, SSBP3, MEX3B, MEX3C, SHANK1, KCNK9, HECTD4, NFIB, BCL6, BNC1, LRP4, HTR7, TAB3, MPPED2, OAZ2, NRIP1, NOTCH2, E2F8, SCRIB, TFAP2A, TONSL, DUSP7, PURG, GNA13, ACTL6B, MBD2, PPP3CA, PTCH1, DEDD2, SLC1A2, SMARCC2	organ development [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], positive regulation of gluconeogenesis [BP], transcription coactivator activity [MF], post-embryonic development [BP], embryonic placenta development [BP], limb morphogenesis [BP], protein binding transcription factor activity [MF], regulation of transcription, DNA-dependent [BP], blood vessel development [BP], cell differentiation [BP], skeletal system development [BP], chondroitin sulfate biosynthetic process [BP], organ morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], negative regulation of Wnt receptor signaling pathway [BP], canonical Wnt receptor signaling pathway [BP], stress-activated MAPK cascade [BP], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], gene expression [BP], positive regulation of gene expression [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity [MF], positive regulation of mesenchymal cell proliferation [BP], cell communication [BP], nervous system development [BP], orbitofrontal cortex development [BP], synaptic transmission [BP], regulation of signal transduction [BP], cell development [BP], pattern specification process [BP], DNA binding [MF], embryonic digit morphogenesis [BP], transcription regulatory region DNA binding [MF], extrinsic to membrane [CC], embryonic limb morphogenesis [BP], chromatin binding [MF], intracellular [CC], cartilage morphogenesis [BP], vasculature development [BP], negative regulation of transcription from RNA polymerase II promoter [BP], cartilage development [BP], transcription cofactor activity [MF], tissue development [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], intracellular signal transduction [BP], placenta development [BP], trachea cartilage morphogenesis [BP], ear development [BP], cell surface receptor signaling pathway [BP], signal transduction [BP], transcription factor complex [CC], cellular component movement [BP], chordate embryonic development [BP], branching involved in salivary gland morphogenesis [BP], sequence-specific DNA binding [MF], regulation of cell differentiation [BP], mesenchymal cell proliferation [BP], in utero embryonic development [BP], growth [BP], lung epithelium development [BP], cellular response to growth factor stimulus [BP], positive regulation of apoptotic process [BP], anatomical structure morphogenesis [BP], mammary gland epithelium development [BP], Wnt receptor signaling pathway [BP], embryonic pattern specification [BP], visceral serous pericardium development [BP], cellular protein modification process [BP], forebrain development [BP], cellular metabolic process [BP], muscle organ development [BP], negative regulation of sequence-specific DNA binding transcription factor activity [BP], brain development [BP], protein localization [BP], generation of neurons [BP], multicellular organismal development [BP], nucleus [CC], cellular protein metabolic process [BP], embryonic skeletal system development [BP], sequence-specific DNA binding transcription factor activity [MF], nucleocytoplasmic transport [BP], embryonic organ development [BP], response to growth factor stimulus [BP], intracellular membrane-bounded organelle [CC], RNA metabolic process [BP], cell morphogenesis involved in differentiation [BP], fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [BP], positive regulation of transcription, DNA-dependent [BP], developmental growth [BP], central nervous system development [BP], negative regulation of cell differentiation [BP], skeletal muscle organ development [BP], negative regulation of gene expression [BP], lung-associated mesenchyme development [BP], regulation of transcription from RNA polymerase II promoter [BP], labyrinthine layer development [BP], neural tube closure [BP], regulation of heart growth [BP], morphogenesis of embryonic epithelium [BP], nucleoplasm [CC], cell-cell signaling [BP]
CG_h9laurent_promoter_n_RM_14_291_11	3	0.5	4.19E-04	MED20, FKBP5, CBX8, NFYB, CHD5, THRB, SIX2, ZNF516, HSPB6, EBF3, BCOR, GATA2, PNCK, BNC2, PKD1, CHTF8, ZBTB46, GATAD2B, BATF3, LIN54, HES4, HIRIP3, MORC2	transcription, DNA-dependent [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_12_285_19	4	0.5	3.48E-04	DICER1, ALX4, SALL1, SRSF12, GAS1, TGFB3	olfactory bulb interneuron differentiation [BP], limb development [BP], embryonic digit morphogenesis [BP], hindlimb morphogenesis [BP], cytoplasmic transport [BP], digestive tract development [BP], outer ear morphogenesis [BP]
CG_h9laurent_promoter_n_RM_14_295_5	4	0.5	2.80E-04	SORT1	neurotensin receptor activity, non-G-protein coupled [MF], nerve growth factor receptor activity [MF], vesicle organization [BP], plasma membrane to endosome transport [BP]
CG_h9laurent_promoter_n_RM_12_492_20	3	0.5	4.17E-04	ABCC8, KCNMA1, KCNG3	voltage-gated potassium channel complex [CC], potassium ion transmembrane transport [BP], potassium ion transmembrane transporter activity [MF]
CG_h9laurent_promoter_n_RM_12_198_12	2	0.25	2.21E-04	EZH2	pronucleus [CC]
CG_h9laurent_promoter_n_RM_14_107_8	2	0.25	3.00E-04	TRERF1, FOXN3, FOXI3	DNA binding, bending [MF]
CG_h9laurent_promoter_n_RM_12_212_12	3	0.5	3.42E-04	CELSR1	wound healing [BP]
CG_h9laurent_promoter_n_RM_12_399_15	2	0.5	3.15E-04	B4GALT6	galactosyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_129_4	2	0.25	2.11E-04	PREX1, ARHGAP4	Rho GTPase activator activity [MF]
CG_h9laurent_promoter_n_RM_12_258_29	4	1.0	3.86E-04	AAAS, IMPAD1, CTNND2, ACER1, DLG4, PTBP3, JAG1, RMDN3, TNK2, MTSS1, CHRNA3, LEF1, ROR2, SHANK1, ZNF3, RSPO2, BMP4, LRP6, GNAQ, WNT3, PTCH1, EFNB2	G-protein coupled receptor binding [MF], head morphogenesis [BP], trachea cartilage morphogenesis [BP], regulation of cell development [BP], forebrain neuroblast division [BP], cell surface receptor signaling pathway [BP], generation of neurons [BP], embryonic hindlimb morphogenesis [BP], vocalization behavior [BP], forebrain radial glial cell differentiation [BP], negative regulation of fat cell differentiation [BP], negative regulation of epithelial cell proliferation [BP], limb morphogenesis [BP], glomerulus morphogenesis [BP], regulation of cell differentiation [BP], formation of radial glial scaffolds [BP], morphogenesis of a branching structure [BP], trachea development [BP], pulmonary artery morphogenesis [BP], cell differentiation [BP], neurogenesis [BP], neuron differentiation [BP], anatomical structure morphogenesis [BP], learning [BP], embryonic digit morphogenesis [BP], osteoblast differentiation [BP], embryonic limb morphogenesis [BP], cell morphogenesis [BP], somite development [BP], embryonic forelimb morphogenesis [BP], hindlimb morphogenesis [BP], frizzled binding [MF], cardiac septum development [BP], mammary gland formation [BP], regulation of excitatory postsynaptic membrane potential [BP], neural tube patterning [BP], receptor binding [MF], mammary gland development [BP]
CG_h9laurent_promoter_n_RM_12_546_20	2	0.5	3.28E-04	LIFR, CNTFR	ciliary neurotrophic factor receptor activity [MF], ciliary neurotrophic factor-mediated signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_116_10	2	0.25	3.16E-04	SCFD2, PFN2, HRAS	striated muscle cell differentiation [BP], vesicle docking involved in exocytosis [BP], regulation of synaptic vesicle exocytosis [BP]
CG_h9laurent_promoter_n_RM_12_271_7	4	0.5	3.66E-04	HDDC3, HAAO	3-hydroxyanthranilate 3,4-dioxygenase activity [MF], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF]
CG_h9laurent_promoter_n_RM_12_424_23	2	0.25	3.50E-04	MAP3K15, RAF1	MAP kinase kinase kinase activity [MF]
CG_h9laurent_promoter_n_RM_14_39_13	2	0.25	3.03E-04	PTK2, LRP6, CELSR1, ADAM8, CYTH1, LAMA1	regulation of embryonic development [BP], establishment of epithelial cell polarity [BP], positive regulation of bone resorption [BP], establishment of cell polarity [BP], planar cell polarity pathway involved in neural tube closure [BP]
CG_h9laurent_promoter_n_RM_16_37_2	2	0.25	1.58E-04	KCNMA1, MFSD10	negative regulation of cell volume [BP], cellular potassium ion homeostasis [BP], tetracycline transporter activity [MF], eye blink reflex [BP], tetracycline transport [BP], large conductance calcium-activated potassium channel activity [MF]
CG_h9laurent_promoter_n_RM_12_81_24	2	0.5	2.08E-04	HMGB1	V(D)J recombination [BP]
CG_h9laurent_promoter_n_RM_14_34_2	1	0.25	6.77E-04	SSU72, HDAC4	response to denervation involved in regulation of muscle adaptation [BP], dephosphorylation of RNA polymerase II C-terminal domain [BP]
CG_h9laurent_promoter_n_RM_14_218_26	3	0.5	3.40E-04	ZBTB7A, DLG4, RGS11, TRIM33, TSHZ3, LRP8, DKK3, GNG12, WNT4, GNG4, RGS7, WDFY3, CDK5, CBX4, PTPRK, KCTD1, IRF1	extrinsic to internal side of plasma membrane [CC], dendritic spine morphogenesis [BP], extrinsic to membrane [CC], layer formation in cerebral cortex [BP], negative regulation of transcription, DNA-dependent [BP], heterotrimeric G-protein complex [CC], negative regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_14_41_3	2	0.25	2.91E-04	MEX3D	mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_12_230_9	2	0.25	3.20E-04	HR, THRB, TAL1, YAF2, NEUROD2	transcription corepressor activity [MF], E-box binding [MF]
CG_h9laurent_promoter_n_RM_16_33_8	3	0.5	4.11E-04	TFEB, TWIST1, ACAP3, JAG2, FGFR2, LTBP3	protein domain specific binding [MF], embryonic placenta development [BP], cranial suture morphogenesis [BP], bone morphogenesis [BP], in utero embryonic development [BP], bone mineralization [BP]
CG_h9laurent_promoter_n_RM_12_36_10	3	0.5	3.15E-04	RPS6KA3, DIRAS3, GSK3B, PHIP	regulation of gene expression by genetic imprinting [BP], positive regulation of peptidyl-threonine phosphorylation [BP], regulation of translation in response to stress [BP]
CG_h9laurent_promoter_n_RM_14_293_12	4	0.5	4.25E-04	OMA1	mitochondrial protein processing [BP]
CG_h9laurent_promoter_n_RM_16_35_3	2	0.25	3.06E-04	SETD2, AXIN2, RGS10, BID, ABCB10	embryonic placenta morphogenesis [BP], termination of G-protein coupled receptor signaling pathway [BP], integral to mitochondrial membrane [CC]
CG_h9laurent_promoter_n_RM_12_171_12	2	0.25	3.46E-04	PKM, KIAA1161, A4GALT	glycosphingolipid biosynthetic process [BP], carbohydrate metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_542_30	3	0.5	3.62E-04	PURB, NELFA, STAT5B, TARBP1, MAFB, DLL1, MNX1, HES6, NFIB	regulation of myeloid cell differentiation [BP], negative regulation of erythrocyte differentiation [BP], negative regulation of myeloid cell differentiation [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_14_280_9	2	0.5	3.61E-04	SOD2	detection of oxygen [BP]
CG_h9laurent_promoter_n_RM_12_420_12	3	0.5	3.10E-04	GNAQ, AXIN1, PRKAR1B, MAF, WNT5A, OIP5, PLCB2	negative regulation of mesenchymal cell proliferation [BP], activation of phospholipase C activity [BP], chromatin [CC], positive regulation of peptidyl-threonine phosphorylation [BP], post-anal tail morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_390_16	1	0.25	3.25E-04	ANXA2, DOC2B	positive regulation of vesicle fusion [BP]
CG_h9laurent_promoter_n_RM_12_437_15	5	0.75	1.96E-04	TWIST1, IL12RB1, TBX18	interleukin-12 receptor complex [CC], negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], cell proliferation involved in heart valve development [BP], interleukin-12 receptor activity [MF]
CG_h9laurent_promoter_n_RM_20_7_3	1	0.25	3.20E-04	ACSL6, SLC25A29	positive regulation of plasma membrane long-chain fatty acid transport [BP], acyl carnitine transmembrane transporter activity [MF]
CG_h9laurent_promoter_n_RM_12_412_26	3	0.75	3.08E-04	CUL3, KEAP1	Cul3-RING ubiquitin ligase complex [CC]
CG_h9laurent_promoter_n_RM_14_276_7	3	0.5	1.96E-04	KCNJ4, SNTB1, ACTG1, CSPG5, MECP2, CCSAP, AHI1, RGS19, PHOX2A, LPAR1, HES4, ITGB1	hindbrain development [BP], G-protein alpha-subunit binding [MF], PDZ domain binding [MF], regulation of respiratory gaseous exchange [BP], cerebellum development [BP], nervous system development [BP], ciliary transition zone [CC], sarcomere organization [BP]
CG_h9laurent_promoter_n_RM_12_582_18	4	0.5	5.86E-04	CAMK1, IL15RA, CD47, TONSL, BAZ1A, ARID4B, TMEM30B, DEDD2, GEM, SERTAD1	protein binding [MF], ACF complex [CC]
CG_h9laurent_promoter_n_RM_12_348_12	3	0.5	4.53E-04	PHF12, TBX18	RNA polymerase II transcription corepressor activity [MF]
CG_h9laurent_promoter_n_RM_18_14_32	2	0.25	4.00E-04	FBXO11, PODXL, MAFA, CDK2AP1, SMAD9, SIX4, NFE2L2, IRF2BP2, CUL7, IRX2, ZNF367, EVX2, CENPV, SETD2, THOC7, BRD3, SBF1, STRBP, HCN1, KLLN, GSK3B, GFRA2, YBX2, ELAVL2, RRP9, ZNF219, CDYL2, MNX1, NCKAP1, GTF2E2, ZIC5, TOP2A, ZZZ3, DNASE1L1, VEGFC, ANAPC2, IRF2, TOX3, LCORL, HDAC4, JAZF1, RCOR2, TAF11, SHROOM4, NCOR2, HOXA10, WDR26, RANBP9, PAX3, ASH1L, PHF21A, MECP2, TPMT, CELSR1, TCEA1, ARFGEF1, BCOR, HEY1, CNOT6L, APBA1, SOS2, PLXNA2, PDE4DIP, RILPL1, PIP4K2B, PREP, PRKD3, LMF1, PTK2, USP7, GTF2A1, CUL3, ELF2, ANKRD11, DGKI, JAG2, NKX6-2, ZC3H7A, RP9, MSI1, TTBK2, MEX3D, SOX21, PCDH1, SCRIB, ZBTB45, ZCCHC14	nervous system development [BP], nucleus [CC], protein glycosylation in Golgi [BP], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], nucleic acid binding [MF], histone H3-K36 methylation [BP], epithelial tube formation [BP], DNA binding [MF], apical protein localization [BP], anatomical structure morphogenesis [BP], mRNA destabilization [BP], endomembrane system organization [BP], regulation of transcription from RNA polymerase II promoter [BP], methylation [BP], neural tube closure [BP], morphogenesis of embryonic epithelium [BP], asymmetric protein localization [BP], neural tube development [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], regulation of Rho protein signal transduction [BP]
CG_h9laurent_promoter_n_RM_12_179_12	4	0.25	4.12E-04	DLG4, PLK2, GJC1, DVL1, FKBP1A, HSP90AA1, CACNG2, HEY1, RPS6KA3	synaptic transmission [BP], ionotropic glutamate receptor binding [MF], regulation of synaptic plasticity [BP], protein refolding [BP], receptor clustering [BP], axon guidance [BP], alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex [CC], heart trabecula formation [BP]
CG_h9laurent_promoter_n_RM_12_480_13	2	0.5	2.06E-04	SRXN1	sulfiredoxin activity [MF]
CG_h9laurent_promoter_n_RM_16_69_6	2	0.25	4.73E-04	SOX10	extrinsic to mitochondrial outer membrane [CC]
CG_h9laurent_promoter_n_RM_14_45_5	2	0.25	2.73E-04	MKX, RBBP7, PAXIP1, NACC2	tendon sheath development [BP], positive regulation of histone H3-K36 methylation [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], histone methyltransferase complex [CC], NuRD complex [CC], cellular heat acclimation [BP], cellular protein complex localization [BP]
CG_h9laurent_promoter_n_RM_14_36_6	3	0.5	1.87E-04	FAM132A, ASPM, TGFB1	defense response to fungus, incompatible interaction [BP], negative regulation of hyaluronan biosynthetic process [BP], negative regulation of asymmetric cell division [BP], negative regulation of release of sequestered calcium ion into cytosol [BP], response to glucose stimulus [BP], protein kinase B signaling cascade [BP], maintenance of centrosome location [BP], positive regulation of protein kinase B signaling cascade [BP], active induction of host immune response by virus [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP], positive regulation of isotype switching to IgA isotypes [BP]
CG_h9laurent_promoter_n_RM_12_325_13	3	0.5	2.37E-04	GNPNAT1, WNT11, PLA2G6	positive regulation of protein kinase C signaling cascade [BP], N-acetylglucosamine metabolic process [BP]
CG_h9laurent_promoter_n_RM_14_56_9	2	0.25	3.18E-04	ELAVL1, MEX3D	AU-rich element binding [MF]
CG_h9laurent_promoter_n_RM_12_137_6	1	0.25	2.32E-04	AXIN1, MBOAT4, CITED2	embryonic eye morphogenesis [BP], positive regulation of transforming growth factor beta receptor signaling pathway [BP], peptidyl-serine octanoylation [BP], serine O-acyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_43_2	2	0.25	3.63E-04	AGO2	endoribonuclease activity, cleaving siRNA-paired mRNA [MF]
CG_h9laurent_promoter_n_RM_14_315_9	5	0.75	3.12E-04	VGF	generation of precursor metabolites and energy [BP]
CG_h9laurent_promoter_n_RM_14_55_11	2	0.25	2.34E-04	SF1, NCBP2, NR2F6, CA12, ZNF704, POLR2E, ANKMY1, FASN, WDR82, RAPGEF3, PID1, RNF130, WDHD1, LENG9, CREBBP, MLL3	energy reserve metabolic process [BP], histone methyltransferase activity (H3-K4 specific) [MF], nucleoplasm [CC], zinc ion binding [MF]
CG_h9laurent_promoter_n_RM_12_601_16	3	0.5	3.51E-04	NCBP2, GEMIN8	spliceosomal snRNP assembly [BP], mRNA cis splicing, via spliceosome [BP]
CG_h9laurent_promoter_n_RM_12_100_12	2	0.25	3.70E-04	DICER1, PARN, GCLC, IRF1, RPL22, SRP68, RAB3A, MNX1, BCL2, NR3C1	regulation of mitochondrial depolarization [BP], regulation of viral genome replication [BP], gene expression [BP], CD8-positive, alpha-beta T cell differentiation [BP], post-embryonic development [BP]
CG_h9laurent_promoter_n_RM_12_197_22	2	0.5	4.08E-04	PAX6, PTPRS, LHX6, ULK2	negative regulation of collateral sprouting [BP], forebrain neuron fate commitment [BP], cerebral cortex development [BP], negative regulation of neurogenesis [BP]
CG_h9laurent_promoter_n_RM_12_234_21	4	0.75	3.73E-04	CBX4, CHD4, HIRA, SIX4, SOX15, SMAD2, HOXB5, HOXB2, GAS1, SETD2, BRD3, CNR1	chromatin organization [BP], regulation of penile erection [BP], embryonic cranial skeleton morphogenesis [BP], chromatin modification [BP], embryonic skeletal system morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_332_13	2	0.25	2.20E-04	PARD3, SIAH1, AXIN1, SCRIB, NDRG1, GCNT4	beta-catenin destruction complex [CC], cell-cell adherens junction [CC], tissue morphogenesis [BP]
CG_h9laurent_promoter_n_RM_16_70_4	3	0.25	4.47E-04	CITED2, GOLPH3, LRP2, ADAMTS8, TWIST1	cell proliferation [BP], neural tube closure [BP], cardiac neural crest cell development involved in heart development [BP], cell aging [BP], embryonic camera-type eye morphogenesis [BP], low affinity phosphate transmembrane transporter activity [MF], bone morphogenesis [BP], cellular response to hypoxia [BP], outflow tract morphogenesis [BP], cell proliferation involved in heart valve development [BP], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], endocardial cushion development [BP]
CG_h9laurent_promoter_n_RM_12_346_20	5	0.75	2.89E-04	PMP22, BTG3, GNB1, RPS6KA2, SESTD1, CDK5, NACC2, KIF16B	receptor catabolic process [BP], peripheral nervous system development [BP], phosphatidylinositol-3,4-bisphosphate binding [MF], phosphatidylinositol-3-phosphate binding [MF], regulation of receptor recycling [BP], cardiac muscle cell apoptotic process [BP], negative regulation of cell proliferation [BP], phosphatidylinositol-3,5-bisphosphate binding [MF]
CG_h9laurent_promoter_n_RM_14_272_6	2	0.25	2.56E-04	TONSL, PKD1	cytoplasmic sequestering of transcription factor [BP]
CG_h9laurent_promoter_n_RM_12_210_13	2	0.25	3.53E-04	TOLLIP, ARNT, MLXIPL, PARD3, SMARCD3, SMARCC1	positive regulation of glycolysis [BP], npBAF complex [CC], nBAF complex [CC], wound healing, spreading of cells [BP], positive regulation of protein sumoylation [BP]
CG_h9laurent_promoter_n_RM_12_359_12	3	0.5	3.40E-04	CBX8, PHC2	PRC1 complex [CC]
CG_h9laurent_promoter_n_RM_12_493_25	3	0.5	2.80E-04	SLC2A1, GCLC	L-ascorbic acid metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_11_17	1	0.25	2.55E-04	SIRT6	nuclear telomeric heterochromatin [CC]
CG_h9laurent_promoter_n_RM_12_228_28	2	0.5	2.73E-04	TFAP2A, CREBBP, SIX4	inner ear morphogenesis [BP], RNA polymerase II transcription coactivator activity [MF]
CG_h9laurent_promoter_n_RM_14_274_6	2	0.25	4.13E-04	PRPSAP1, PRDX3	negative regulation of kinase activity [BP]
CG_h9laurent_promoter_n_RM_20_8_9	1	0.25	3.88E-06	ZFHX3, ARF3	GTPase activity [MF], GTP binding [MF]
CG_h9laurent_promoter_n_RM_12_55_10	3	0.5	2.06E-04	APBB1	axonogenesis [BP]
CG_h9laurent_promoter_n_RM_12_351_12	3	0.25	3.18E-04	PER2, MTNR1A, PANK4, NR1D1, PANK1	coenzyme A biosynthetic process [BP], pantothenate kinase activity [MF], circadian rhythm [BP]
CG_h9laurent_promoter_n_RM_14_375_4	2	0.25	2.78E-04	NCBP2, PLXNA2, CHSY1, TCF3, SDC1, ELL	cerebellar granule cell precursor tangential migration [BP], protein complex [CC], positive regulation of viral transcription [BP], muscle cell differentiation [BP], chondroitin sulfate metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_158_8	2	0.25	2.22E-04	CHSY1, CSPG5	chondroitin sulfate biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_238_12	3	0.25	2.48E-04	IRF7, PRKAA1, UBE2N, UBE2V1	nucleotide-binding oligomerization domain containing signaling pathway [BP], toll-like receptor 4 signaling pathway [BP], response to activity [BP], UBC13-UEV1A complex [CC], ubiquitin ligase complex [CC], MyD88-dependent toll-like receptor signaling pathway [BP], protein K63-linked ubiquitination [BP], Toll signaling pathway [BP], toll-like receptor signaling pathway [BP], ubiquitin conjugating enzyme complex [CC]
CG_h9laurent_promoter_n_RM_12_333_9	3	0.25	2.75E-04	LPHN1, DENND1A, PCDH8	presynaptic membrane [CC]
CG_h9laurent_promoter_n_RM_12_304_13	4	0.75	3.06E-04	FOXJ1, PRX, DICER1, LRP4, HIRA, RAD21, PCSK6, NOTCH1, RTN2, SAV1, BARX1, ABCA2, IRF7, SHH, IRF1, SIGMAR1, NCKAP1, TOP2A, SMURF1	regulation of MyD88-dependent toll-like receptor signaling pathway [BP], regulation of oligodendrocyte differentiation [BP], cell death [BP], lung epithelium development [BP], nuclear chromosome [CC], stem cell development [BP], zygotic determination of anterior/posterior axis, embryo [BP], hair follicle morphogenesis [BP], digestive system development [BP], foregut morphogenesis [BP], embryonic hindlimb morphogenesis [BP], embryonic heart tube development [BP], negative regulation of ossification [BP], embryo development [BP], hair follicle development [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_14_253_12	3	0.5	3.13E-04	LMO2, TWIST1	E-box binding [MF], bHLH transcription factor binding [MF]
CG_h9laurent_promoter_n_RM_14_239_6	2	0.25	4.38E-04	GNB1, PHLPP2	photoreceptor inner segment [CC], photoreceptor outer segment membrane [CC]
CG_h9laurent_promoter_n_RM_12_113_9	2	0.25	2.76E-04	CDK5, CYTH1	skeletal muscle tissue development [BP], regulation of ARF protein signal transduction [BP]
CG_h9laurent_promoter_n_RM_16_51_5	3	0.5	3.96E-04	RAB3A	response to electrical stimulus [BP]
CG_h9laurent_promoter_n_RM_12_22_18	4	0.25	3.44E-04	GDF2	negative regulation of blood vessel endothelial cell migration [BP]
CG_h9laurent_promoter_n_RM_14_378_6	2	0.25	4.09E-04	NPLOC4, MAPK1, PHIP, CTBP1	Golgi organization [BP], positive regulation of peptidyl-threonine phosphorylation [BP]
CG_h9laurent_promoter_n_RM_16_10_2	1	0.25	3.38E-04	WDHD1, ABCC4	15-hydroxyprostaglandin dehydrogenase (NAD+) activity [MF], heterochromatin maintenance [BP]
CG_h9laurent_promoter_n_RM_16_55_2	4	0.5	2.59E-04	ADRA1D, PAXIP1, POLR2E, BRF1, SLX4, SMURF2	ERCC4-ERCC1 complex [CC], negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [BP], DNA metabolic process [BP], positive regulation of histone H3-K36 methylation [BP], DNA recombination [BP], Holliday junction resolvase complex [CC], transcription from RNA polymerase III promoter [BP], transcription factor TFIIIB complex [CC], DNA repair [BP], transcription initiation from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_520_20	3	0.75	2.56E-04	MAD2L2, NCAPG2, ELAVL1, POLQ, TLE2, FOXO1, SLC2A1, CBX8, CHD1, LHCGR, SIK1, THRB, MAPK9, TTLL1, MDC1, CEP41, ALYREF, PTGIR, TP53BP1, ANAPC1, COIL, ICMT, TOLLIP, SOCS3, GEMIN4, GRB2, CDK5, MBD2, XAB2, HMX1	branching involved in labyrinthine layer morphogenesis [BP], methylated histone residue binding [MF], negative regulation of transcription, DNA-dependent [BP], cAMP response element binding protein binding [MF], protein polyglutamylation [BP], kinase binding [MF], positive regulation of cAMP-mediated signaling [BP], nucleoplasm [CC]
CG_h9laurent_promoter_n_RM_12_261_21	2	0.5	7.77E-05	CTBP1, ANKH	inorganic diphosphate transmembrane transporter activity [MF], regulation of transcription by chromatin organization [BP]
CG_h9laurent_promoter_n_RM_12_515_11	2	0.25	2.26E-04	SCARB2, FLT4, KRT1, WNT11, TBC1D8	positive regulation of protein kinase C signaling cascade [BP], membrane [CC]
CG_h9laurent_promoter_n_RM_12_265_11	4	0.5	3.19E-04	AKT1, PSMD12, EDC3, PSMB5, MGEA5, BCL2L1	positive regulation of protein complex disassembly [BP], mRNA metabolic process [BP], cell cycle checkpoint [BP], negative regulation of release of cytochrome c from mitochondria [BP]
CG_h9laurent_promoter_n_RM_12_106_10	3	0.25	3.66E-04	HOXA5, FGFR2, MAP3K14	lung-associated mesenchyme development [BP], MAP kinase kinase kinase activity [MF]
CG_h9laurent_promoter_n_RM_16_53_5	4	0.5	2.32E-04	KCNMA1, CIZ1	negative regulation of cell volume [BP], cellular potassium ion homeostasis [BP], eye blink reflex [BP], maintenance of nucleus location [BP]
CG_h9laurent_promoter_n_RM_12_580_12	2	0.25	2.52E-04	DOCK4	guanyl-nucleotide exchange factor activity [MF]
CG_h9laurent_promoter_n_RM_14_313_9	3	0.5	4.71E-04	BCL6, DLG4, LRP4, ADAM17, GRIK3	receptor clustering [BP], dendrite cytoplasm [CC], germinal center formation [BP]
CG_h9laurent_promoter_n_RM_14_334_4	2	0.25	2.30E-04	AFG3L2, SNTA1	neuromuscular junction development [BP]
CG_h9laurent_promoter_n_RM_16_59_3	1	0.25	3.50E-04	SYNE1	nuclear matrix anchoring at nuclear membrane [BP]
CG_h9laurent_promoter_n_RM_14_198_15	4	0.5	4.78E-04	SMARCC1, HMGB2, TLE1, PPP4R1, POLE, CBX4, MNX1, SAP130, NCOA2, SMURF2, TWIST1, DGCR2, ARPP19, KLF4, MED16, TLE2, MTA2, CITED4, ALYREF, LDB1, BCOR, GMEB2, BRD3, SOX21, NFIB, TRPS1, HIRA, TCF15, SMEK1, SMARCC2	transcription factor binding transcription factor activity [MF], positive regulation of gluconeogenesis [BP], protein phosphatase 4 complex [CC], transcription coactivator activity [MF], transcription corepressor activity [MF], organ morphogenesis [BP], positive regulation of hemoglobin biosynthetic process [BP], thyroid hormone receptor coactivator activity [MF], transcription cofactor activity [MF], negative regulation of transcription, DNA-dependent [BP], chromatin binding [MF], chromatin organization [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_7_17	2	0.25	3.32E-04	ACSL1, ELOVL4	long-chain fatty-acyl-CoA biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_359_8	2	0.5	2.67E-04	GCLC, OPLAH, USP4	glutathione biosynthetic process [BP], negative regulation of protein ubiquitination [BP]
CG_h9laurent_promoter_n_RM_14_91_23	7	0.75	4.05E-04	NCBP2, SMG5, GRSF1, DEAF1, GLIS1, HNRPLL, SOX15, MLL3, EID2B, STK39, MNX1, CREBZF, PIAS2, KANSL1, HECTD4, SIX4, SIX5, DGKQ, HOXA13, BHLHE23, WHSC1L1, HOXA10, IRF2BP2, FOSL1, ATE1, ZNF644, RLIM, ZNF514, ZBTB2, POU3F1, SP3, SIAH1, USP28, XPO1, MIER3, ALYREF, SLC25A22, SS18, PAX3, SNAPC4, SETD3, USP48, PNCK, HIRA, UBE2N, SUGP2, ADARB2, IRS1, E2F8, HOXA7, TONSL, SMEK1, PPP1R13B, ELK4, MBD2, MLF1IP, TUBGCP2, BCL6, WIZ, SLBP	transcription from RNA polymerase II promoter [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], gene expression [BP], RNA metabolic process [BP], mRNA binding [MF], nucleus [CC]
CG_h9laurent_promoter_n_RM_12_564_16	3	0.75	3.79E-04	ALG5, TNIP1, NKX3-1, SAR1B, MAN1A1, BCL2, ALG2	glycoprotein biosynthetic process [BP], negative regulation of mitotic cell cycle [BP], protein N-linked glycosylation via asparagine [BP]
CG_h9laurent_promoter_n_RM_16_12_3	1	0.25	2.56E-04	GATM	glycine amidinotransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_195_9	7	1.0	3.61E-04	BAG6, FZD5, CTTNBP2	brain development [BP]
CG_h9laurent_promoter_n_RM_12_13_23	4	0.75	3.48E-04	KIF16B	regulation of receptor recycling [BP]
CG_h9laurent_promoter_n_RM_14_351_16	3	0.5	2.96E-04	IGF2, ACTB, IRS1, EPC1, CPT1A	insulin-like growth factor receptor binding [MF], positive regulation of glycogen biosynthetic process [BP], positive regulation of insulin receptor signaling pathway [BP], positive regulation of fatty acid beta-oxidation [BP], NuA4 histone acetyltransferase complex [CC]
CG_h9laurent_promoter_n_RM_14_28_13	1	0.25	3.59E-04	TXN, MINA	RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF], peptide disulfide oxidoreductase activity [MF]
CG_h9laurent_promoter_n_RM_12_568_28	4	0.5	3.71E-04	AXIN1, PHIP, RRP8	regulation of transcription by glucose [BP], positive regulation of peptidyl-threonine phosphorylation [BP]
CG_h9laurent_promoter_n_RM_12_446_16	3	0.5	3.41E-04	WLS, LAMA5, CRLF1, TLE2, CDX2, DKK3, WNT4, DLL1, HAND2, CXCR4, SHH, TRABD2B, WNT11, SOX18	adrenal gland development [BP], immature T cell proliferation in thymus [BP], anterior/posterior pattern specification [BP], ureteric bud morphogenesis [BP], positive regulation of oligodendrocyte differentiation [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], blood vessel development [BP], neural crest cell migration [BP], renal system development [BP], heart morphogenesis [BP], negative regulation of Wnt receptor signaling pathway [BP], canonical Wnt receptor signaling pathway [BP], lung-associated mesenchyme development [BP], pattern specification process [BP], somite development [BP], ureteric bud development [BP], Wnt receptor signaling pathway [BP], vasculature development [BP], determination of left/right symmetry [BP], heart looping [BP], embryonic heart tube development [BP], axis specification [BP]
CG_h9laurent_promoter_n_RM_12_529_15	3	0.25	3.21E-04	AK3	UTP metabolic process [BP]
CG_h9laurent_promoter_n_RM_14_338_3	1	0.25	3.25E-04	CTGF, HDAC4, SYNC, MAP3K11	positive regulation of JNK cascade [BP], neuromuscular junction [CC]
CG_h9laurent_promoter_n_RM_12_52_11	3	0.5	3.28E-04	ATP1A3, GRIK3	ionotropic glutamate receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_344_17	3	0.5	2.33E-04	GRIK3, SCN5A, SMAD7	membrane depolarization involved in regulation of action potential [BP], membrane depolarization involved in regulation of cardiac muscle cell action potential [BP], regulation of membrane potential [BP], regulation of ventricular cardiac muscle cell membrane depolarization [BP]
CG_h9laurent_promoter_n_RM_12_370_15	3	0.5	3.43E-04	MED13, NFKBIA, KCTD1, HES6, TLE1	RNA polymerase II transcription cofactor activity [MF], transcription factor binding [MF], transcription cofactor activity [MF]
CG_h9laurent_promoter_n_RM_14_224_7	2	0.25	2.35E-04	SYNJ1	synaptic vesicle endocytosis [BP]
CG_h9laurent_promoter_n_RM_12_313_17	3	0.75	2.68E-04	HLCS, PAX6, CEBPA, STAT6	RNA polymerase II core promoter sequence-specific DNA binding [MF], chromatin [CC], HMG box domain binding [MF]
CG_h9laurent_promoter_n_RM_12_527_10	3	0.5	2.73E-04	NT5C2, MECR	nucleotide binding [MF]
CG_h9laurent_promoter_n_RM_12_172_12	3	0.5	2.96E-04	ATXN1, KHDRBS2	poly(U) RNA binding [MF]
CG_h9laurent_promoter_n_RM_14_318_7	4	0.75	2.74E-04	ADCY9, SHANK1, UCN	dendritic spine morphogenesis [BP], positive regulation of dendritic spine development [BP], activation of protein kinase A activity [BP]
CG_h9laurent_promoter_n_RM_12_394_21	2	0.25	3.43E-04	BUD13, NR3C1, MEX3D	RES complex [CC], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], glucocorticoid receptor activity [MF]
CG_h9laurent_promoter_n_RM_12_396_6	2	0.25	1.81E-04	MICAL1	oxidation-reduction process [BP]
CG_h9laurent_promoter_n_RM_12_245_25	2	0.25	2.72E-04	FBXO31, PTCH1	cyclin binding [MF]
CG_h9laurent_promoter_n_RM_12_120_11	3	0.5	1.86E-04	CD24, TOP2B, PXN, AKT1, FLNA	protein kinase C binding [MF], protein kinase binding [MF]
CG_h9laurent_promoter_n_RM_12_3_12	2	0.25	6.10E-05	OPLAH, SDF4	zymogen granule exocytosis [BP], 5-oxoprolinase (ATP-hydrolyzing) activity [MF]
CG_h9laurent_promoter_n_RM_12_150_21	2	0.5	2.77E-04	PTK2, ITGA5, EPHB4, PRKD1, SETD2	angiogenesis [BP], integrin-mediated signaling pathway [BP], negative regulation of anoikis [BP]
CG_h9laurent_promoter_n_RM_12_549_13	2	0.5	2.74E-04	UCK1, PFN2, UCKL1, PIP5K1C	regulation of synaptic vesicle exocytosis [BP], nucleoside kinase activity [MF], uridine kinase activity [MF], CTP salvage [BP], UMP salvage [BP], synaptic vesicle exocytosis [BP]
CG_h9laurent_promoter_n_RM_14_46_5	2	0.25	3.41E-04	HOXA1, KCNK9	cochlea development [BP]
CG_h9laurent_promoter_n_RM_12_39_12	3	0.5	3.58E-04	PCBD1, GCH1	pteridine-containing compound biosynthetic process [BP], tetrahydrobiopterin biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_300_13	4	0.5	2.54E-04	CDKN2A, SYT7, MYH10	negative regulation of ubiquitin-protein ligase activity [BP], plasma membrane repair [BP]
CG_h9laurent_promoter_n_RM_12_513_21	2	0.25	2.69E-04	INPP5K, PYGL, CTNND2, PPP1CA, TTLL7	regulation of glycogen biosynthetic process [BP], glycogen metabolic process [BP], perikaryon [CC]
CG_h9laurent_promoter_n_RM_14_197_11	2	0.25	2.63E-04	POM121C, KPNA1, KRAS, MAD1L1	nuclear pore [CC], LRR domain binding [MF]
CG_h9laurent_promoter_n_RM_12_400_16	5	0.75	2.75E-04	MCFD2, P4HB, HECTD1, YBX2, SMURF1	endoplasmic reticulum-Golgi intermediate compartment [CC], protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP], translational attenuation [BP]
CG_h9laurent_promoter_n_RM_16_39_6	5	0.5	2.12E-04	RAF1, MAP3K6, ERCC1	syncytium formation [BP], MAP kinase kinase kinase activity [MF]
CG_h9laurent_promoter_n_RM_12_200_23	2	0.25	3.55E-04	TENM4, DICER1	positive regulation of myelination [BP]
CG_h9laurent_promoter_n_RM_12_5_14	2	0.5	4.90E-04	GPR143, LPHN1	calcium-mediated signaling using intracellular calcium source [BP]
CG_h9laurent_promoter_n_RM_12_486_14	2	0.25	2.69E-04	CDKN2B, PIEZO1, CDKN1C, PODXL	cyclin-dependent protein kinase inhibitor activity [MF], positive regulation of cell-cell adhesion mediated by integrin [BP]
CG_h9laurent_promoter_n_RM_14_76_20	2	0.25	3.99E-04	HDAC4, BACH2, SPIRE1, IRS2, EZH2, GPC4, ZFHX3, FOXN4, RHOA, IRX2, FOXI3, ADNP, FZD4	cleavage furrow formation [BP], sequence-specific DNA binding [MF], anatomical structure morphogenesis [BP], brain development [BP], cerebellar cortex development [BP]
CG_h9laurent_promoter_n_RM_16_7_35	2	0.25	3.98E-04	UBL3, ZCCHC14, FBXO11, PODXL, MAFA, PYCR1, CDK2AP1, HDAC4, SIX4, NFE2L2, LMF1, IRF2BP2, ESRP2, DGKI, CUL7, NECAB3, IRX2, ZNF367, EVX2, CENPV, SETD2, NKX6-2, BRD3, SBF1, STRBP, HCN1, KLLN, GSK3B, GFRA2, PIP4K2B, PKM, YBX2, ADNP, ELAVL2, RRP9, ZNF219, MLL3, CDYL2, MNX1, FOXI3, NCKAP1, DHX37, SRSF4, GTF2E2, CSRNP1, ZIC5, REXO1, TOP2A, ZZZ3, TCF3, DNASE1L1, VEGFC, ANAPC2, THOC7, IRF2, TAF4, PSMD12, TOX3, LIN54, LCORL, SMAD9, JAZF1, ZFHX3, RCOR2, TAF11, SHROOM4, PRKD3, ATXN7L3, NCOR2, IKZF2, TBC1D9, ZHX3, HOXA10, WDR26, PERP, RANBP9, PAX3, ASH1L, PHF21A, MECP2, TPMT, CELSR1, TCEA1, AGAP2, BARX1, ARFGEF1, BCOR, GMEB2, HEY1, CNOT6L, APBA1, SOS2, PLXNA2, PDE4DIP, NKX3-2, RILPL1, CUL3, PREP, GTF2A1, KCTD1, PTK2, JHDM1D, USP7, WASL, CPSF7, ELF2, ODC1, ANKRD11, RPS6KA3, KLF4, JAG2, ZC3H7A, RP9, MSI1, GPC3, EBF3, TTBK2, CLTCL1, MEX3D, SOX21, PCDH1, RPL35, NOTCH3, SCRIB, ZBTB45, RYK	protein binding transcription factor activity [MF], transcription factor complex [CC], nervous system development [BP], protein glycosylation in Golgi [BP], nucleobase-containing compound metabolic process [BP], regulation of transcription, DNA-dependent [BP], cell development [BP], sequence-specific DNA binding transcription factor activity [MF], nucleic acid binding [MF], epithelial tube formation [BP], nucleus [CC], RNA metabolic process [BP], apical protein localization [BP], anatomical structure morphogenesis [BP], mRNA destabilization [BP], intracellular [CC], endomembrane system organization [BP], regulation of transcription from RNA polymerase II promoter [BP], methylation [BP], DNA binding [MF], asymmetric protein localization [BP], morphogenesis of embryonic epithelium [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], nucleoplasm [CC], regulation of gene expression [BP], embryo development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_72_14	2	0.25	2.50E-04	DICER1, DYNC1LI2, PLXNA2	centrosome localization [BP], neuron projection morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_155_16	3	0.25	3.20E-04	GABBR2, RUNX1, GABBR1, POU4F1	peripheral nervous system neuron development [BP], G-protein coupled GABA receptor activity [MF], regulatory region DNA binding [MF]
CG_h9laurent_promoter_n_RM_14_168_14	3	0.5	2.10E-04	FAF1, GPRIN1, DPYSL3, XPO1	phosphoprotein binding [MF], regulation of protein catabolic process [BP]
CG_h9laurent_promoter_n_RM_14_192_4	2	0.25	4.09E-04	TRPS1, STX6, KIF13A, PDGFA, GLG1	regulation of chondrocyte differentiation [BP], trans-Golgi network membrane [CC], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_h9laurent_promoter_n_RM_12_142_16	2	0.25	3.64E-04	NCOR1, EGR2	RNA polymerase II activating transcription factor binding [MF]
CG_h9laurent_promoter_n_RM_14_188_5	2	0.25	1.78E-04	CLCN7, CLCN2	response to pH [BP], voltage-gated chloride channel activity [MF]
CG_h9laurent_promoter_n_RM_14_37_9	3	0.5	3.95E-04	PTK2, FGFR2, CCDC78, KCND3	sarcolemma [CC], branching involved in salivary gland morphogenesis [BP], regulation of osteoblast differentiation [BP]
CG_h9laurent_promoter_n_RM_12_521_14	4	0.75	2.60E-04	TXN	response to dexamethasone stimulus [BP]
CG_h9laurent_promoter_n_RM_12_252_27	2	0.25	2.81E-04	TNFRSF10D, TNFRSF10B, DLL1	TRAIL binding [MF], loop of Henle development [BP]
CG_h9laurent_promoter_n_RM_12_168_14	4	0.5	3.56E-04	PIP5K1C, SEPHS1, GNB1, ADCY9, PASK, RUNX3, ABCB10, TOR1A, ABCA3, ATP9A, PHLPP2, DHX37, MAP4K3	photoreceptor outer segment membrane [CC], ATP binding [MF]
CG_h9laurent_promoter_n_RM_12_508_10	3	0.25	2.36E-04	NKX2-2, ZXDC, SIX1, ZFHX3, PURB, SATB2, MAF, TBX18, BRD7, DEDD2, IRX3, FOXN3, NEUROD2	positive regulation of mesenchymal cell proliferation involved in ureter development [BP], negative regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_n_RM_12_37_24	3	0.25	3.52E-04	BCAR1, ADCY3, SPRY2	epidermal growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_247_19	2	0.25	3.77E-04	NT5C, IMPDH1, APRT	purine nucleobase metabolic process [BP]
CG_h9laurent_promoter_n_RM_16_14_3	2	0.25	1.75E-04	MLXIPL	glucose mediated signaling pathway [BP], carbohydrate response element binding [MF]
CG_h9laurent_promoter_n_RM_12_26_18	2	0.5	3.24E-04	TAPT1	embryonic skeletal system development [BP]
CG_h9laurent_promoter_n_RM_14_155_3	3	0.25	4.63E-04	COL16A1, BRD7, CDK5, XRCC1	p53 binding [MF], collagen type XVI [CC], hippocampus development [BP], acetylcholine receptor activator activity [MF]
CG_h9laurent_promoter_n_RM_12_302_15	4	0.75	2.77E-04	IRF1, LHX3, IRF7, DLG4, VAX1, ELAVL3, KLF7, CBS, SCRT1, SIK1, KCNA2, MCCC1, GBX2	regulation of MyD88-dependent toll-like receptor signaling pathway [BP], juxtaparanode region of axon [CC], positive regulation of interferon-beta production [BP], regulation of cell differentiation [BP], axon guidance [BP], sequence-specific DNA binding transcription factor activity [MF], regulation of transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_64_23	2	0.5	2.81E-04	ABCG2, ABCB6, GNAQ, SLC18A1	heme transporter activity [MF], drug transmembrane transporter activity [MF], regulation of melanocyte differentiation [BP], heme transport [BP]
CG_h9laurent_promoter_n_RM_14_157_5	2	0.25	3.40E-04	NR2F6, SMAD7, RBBP7, PTCH1, KIF3A, AES	negative regulation of transcription from RNA polymerase II promoter [BP], neural tube patterning [BP], negative regulation of transcription, DNA-dependent [BP], dorsal/ventral neural tube patterning [BP], negative regulation of gene expression [BP], cellular heat acclimation [BP]
CG_h9laurent_promoter_n_RM_12_602_13	2	0.5	2.84E-04	GRSF1, ZC3H3, SYMPK, ALYREF, IL6ST, U2AF1, CNTFR, CRLF1	ciliary neurotrophic factor receptor binding [MF], mRNA 3'-end processing [BP], ciliary neurotrophic factor-mediated signaling pathway [BP], ciliary neurotrophic factor receptor activity [MF], mRNA polyadenylation [BP]
CG_h9laurent_promoter_n_RM_12_33_17	2	0.25	2.67E-04	BCL2	pigment granule organization [BP]
CG_h9laurent_promoter_n_RM_12_383_16	4	0.25	5.06E-04	CRAT	carnitine O-acetyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_331_7	2	0.25	2.70E-04	FOSL1, NOTCH1, GABBR1	venous endothelial cell differentiation [BP], regulation of extracellular matrix assembly [BP], presynaptic membrane [CC], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], G-protein coupled receptor dimeric complex [CC]
CG_h9laurent_promoter_n_RM_12_260_11	3	0.5	3.19E-04	CPT1B, USP7, AXIN1, WNT2, WNT4, SLC25A20, STRN, BCL11B, SETD7, NR3C1	receptor agonist activity [MF], armadillo repeat domain binding [MF], p53 binding [MF], regulation of lipid metabolic process [BP], mammary gland epithelium development [BP], carnitine shuttle [BP], regulation of glucocorticoid biosynthetic process [BP], regulation of fatty acid oxidation [BP]
CG_h9laurent_promoter_n_RM_12_565_14	4	0.25	3.30E-04	RALGDS, ADCY9, STAT5B, LDB1, PRKACA, DUSP7, NGEF	nerve growth factor receptor signaling pathway [BP], negative regulation of erythrocyte differentiation [BP]
CG_h9laurent_promoter_n_RM_12_23_27	2	0.5	3.57E-04	STIL, ZIC5, SCRIB	neural tube closure [BP]
CG_h9laurent_promoter_n_RM_12_274_12	2	0.25	3.75E-04	CEBPA, CPT1B, TWIST1, HDAC4, NFYB, SUN2, IRS1, IRS2, PRDM5, NACC2, CTBP1, SOX7, MYH10	fatty acid beta-oxidation [BP], transcription regulatory region DNA binding [MF], repressing transcription factor binding [MF], nuclear migration [BP], histone deacetylation [BP], positive regulation of fatty acid beta-oxidation [BP], regulation of fatty acid oxidation [BP]
CG_h9laurent_promoter_n_RM_14_151_7	2	0.25	3.34E-04	SNX3, SH3PXD2B	phosphatidylinositol-3-phosphate binding [MF]
CG_h9laurent_promoter_n_RM_16_34_7	2	0.25	3.28E-04	GTF2A1, TCEB2, POLR2L	transcription elongation from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_69_9	6	0.75	2.40E-04	CARD9, MAPK1, HOOK2	response to epidermal growth factor stimulus [BP], early endosome to late endosome transport [BP], response to exogenous dsRNA [BP]
CG_h9laurent_promoter_n_RM_12_335_19	3	0.5	3.71E-04	PTK2, SLBP, SYNCRIP	histone pre-mRNA 3'end processing complex [CC], establishment of nucleus localization [BP]
CG_h9laurent_promoter_n_RM_14_353_14	3	0.75	2.84E-04	STRA13, PRPSAP1, FOXN3, FOXN4	negative regulation of kinase activity [BP], double-stranded DNA binding [MF]
CG_h9laurent_promoter_n_RM_12_353_20	3	0.5	1.42E-04	HLCS, DICER1, PKD1, PCSK6, PDGFA	skin development [BP], biotin-protein ligase activity [MF], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], metanephric distal tubule morphogenesis [BP], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], lung development [BP], eukaryotic cell surface binding [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], cell surface binding [MF], histone biotinylation [BP]
CG_h9laurent_promoter_n_RM_12_294_9	3	0.5	3.61E-04	REV3L, VCP	translesion synthesis [BP]
CG_h9laurent_promoter_n_RM_14_286_7	3	0.5	2.33E-04	TLE2, BATF3, CEP41, THRB, TTLL1	transcription corepressor activity [MF], protein polyglutamylation [BP]
CG_h9laurent_promoter_n_RM_16_1_4	1	0.25	5.19E-04	PRKCQ, CDC42EP3, COBL	actin filament network formation [BP], cytoskeletal regulatory protein binding [MF], positive regulation of T-helper 2 cell activation [BP]
CG_h9laurent_promoter_n_RM_14_298_6	2	0.25	3.26E-04	GSK3B, GIPC1	dendritic shaft [CC]
CG_h9laurent_promoter_n_RM_12_385_13	1	0.25	3.72E-04	RAB35, NCBP2, ERCC1, ERCC3, CD34, TNS3, EZH2, SATB2, CXCR4, SLC8A1, POLR2L, WNT11, YBX2, TGFBR3	transcription-coupled nucleotide-excision repair [BP], positive regulation of viral transcription [BP], transcription elongation from RNA polymerase II promoter [BP], 7-methylguanosine mRNA capping [BP], palate development [BP], cell migration [BP], response to hypoxia [BP], intercellular bridge [CC], nucleotide-excision repair, DNA incision [BP], regulation of gliogenesis [BP], negative regulation of gene expression [BP], cell motility [BP], transcription from RNA polymerase II promoter [BP], UV protection [BP], positive regulation of transforming growth factor beta production [BP]
CG_h9laurent_promoter_n_RM_16_30_3	3	0.5	4.23E-04	PXN	BH4 domain binding [MF]
CG_h9laurent_promoter_n_RM_14_94_9	2	0.25	3.75E-04	CDK6, HMGB1, RORA, OVOL2, KPNA1, HNRNPR, CDK5, TRPS1	regulation of keratinocyte proliferation [BP], apoptotic DNA fragmentation [BP], cyclin-dependent protein kinase activity [MF], cyclin-dependent protein kinase holoenzyme complex [CC], cerebellar cortex formation [BP], NLS-bearing substrate import into nucleus [BP], gene expression [BP]
CG_h9laurent_promoter_n_RM_12_525_16	5	0.75	3.41E-04	CEBPA, PTK2, ACVR1, PPP1R3B, SOCS3, PPP1CA, TOP2B, NOTCH1, TESC, RUNX1, PLXNB1, COL1A1, AMPH, PLXND1, FGFR2, DIAPH1, FOXJ1	protein domain specific binding [MF], axonogenesis [BP], regulation of ossification [BP], endocardial cell differentiation [BP], neuron projection development [BP], protein phosphatase type 1 complex [CC], osteoblast differentiation [BP], positive regulation of cell differentiation [BP], regulation of osteoblast differentiation [BP], semaphorin receptor activity [MF], hair follicle morphogenesis [BP], neuron projection morphogenesis [BP], mitral valve morphogenesis [BP], lung development [BP], epidermis morphogenesis [BP], branching involved in labyrinthine layer morphogenesis [BP], glycogen granule [CC], positive regulation of granulocyte differentiation [BP], regulation of glycogen catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_157_12	2	0.5	3.32E-04	TLE2, SIAH2, LRP4, MAD2L2	negative regulation of canonical Wnt receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_64_11	2	0.25	3.65E-04	HOXA5, DICER1, CFL1, STAT5B	multicellular organism growth [BP], intestinal epithelial cell development [BP], response to amino acid stimulus [BP], negative regulation of erythrocyte differentiation [BP]
CG_h9laurent_promoter_n_RM_20_6_6	1	0.25	1.35E-04	RGS11, WNT4, GNG4, RGS19, UFSP1, RAP1GAP	regulation of G-protein coupled receptor protein signaling pathway [BP], termination of G-protein coupled receptor signaling pathway [BP], negative regulation of testosterone biosynthetic process [BP], UFM1 hydrolase activity [MF], negative regulation of testicular blood vessel morphogenesis [BP], heterotrimeric G-protein complex [CC], GTPase activator activity [MF], positive regulation of GTPase activity [BP], positive regulation of cortisol biosynthetic process [BP], negative regulation of male gonad development [BP]
CG_h9laurent_promoter_n_RM_12_393_8	2	0.25	3.04E-04	KCNB1, KCNMA1, KCNJ11	voltage-gated potassium channel complex [CC], voltage-gated potassium channel activity [MF]
CG_h9laurent_promoter_n_RM_12_97_14	2	0.5	2.41E-04	SLBP, JHDM1D, NARG2, ANO2, TBX3, PPIL4, ARHGAP4, NPLOC4, GSC2, XPO1, AXIN2, KLF14, MLH3, CSNK1D, ICA1, AKAP8L, R3HDM4, CBLB, KPNA1, FBXO43, SCAF11, FAF1, C8orf42, ZNF827, SATB1, FADS1, CENPV, MEX3B, BRD1, RGS17, ZNF521, UCKL1, PPP2CB, CAMKK1, ZBTB46, ACTR8, HIVEP2, NUDCD2	intracellular [CC], regulation of protein catabolic process [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_14_372_12	3	0.25	4.10E-04	BCL2, RELA	response to UV-B [BP]
CG_h9laurent_promoter_n_RM_12_188_25	3	0.25	3.84E-04	CD34, NES, MYO1C	basal plasma membrane [CC], stem cell proliferation [BP]
CG_h9laurent_promoter_n_RM_20_3_31	1	0.25	3.81E-04	PTK2, HDAC4, RRP9, FBXO11, ZNF219, USP7, SBF1, RCOR2, TAF11, ANKRD11, CDYL2, CDK2AP1, SHROOM4, ELF2, MNX1, NCOR2, NCKAP1, SMAD9, HEY1, SETD2, SIX4, SEMA4D, EVX2, HOXA10, WDR26, DGKI, RANBP9, JAG2, CUL7, MECP2, CUL3, ASH1L, ZZZ3, EXT1, RP9, DNASE1L1, MSI1, TPMT, ZNF367, TCEA1, ARFGEF1, PAX3, IRX2, ANAPC2, THOC7, BRD3, SOX21, PHF21A, RPS6KA3, SOS2, PCDH1, GSK3B, TOX3, PLXNA2, RILPL1, PIP4K2B, TOP2A, LCORL, LMF1	methylation [BP], vasculogenesis [BP], DNA binding [MF], anatomical structure morphogenesis [BP], embryonic cleavage [BP], endomembrane system organization [BP], protein glycosylation in Golgi [BP], central nervous system development [BP], chromatin binding [MF], axon guidance [BP], sequence-specific DNA binding transcription factor activity [MF], nucleic acid binding [MF], cyclin catabolic process [BP], nucleus [CC], skeletal system development [BP], embryo development [BP], regulation of transcription from RNA polymerase II promoter [BP], transcription from RNA polymerase II promoter [BP], regulation of Rho protein signal transduction [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_518_10	4	0.75	2.77E-04	SLC25A11	oxoglutarate:malate antiporter activity [MF]
CG_h9laurent_promoter_n_RM_12_499_18	2	0.25	3.26E-04	ABCA2, ARC	endosome [CC]
CG_h9laurent_promoter_n_RM_12_531_25	3	0.75	3.37E-04	CDO1, CBS	L-cysteine catabolic process [BP], cysteine metabolic process [BP]
CG_h9laurent_promoter_n_RM_14_110_2	2	0.25	3.92E-04	SLC35D1	UDP-glucuronic acid transmembrane transporter activity [MF], UDP-N-acetylgalactosamine transport [BP], UDP-glucuronic acid transport [BP], UDP-N-acetylgalactosamine transmembrane transporter activity [MF]
CG_h9laurent_promoter_n_RM_12_256_17	3	0.5	4.03E-04	TLE1, CNOT6L, CITED1, MEX3D	negative regulation of Wnt receptor signaling pathway [BP], mRNA destabilization [BP]
CG_h9laurent_promoter_n_RM_14_26_10	4	0.5	2.61E-04	CCSAP, IFT140	cilium basal body [CC]
CG_h9laurent_promoter_n_RM_12_278_5	4	0.5	3.22E-04	TAL1, RPS2, MRPL28, MRPL36	structural constituent of ribosome [MF], Lsd1/2 complex [CC]
CG_h9laurent_promoter_n_RM_12_541_15	4	0.5	3.29E-04	SERGEF, BAZ1A, OAT, RANBP10, MESP1, TOP2B, CDK2AP1, H2AFX	DNA-dependent DNA replication [BP], replication fork [CC], positive regulation of striated muscle cell differentiation [BP], cellular amino acid biosynthetic process [BP], Ran guanyl-nucleotide exchange factor activity [MF]
CG_h9laurent_promoter_n_RM_14_247_14	3	0.5	2.92E-04	JAG1, CARD9	response to muramyl dipeptide [BP]
CG_h9laurent_promoter_n_RM_12_375_13	3	0.75	3.00E-04	RASGEF1C, RASGEF1A, TBL1XR1, RGL2, TNIP1, SIGIRR, C11orf95, TBC1D10A, HDAC4, RERE	histone deacetylase complex [CC], intracellular [CC]
CG_h9laurent_promoter_n_RM_12_84_14	4	0.5	5.36E-04	DCTD	dCMP deaminase activity [MF]
CG_h9laurent_promoter_n_RM_12_226_13	2	0.25	3.11E-04	EPB41L4B, GNG7, GNA13, ARRB1, LPAR1, EEA1	Rho protein signal transduction [BP], positive regulation of Rho protein signal transduction [BP], extrinsic to internal side of plasma membrane [CC], angiotensin receptor binding [MF], extrinsic to membrane [CC], extrinsic to plasma membrane [CC], heterotrimeric G-protein complex [CC]
CG_h9laurent_promoter_n_RM_14_22_17	2	0.5	4.02E-04	PRKAR1B, ADCY9	activation of protein kinase A activity [BP]
CG_h9laurent_promoter_n_RM_12_478_18	3	0.5	2.32E-04	HDAC4, TFAP2A, TSHZ3, COMMD7, NRARP, WNT4, ROR2, FOXN3, ZBTB7A	pattern specification process [BP], negative regulation of transcription, DNA-dependent [BP], negative regulation of gene expression [BP], positive regulation of canonical Wnt receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_357_28	3	0.75	3.24E-04	ELK4, ELOVL7, ELOVL2, NKX3-1, JAG2, ESR2	fatty acid elongation, polyunsaturated fatty acid [BP], core promoter binding [MF], gamma-delta T cell differentiation [BP], very long-chain fatty acid biosynthetic process [BP], estrogen receptor activity [MF]
CG_h9laurent_promoter_n_RM_14_114_4	2	0.25	2.88E-04	CDK5	sensory perception of pain [BP]
CG_h9laurent_promoter_n_RM_16_71_7	3	0.25	5.24E-04	EZH2, EXOSC6, DONSON, TWIST1, THOC7, AFF3, BHLHE23, RORA, MAPK1, PHIP, TBX18, SMEK1, BRWD1, POU3F1, LARP6, MCM6, HSF2BP, TP53INP1, MEX3D, FGFR2, H2AFV, TRPS1, LRP6, APBA3, LRP8, ACSL6, TCF15, CAMKK1, TOX3, ACTL6B, GAS1, ZNF503, ANKRD54	neuroblast proliferation [BP], ear development [BP], positive regulation of mesenchymal cell proliferation [BP], positive regulation of peptidyl-threonine phosphorylation [BP], embryonic hindlimb morphogenesis [BP], nucleus [CC], skeletal system morphogenesis [BP], cranial suture morphogenesis [BP], regulation of transcription, DNA-dependent [BP], cerebellum morphogenesis [BP], embryonic organ development [BP], caveola [CC], RNA metabolic process [BP], protein dimerization activity [MF], skeletal system development [BP], embryonic digit morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], apolipoprotein binding [MF], somitogenesis [BP], embryonic limb morphogenesis [BP], embryonic organ morphogenesis [BP], regulation of transcription from RNA polymerase II promoter [BP], morphogenesis of embryonic epithelium [BP], transcription, DNA-dependent [BP], regulation of gene expression [BP], eye morphogenesis [BP], outer ear morphogenesis [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_12_34_8	2	0.25	2.49E-04	CELSR1, DVL1	planar cell polarity pathway involved in neural tube closure [BP], establishment of planar polarity of embryonic epithelium [BP]
CG_h9laurent_promoter_n_RM_14_173_4	1	0.25	2.06E-04	NKX6-2, MNX1, RP9, GPATCH2	endocrine pancreas development [BP], spinal cord motor neuron cell fate specification [BP], nucleic acid binding [MF]
CG_h9laurent_promoter_n_RM_14_5_13	3	0.25	2.87E-04	EFNB2	cell migration involved in sprouting angiogenesis [BP]
CG_h9laurent_promoter_n_RM_14_207_16	3	0.5	3.40E-04	RAB9B, HRAS, NOTCH1, APBB2, RRAS, MAPK1, PLXND1, BCL6, RAB15, PRKD3, PLXNB2	axonogenesis [BP], negative regulation of S phase of mitotic cell cycle [BP], intracellular signal transduction [BP], Ras protein signal transduction [BP], small GTPase mediated signal transduction [BP], cell morphogenesis [BP], semaphorin-plexin signaling pathway [BP], semaphorin receptor activity [MF]
CG_h9laurent_promoter_n_RM_12_510_12	2	0.5	1.84E-04	MLL3, FAM200A, PTCH1, GRIN2C, MNX1, THRB, KCNMA1, DNAJC2, FHL2, SALL4, BARX1, TOX3, ZNF786, SATB1, CBX8, ZSCAN10, SSBP2, ZNF800, IGDCC3, SP8	nucleic acid binding [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], neuromuscular process controlling balance [BP], heterochromatin [CC], DNA binding [MF], dorsal/ventral neural tube patterning [BP], reflex [BP]
CG_h9laurent_promoter_n_RM_14_230_19	3	0.5	3.33E-04	TRMT112, CDKN2A, NCOA6, STRN3, ELL, TRIM33, MED20, HMGB1, GCH1, PARP1, NOTCH1, CORO2A, SURF6, TOP2A, JAZF1	transcriptional repressor complex [CC], protein complex [CC], nucleoplasm [CC], transcription initiation from RNA polymerase II promoter [BP], nucleoplasm part [CC]
CG_h9laurent_promoter_n_RM_12_500_7	1	0.25	4.24E-04	UBC	energy homeostasis [BP]
CG_h9laurent_promoter_n_RM_12_570_21	3	0.5	2.88E-04	SULF2, GNS	N-acetylglucosamine-6-sulfatase activity [MF]
CG_h9laurent_promoter_n_RM_12_248_12	3	0.5	3.07E-04	NCKAP1	basal protein localization [BP], establishment or maintenance of actin cytoskeleton polarity [BP]
CG_h9laurent_promoter_n_RM_14_360_35	7	1.0	2.04E-04	PCYT2, ISYNA1, GBGT1	glycolipid biosynthetic process [BP], phospholipid biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_311_8	4	0.5	3.71E-04	BAD, RAB34, CDO1, CEBPA, RAB20	response to glucocorticoid stimulus [BP], phagosome-lysosome fusion [BP]
CG_h9laurent_promoter_n_RM_18_20_3	2	0.25	5.53E-04	UNC93B1, ICMT, SCRIB	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], C-terminal protein methylation [BP], toll-like receptor 9 signaling pathway [BP], toll-like receptor 7 signaling pathway [BP], early phagosome [CC], synaptic vesicle targeting [BP], protein C-terminal carboxyl O-methyltransferase activity [MF], protein localization to adherens junction [BP], Scrib-APC-beta-catenin complex [CC]
CG_h9laurent_promoter_n_RM_16_52_2	1	0.25	1.55E-04	ZNF709, ZNF44, ZNF442, ZNF433, LMO1	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_h9laurent_promoter_n_RM_12_327_16	2	0.25	3.26E-04	AP3S2, AP3D1, PLAG1, PTPN14, SOX18	negative regulation of gene expression [BP], lymphangiogenesis [BP], anterograde synaptic vesicle transport [BP]
CG_h9laurent_promoter_n_RM_12_547_11	2	0.25	4.33E-04	DAPK2, PRKAG2, FA2H, DPYD, RAPGEF3	dihydropyrimidine dehydrogenase (NADP+) activity [MF], fatty acid alpha-hydroxylase activity [MF], thymidine catabolic process [BP], autophagic vacuole lumen [CC], sebaceous gland cell differentiation [BP], cAMP-dependent protein kinase regulator activity [MF]
CG_h9laurent_promoter_n_RM_12_586_35	4	0.5	3.08E-04	PARS2, PRKDC, COBL, EPRS, MEOX2, PCDH8	proline-tRNA ligase activity [MF], somite specification [BP], somitogenesis [BP], prolyl-tRNA aminoacylation [BP]
CG_h9laurent_promoter_n_RM_16_38_13	5	0.5	2.56E-04	MYO9A, MYO1C	unconventional myosin complex [CC]
CG_h9laurent_promoter_n_RM_14_142_13	2	0.5	3.40E-04	HSPA5, YIF1A, MPPE1	endoplasmic reticulum-Golgi intermediate compartment [CC]
CG_h9laurent_promoter_n_RM_12_41_20	2	0.25	2.65E-04	ASXL2, WNT11, MEF2D, CEBPA	osteoblast differentiation [BP], positive regulation of fat cell differentiation [BP]
CG_h9laurent_promoter_n_RM_16_50_6	3	0.5	3.62E-04	IGF2, CEBPA, RDX, IRS2, ZFAND5, CELSR1, RAB3A, ABCB6, CPT1A	apical protein localization [BP], positive regulation of glycogen biosynthetic process [BP], respiratory system process [BP], lung development [BP], integral to mitochondrial outer membrane [CC], positive regulation of fatty acid beta-oxidation [BP]
CG_h9laurent_promoter_n_RM_14_380_11	2	0.25	3.71E-04	ANAPC7, JUP	protein phosphatase binding [MF]
CG_h9laurent_promoter_n_RM_12_349_21	3	0.5	3.01E-04	CDKN2A, SIK1, TOLLIP, FAF1, REEP1, ADCY6	protein insertion into membrane [BP], positive regulation of protein sumoylation [BP], intracellular signal transduction [BP], NF-kappaB binding [MF], protein kinase binding [MF], kinase binding [MF]
CG_h9laurent_promoter_n_RM_14_79_19	5	0.5	3.94E-04	HDAC5, SHROOM4, GSPT1, METTL5, TAF11, GTF2A1, SOX3, MAFA, CSDA, MNX1, CDK2AP1, TNRC18, GTF2E2, LHX3, CHD5, AXIN1, NFE2L2, EVX2, AFF4, THOC7, ZNF704, IRF2BP2, ZIC5, PHIP, ZNF644, HEY1, CNOT7, KDM5B, MCL1, SUGP1, HSPB6, NR3C2, NR3C1, DDIT3, H2AFY, ZC3H7A, LSM5, PSME4, ASIC2, RILPL1, SALL1, TP53BP2, GMEB2, RPS29, AGTPBP1, CSNK2A2, BRD3, SOX21, STRBP, APBA1, ARX, PIP4K2A, KLLN, CAPN12, RFX2, WNT4, TXNL1, YY1AP1, ZBTB45, GAS1, BCL6, HPSE, LCORL, HOXA9, YBX2, KCTD1	central nervous system development [BP], intracellular [CC], DNA binding [MF], renal vesicle formation [BP], adrenal gland development [BP], protein binding transcription factor activity [MF], transcription corepressor activity [MF], RNA metabolic process [BP], intracellular membrane-bounded organelle [CC], cell fate commitment [BP], forebrain development [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], regulation of glucocorticoid biosynthetic process [BP], nucleic acid binding [MF], olfactory bulb development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], pituitary gland development [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_12_257_20	2	0.25	3.15E-04	BAZ1B, TONSL	nuclear replication fork [CC]
CG_h9laurent_promoter_n_RM_12_371_19	2	0.25	3.42E-04	HMGB1, PTCH1, SERPINE2, NRARP, PYCARD	myeloid dendritic cell activation [BP], regulation of cell-cell adhesion [BP], negative regulation of smoothened signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_552_11	3	0.5	3.15E-04	SMAD9, TFAP2A, ACAP3, ARFGAP2, GIT1, NPTX1, TP53BP2, GAS1, SSH2, MNX1, HOXA1, TADA3, FNIP1	hindbrain development [BP], ARF GTPase activator activity [MF], embryo development ending in birth or egg hatching [BP], regulation of protein phosphorylation [BP], central nervous system development [BP], regulation of ARF GTPase activity [BP], embryonic cranial skeleton morphogenesis [BP], outer ear morphogenesis [BP], protein tyrosine/serine/threonine phosphatase activity [MF], nerve development [BP]
CG_h9laurent_promoter_n_RM_12_235_15	4	0.5	4.46E-04	FGFR1, EIF2AK3	positive regulation of cell cycle [BP], insulin-like growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_2_28	6	0.75	3.92E-04	FANCG, FANCC, FANCA, TENM4, NKX2-2	Fanconi anaemia nuclear complex [CC], positive regulation of oligodendrocyte differentiation [BP]
CG_h9laurent_promoter_n_RM_12_315_8	3	0.5	2.89E-04	H2AFY	chromatin modification [BP]
CG_h9laurent_promoter_n_RM_12_83_12	4	0.5	2.89E-04	DICER1, PANK4, KCTD8, PDE2A, SCRIB, PRKRA, PDE10A, PANK1	pantothenate kinase activity [MF], presynaptic membrane [CC], cGMP catabolic process [BP], production of siRNA involved in RNA interference [BP], cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [MF]
CG_h9laurent_promoter_n_RM_12_491_15	3	0.75	3.58E-04	GLI3, TBX20, DOLK	anterior semicircular canal development [BP], lambdoid suture morphogenesis [BP], dolichyl monophosphate biosynthetic process [BP], embryonic heart tube elongation [BP], lateral semicircular canal development [BP], sagittal suture morphogenesis [BP], lateral ganglionic eminence cell proliferation [BP], dolichol kinase activity [MF]
CG_h9laurent_promoter_n_RM_12_388_24	3	0.5	3.42E-04	CHD4, STAT5B, TNIP2, AKT1, NUP155, BCL6, NFIB	protein import into nucleus, translocation [BP], protein import into nucleus [BP], valine metabolic process [BP], positive regulation of B cell activation [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_512_12	2	0.5	1.56E-04	PHOX2B, NACC2	RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF]
CG_h9laurent_promoter_n_RM_14_262_5	2	0.25	2.65E-04	HLCS	biotin-protein ligase activity [MF], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], response to biotin [BP], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], histone biotinylation [BP]
CG_h9laurent_promoter_n_RM_14_260_4	2	0.25	4.30E-04	LRP4, MAP3K5, TRIM9, RUNX1, ANKS6, MPPE1, CCBL2, BCAP31	endoplasmic reticulum-Golgi intermediate compartment membrane [CC], protein homodimerization activity [MF], identical protein binding [MF]
CG_h9laurent_promoter_n_RM_12_402_9	2	0.25	3.44E-04	NCBP2, ERCC1, SMAD7, EPB41L4A, SATB1, RYBP, POLR3K, CTDSP2, WT1	nucleoplasm [CC], extrinsic to membrane [CC]
CG_h9laurent_promoter_n_RM_14_179_9	2	0.25	3.53E-04	IRF1, FBXW11, PURB, JAG2, NCOR2, ZNF746	Notch binding [MF], negative regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_n_RM_12_360_16	2	0.5	2.88E-04	PNCK, ELAVL1, EEF1A1, EEF1A2, BCL11A, TTF1, EZH1, NFYB, EZH2, ZNF32, GTF2A1, CBX8, NDRG1, RB1CC1, ZNF496, FLT3, RYK, CDYL2, HN1, STIL, SLC11A2, ZBTB14, POLDIP3, DGKQ, CSRNP1, INSL3, IRF2BP2, PLEKHA7, FASN, RANBP9, ZNF644, TLE1, ULK2, CASP6, NR3C1, SOD2, CLIC3, PELI1, RNF130, TNIP2, APPL2, FOXN4, POLR2L, RMDN3, SLC39A3, SLC39A4, RELA, SFRP2, TRIM7, SFRP1, RAPGEF5, BNC2, WNT3, IFNA2, ROCK2, ATXN3, AKT3, ELOVL7, SREBF1, ELOVL2, PRKD2, MAF, SIX4, AHNAK2, ZNF395, HIVEP2, RPS2, ERRFI1	positive regulation of collateral sprouting [BP], negative regulation of cell growth [BP], zinc ion transmembrane transporter activity [MF], negative regulation of B cell differentiation [BP], negative regulation of collateral sprouting [BP], regulation of apoptotic process [BP], organ development [BP], Wnt-protein binding [MF], axon extension [BP], nervous system development [BP], Wnt receptor signaling pathway involved in somitogenesis [BP], triglyceride biosynthetic process [BP], cellular response to X-ray [BP], positive regulation of cellular metabolic process [BP], regulation of transcription, DNA-dependent [BP], Wnt-activated receptor activity [MF], nucleus [CC], RNA metabolic process [BP], fatty acid synthase activity [MF], detection of oxygen [BP], cell death [BP], long-chain fatty-acyl-CoA biosynthetic process [BP], negative regulation of peptidyl-tyrosine phosphorylation [BP], convergent extension involved in axis elongation [BP], negative regulation of apoptotic process [BP], eukaryotic translation elongation factor 1 complex [CC], negative regulation of gene expression [BP], very long-chain fatty acid biosynthetic process [BP], negative regulation of planar cell polarity pathway involved in axis elongation [BP], regulation of transcription from RNA polymerase II promoter [BP], fatty acid elongation, polyunsaturated fatty acid [BP], negative regulation of axon extension [BP], frizzled binding [MF], transcription, DNA-dependent [BP], response to starvation [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_14_284_19	3	0.5	4.38E-04	LRP4, TWIST1, BRD3, HSPG2, H2AFY, IRS2, CHRDL2, KPNA3, BCOR, CBX8, GAS1, CTBP1, PITX1, FGFR2, SHANK1, BCL2, AXIN1	embryonic skeletal system morphogenesis [BP], chromatin modification [BP], PcG protein complex [CC], positive regulation of mesenchymal cell proliferation [BP], cranial suture morphogenesis [BP], negative regulation of protein metabolic process [BP], ossification [BP], positive regulation of fatty acid beta-oxidation [BP], protein C-terminus binding [MF], negative regulation of ossification [BP], negative regulation of histone acetylation [BP], mesenchymal cell proliferation involved in lung development [BP], outer ear morphogenesis [BP], skeletal system development [BP]
CG_h9laurent_promoter_n_RM_16_54_3	1	0.25	2.65E-04	GATA2, TAF5L, JUN, ZFHX3, NACC2	enhancer sequence-specific DNA binding [MF], transcriptional repressor complex [CC], transcription regulatory region DNA binding [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], sequence-specific DNA binding transcription factor activity [MF], leading edge cell differentiation [BP], cellular response to potassium ion starvation [BP], negative regulation of fat cell proliferation [BP], RNA polymerase II distal enhancer sequence-specific DNA binding [MF]
CG_h9laurent_promoter_n_RM_14_118_3	2	0.25	3.33E-04	IRAK1, EHD1, NUDT18	8-hydroxy-dADP phosphatase activity [MF], lipid particle [CC], 8-oxo-GDP phosphatase activity [MF], 8-oxo-dGDP phosphatase activity [MF]
CG_h9laurent_promoter_n_RM_12_368_18	4	0.75	2.90E-04	TBC1D2B, GOLPH3, OSBPL1A, SNTB1, IRS2, RAPH1, AGAP2, PITPNM3, IQSEC1, PRAM1, STARD10	phospholipid binding [MF], lipid binding [MF]
CG_h9laurent_promoter_n_RM_14_158_14	3	0.5	4.25E-04	PTK2	establishment of nucleus localization [BP]
CG_h9laurent_promoter_n_RM_14_221_9	5	0.5	4.59E-04	SAP130, TAF5L	STAGA complex [CC]
CG_h9laurent_promoter_n_RM_14_266_5	2	0.25	3.70E-04	SLC4A7	stereocilium [CC]
CG_h9laurent_promoter_n_RM_12_575_23	4	0.5	3.18E-04	CAMK2B, ANAPC2	positive regulation of synapse maturation [BP]
CG_h9laurent_promoter_n_RM_14_363_10	2	0.25	4.91E-04	TNK2, TMEM127, LRRC4B, DLG4, GRIK3, RHBDF2, ESYT2, FAT1, GNA12, ABCC9, BTC, MFAP3L, SLC8A2, SLC20A2	dendrite cytoplasm [CC], epidermal growth factor receptor binding [MF], plasma membrane [CC]
CG_h9laurent_promoter_n_RM_12_408_9	4	0.75	3.69E-04	ZFAT	spongiotrophoblast layer development [BP]
CG_h9laurent_promoter_n_RM_12_19_23	1	0.25	2.77E-04	SRXN1, PRDX3, CDCA5, AKT1	interphase of mitotic cell cycle [BP], maternal placenta development [BP], sulfiredoxin activity [MF], alkyl hydroperoxide reductase activity [MF]
CG_h9laurent_promoter_n_RM_14_156_14	3	0.5	4.58E-04	REV3L, MAD2L2	zeta DNA polymerase complex [CC]
CG_h9laurent_promoter_n_RM_12_379_11	2	0.25	2.58E-04	TP53RK, CREBBP, NCBP2, USP7, EIF4E3	p53 binding [MF], mRNA cap binding complex [CC]
CG_h9laurent_promoter_n_RM_12_545_10	1	0.25	3.56E-04	HDAC2, LAMA5, FGF8, PRPF19	odontogenesis of dentin-containing tooth [BP], branching involved in salivary gland morphogenesis [BP], embryo development [BP], odontogenesis [BP], spliceosomal complex assembly [BP]
CG_h9laurent_promoter_n_RM_14_333_13	2	0.25	3.71E-04	FOXJ1	negative regulation of B cell activation [BP]
CG_h9laurent_promoter_n_RM_12_287_10	3	0.5	3.86E-04	NCOA6, TLE1, YBX2, PHF21A, RCOR2, LATS1, AZI1, TUBGCP3, TOP2B, TOP2A, CBX4	mitotic cell cycle G2/M transition decatenation checkpoint [BP], DNA topoisomerase type II (ATP-hydrolyzing) activity [MF], DNA topological change [BP], chromatin binding [MF], G2/M transition of mitotic cell cycle [BP], resolution of meiotic recombination intermediates [BP]
CG_h9laurent_promoter_n_RM_14_319_11	3	0.5	2.71E-04	NKX3-2, DICER1	intestinal epithelial cell development [BP]
CG_h9laurent_promoter_n_RM_12_262_12	3	0.5	3.42E-04	SOX21, TAF4, GNAQ, GRSF1, DEAF1, BARX1, MBD2, HOXA13, EPHA2, HOXB5, HOXA10, SCRIB, HR, ZIC5, HOXB6, NKX3-2, NFIL3, ZBTB21, PTCH1, SATB2, CREBZF	methyl-CpG binding [MF], neural tube closure [BP], embryonic skeletal system development [BP], limb morphogenesis [BP], morphogenesis of embryonic epithelium [BP], sequence-specific DNA binding transcription factor activity [MF], embryonic limb morphogenesis [BP], sequence-specific DNA binding [MF], activation of Rac GTPase activity [BP], neural tube development [BP], mammary gland duct morphogenesis [BP], skeletal system development [BP]
CG_h9laurent_promoter_n_RM_12_51_10	3	0.75	2.08E-04	LPHN1, SDF4, HOXB2, CAMK2B, SLC8A1, LAMA1	muscle fiber development [BP], morphogenesis of an epithelial sheet [BP], calcium ion-dependent exocytosis [BP], positive regulation of synapse maturation [BP]
CG_h9laurent_promoter_n_RM_14_33_3	1	0.25	1.92E-04	RORA, NPPC	cGMP metabolic process [BP], negative regulation of DNA metabolic process [BP]
CG_h9laurent_promoter_n_RM_14_296_4	3	0.5	2.83E-04	KLHL22, KLHL21	Cul3-RING ubiquitin ligase complex [CC]
CG_h9laurent_promoter_n_RM_12_557_6	2	0.25	2.40E-04	NOTCH1, FOXA1	cell fate specification [BP], secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [BP], positive regulation of epithelial cell proliferation [BP]
CG_h9laurent_promoter_n_RM_12_566_8	3	0.5	3.41E-04	SMAD7, MAD2L2	negative regulation of transcription by competitive promoter binding [BP], negative regulation of epithelial to mesenchymal transition [BP]
CG_h9laurent_promoter_n_RM_12_571_23	3	0.5	3.55E-04	PABPC1, ZFP36L1, PASK, EGR2, FOXO1, TNKS1BP1, RANBP9, TUBGCP6, HOXB2	regulation of energy homeostasis [BP], microtubule nucleation [BP], rhombomere 3 development [BP], nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [BP], facial nerve structural organization [BP]
CG_h9laurent_promoter_n_RM_14_138_5	1	0.25	2.42E-04	SMEK1, CDC14B, DUSP18, DUSP7	protein dephosphorylation [BP], protein tyrosine/serine/threonine phosphatase activity [MF], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], protein tyrosine phosphatase activity [MF], peptidyl-tyrosine dephosphorylation [BP]
CG_h9laurent_promoter_n_RM_14_222_11	3	0.5	4.45E-04	RELN, SFRP5, WLS	Wnt-protein binding [MF], positive regulation of protein tyrosine kinase activity [BP]
CG_h9laurent_promoter_n_RM_14_204_5	2	0.25	5.31E-04	IL6ST, NOTCH1	interleukin-11 receptor activity [MF], positive regulation of astrocyte differentiation [BP], interleukin-11 binding [MF]
CG_h9laurent_promoter_n_RM_12_161_13	2	0.5	2.91E-04	EPHA2, AXIN1, USP7, CDK5	p53 binding [MF], axial mesoderm formation [BP]
CG_h9laurent_promoter_n_RM_14_269_8	2	0.25	2.99E-04	CDKN2A, FZD4, SUN2, DCXR, HMGB1, ANKLE2, PHIP, TGFB1	positive regulation of DNA binding [BP], nuclear envelope organization [BP], NADP metabolic process [BP], negative regulation of phagocytosis [BP], myeloid dendritic cell activation [BP], negative regulation of cell-substrate adhesion [BP], positive regulation of peptidyl-threonine phosphorylation [BP], positive regulation of protein dephosphorylation [BP], apoptotic DNA fragmentation [BP]
CG_h9laurent_promoter_n_RM_14_70_6	1	0.25	5.26E-04	CAMK2B	activation of meiosis involved in egg activation [BP], inhibitory G-protein coupled receptor phosphorylation [BP], positive regulation of apoptotic signaling pathway [BP]
CG_h9laurent_promoter_n_RM_14_219_15	2	0.5	3.61E-04	HSPG2, GNB1, ADCY9, GNG12, FBN1, MBOAT2, SCUBE1, IMPAD1, AGPAT2, GNA12, BMP4	extrinsic to plasma membrane [CC], 1-acylglycerol-3-phosphate O-acyltransferase activity [MF], endochondral ossification [BP], cellular response to glucagon stimulus [BP], heart development [BP], heterotrimeric G-protein complex [CC]
CG_h9laurent_promoter_n_RM_16_65_23	4	0.25	4.86E-04	SNX5, ELAVL3, TRIM33, GNA13, TLE1, ZFHX3, ADAM10, SFMBT1, EZH2, CTNND2, HAND2, CDK5, PITX1, MNX1, PBX4, SMURF1, THSD7A, CEBPA, MAP3K9, CERS2, MAML3, FEZF2, TWIST1, SIX5, AFF3, SOX15, WHSC1L1, ADAP1, GNPTAB, GNG5, MYCBP2, MED16, PHIP, JAG2, WDFY3, FGFR2, RELN, POU3F1, RRAGC, RORA, GNB1, ABR, TFAP2A, TP53INP1, MAMSTR, BCOR, PPP3CA, CNTFR, SSBP3, LINGO1, NKX6-2, SHANK1, ADRA1D, NFIB, ZNF521, TRPS1, GNAQ, RPS6KA6, SFRP5, MED13L, SHB, NOTCH2, GJC1, TCF15, SOX10, HOXA5, HSF2BP, BRF1, SHARPIN, ACTL6B, CALCOCO1, PID1, EBF3, TAF5L, CREBBP, HIVEP3, RYK	protein binding transcription factor activity [MF], response to tumor necrosis factor [BP], brain development [BP], cardiac neural crest cell migration involved in outflow tract morphogenesis [BP], multicellular organismal development [BP], nervous system development [BP], RNA polymerase II transcription cofactor activity [MF], forebrain neuron development [BP], central nervous system neuron development [BP], sequence-specific DNA binding [MF], regulation of excitatory postsynaptic membrane potential [BP], regulation of transcription, DNA-dependent [BP], cell development [BP], heterotrimeric G-protein complex [CC], mesenchymal cell proliferation involved in lung development [BP], cell differentiation [BP], skeletal system development [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], transcription regulatory region DNA binding [MF], extrinsic to membrane [CC], cell surface receptor signaling pathway [BP], central nervous system development [BP], skeletal muscle organ development [BP], commissural neuron axon guidance [BP], RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF], regulation of transcription from RNA polymerase II promoter [BP], embryonic limb morphogenesis [BP], extrinsic to internal side of plasma membrane [CC], transcription coactivator activity [MF], RNA polymerase II transcription factor binding transcription factor activity [MF], protein localization to synapse [BP], forebrain development [BP], transcription, DNA-dependent [BP], transcription cofactor activity [MF], embryo development [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_n_RM_14_369_6	2	0.5	3.44E-04	AAMP, BCOR, NES, PDGFA	smooth muscle cell migration [BP], negative regulation of histone H3-K36 methylation [BP], positive regulation of intermediate filament depolymerization [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_h9laurent_promoter_n_RM_14_4_5	3	0.25	2.02E-04	LTBP3, HPGD, SMAD2, ABCC4	lipoxygenase pathway [BP], 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [MF], insulin secretion [BP], transforming growth factor beta receptor signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_532_12	2	0.5	3.55E-04	KPNA3, TLR9, NCOA6, ST3GAL5, ST8SIA6, TLE1, NR2F6, RORC, PGR, STRA13, KPNA1, ELOVL1, ELOVL2, MAPK9, TOP2B, YWHAZ	nuclear localization sequence binding [MF], resolution of meiotic recombination intermediates [BP], ganglioside biosynthetic process [BP], nucleoplasm [CC], fatty acid elongase activity [MF], positive regulation of nitric-oxide synthase biosynthetic process [BP], very long-chain fatty acid biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_584_13	4	0.5	2.91E-04	ACSL6, DRD1, FASN, SRSF12, HOMER1	cytoplasmic transport [BP], behavioral response to cocaine [BP], long-chain fatty-acyl-CoA biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_337_3	2	0.25	2.75E-04	PKD1, PNKP, TWF1	regulation of actin phosphorylation [BP], nucleotide phosphorylation [BP], metanephric distal tubule morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_141_31	3	0.5	2.95E-04	BNIP3, CELSR1	cellular response to cobalt ion [BP], protein localization involved in establishment of planar polarity [BP]
CG_h9laurent_promoter_n_RM_12_215_15	3	0.5	2.51E-04	GLI3, GNA12, DLG4, FLOT2, KIAA1715	cell differentiation involved in kidney development [BP], ionotropic glutamate receptor binding [MF], embryonic digit morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_576_10	3	0.5	3.85E-04	LHX3, CBFA2T3, RPA2, BNIP3, LY6H, PRKDC, RAPGEF5, SMAD2, TBX5, CNTFR, DAB1, MAPK9, MNX1, MAFB, NKX2-5, POU3F1	cardiac conduction system development [BP], anatomical structure morphogenesis [BP], bundle of His development [BP], ventral spinal cord development [BP], positive regulation of cardioblast differentiation [BP], nucleoplasm [CC], cardiac ventricle formation [BP], pattern specification process [BP], transcription factor complex [CC], spinal cord motor neuron cell fate specification [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_14_367_9	2	0.25	3.06E-04	TJP1, SLC8A1	intercalated disc [CC], cell-cell signaling involved in cell-cell junction organization [BP]
CG_h9laurent_promoter_n_RM_14_149_9	3	0.25	4.10E-04	SMAD2, AKT1, FOXO1, CXCR4, NCOR1, CLOCK	myelin maintenance [BP], negative regulation of JNK cascade [BP], negative regulation of stress-activated MAPK cascade [BP], pancreas development [BP], circadian regulation of gene expression [BP], transcription factor complex [CC], regulation of fatty acid transport [BP]
CG_h9laurent_promoter_n_RM_12_147_20	4	0.75	3.74E-04	WNT5A, SPTBN2, HYAL2	cerebellar Purkinje cell layer morphogenesis [BP], positive regulation of interleukin-8 secretion [BP]
CG_h9laurent_promoter_n_RM_12_378_13	4	0.75	4.24E-04	SHANK1, UCN	associative learning [BP]
CG_h9laurent_promoter_n_RM_12_111_20	3	0.75	2.70E-04	GCLM, SIK1, DNMBP, EEA1, EEF1A1, MECP2, PRKAG2, CDO1, SSX2IP, BAD, LDB1, CCNL2, FLNA, CTBP1, PAWR, TLR9, BCAR1, PHKG1, ICMT, FBXO5	protein domain specific binding [MF], cysteine metabolic process [BP], enzyme binding [MF], early endosome to late endosome transport [BP], siRNA binding [MF], protein kinase binding [MF], cAMP response element binding protein binding [MF], negative regulation of histone acetylation [BP]
CG_h9laurent_promoter_n_RM_14_8_7	2	0.25	4.14E-04	BCL11B, PER1	RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF]
CG_h9laurent_promoter_n_RM_12_426_12	1	0.25	3.84E-04	FZD8, FOXO1, EZH2, MBD3, FOXN3, GCNT4	embryo development [BP], tissue morphogenesis [BP], vasculature development [BP], negative regulation of epidermal cell differentiation [BP], tissue development [BP]
CG_h9laurent_promoter_n_RM_14_365_7	2	0.25	3.39E-04	SLC2A1, RRP8	cellular response to glucose starvation [BP]
CG_h9laurent_promoter_n_RM_12_407_14	2	0.25	4.03E-04	FGF8, RAB3A	maintenance of presynaptic active zone structure [BP], cell migration involved in mesendoderm migration [BP]
CG_h9laurent_promoter_n_RM_14_100_4	2	0.25	4.24E-04	INTS1	U2 snRNA 3'-end processing [BP]
CG_h9laurent_promoter_n_RM_14_98_18	4	0.75	3.72E-04	SREBF1, PAX3, ZNF281, TSHZ3	sequence-specific DNA binding [MF]
CG_h9laurent_promoter_n_RM_12_241_20	3	0.25	2.53E-04	KPNA1, TRPS1	NLS-bearing substrate import into nucleus [BP]
CG_h9laurent_promoter_n_RM_14_235_17	4	0.5	3.71E-04	IRS1, ENTPD8, AKT1, FLNA, TOP2A, ACSL1	nucleoside diphosphate biosynthetic process [BP], regulation of fatty acid oxidation [BP], protein kinase C binding [MF], positive regulation of glycogen biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_136_9	2	0.25	3.78E-04	DBN1, ANKRD23, RGS11, CDC42EP3	dendrite terminus [CC], actin cytoskeleton [CC]
CG_h9laurent_promoter_n_RM_14_352_10	2	0.25	3.32E-04	CFL1	neural fold formation [BP]
CG_h9laurent_promoter_n_RM_14_364_7	2	0.25	2.72E-04	SATB2, HMGB1, SIN3A, RCC2	histone deacetylase complex [CC], transcriptional repressor complex [CC], chromosome, centromeric region [CC]
CG_h9laurent_promoter_n_RM_14_9_4	4	0.5	4.03E-04	DLG4, CREBBP, PTCH1	extrinsic to internal side of plasma membrane [CC], regulation of smoothened signaling pathway [BP], smoothened signaling pathway [BP], P2Y1 nucleotide receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_501_11	1	0.25	2.95E-04	TK1, HID1	response to brefeldin A [BP], fetal process involved in parturition [BP], extrinsic to Golgi membrane [CC]
CG_h9laurent_promoter_n_RM_20_9_2	1	0.25	3.75E-04	MLXIPL	glucose mediated signaling pathway [BP], carbohydrate response element binding [MF], negative regulation of oxidative phosphorylation [BP]
CG_h9laurent_promoter_n_RM_12_322_12	3	0.5	4.70E-04	TGFB1, HEG1, NKX2-2	defense response to fungus, incompatible interaction [BP], ventral spinal cord interneuron fate determination [BP], lymph circulation [BP], negative regulation of hyaluronan biosynthetic process [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP], type B pancreatic cell fate commitment [BP]
CG_h9laurent_promoter_n_RM_12_181_13	4	0.75	2.90E-04	C5	C5a anaphylatoxin chemotactic receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_444_6	1	0.25	1.39E-04	HEY1, PNKP, ERCC1	atrioventricular valve formation [BP], nucleotide-excision repair, DNA damage removal [BP], damaged DNA binding [MF], nucleotide phosphorylation [BP]
CG_h9laurent_promoter_n_RM_16_8_5	2	0.25	2.53E-04	SPIRE1, RHOC	cleavage furrow [CC], cell cycle cytokinesis [BP]
CG_h9laurent_promoter_n_RM_12_560_7	3	0.25	2.05E-04	JUP, TUBGCP2, CEP76, PTHLH, CDKN2B	gamma-catenin-TCF7L2 complex [CC], structural constituent of cell wall [MF], G2/M transition of mitotic cell cycle [BP], nipple sheath formation [BP], mammary gland bud elongation [BP]
CG_h9laurent_promoter_n_RM_14_87_9	2	0.25	3.51E-04	TONSL, PURB	DNA replication factor A complex [CC]
CG_h9laurent_promoter_n_RM_14_181_9	2	0.25	4.70E-04	SHANK1, NPHP4, UCN	visual behavior [BP], associative learning [BP]
CG_h9laurent_promoter_n_RM_12_413_16	4	0.5	2.49E-04	VDR, NRIP1, ITGB1	regulation of calcidiol 1-monooxygenase activity [BP], retinoid X receptor binding [MF], cellular response to vitamin D [BP]
CG_h9laurent_promoter_n_RM_14_324_8	3	0.5	3.00E-04	PTK2, LTBP3, MBOAT2, RAPH1, AGPAT2, WNT9A, TRPV4, ITGB1	filopodium [CC], negative regulation of anoikis [BP], negative regulation of chondrocyte differentiation [BP], 1-acylglycerol-3-phosphate O-acyltransferase activity [MF], response to mechanical stimulus [BP]
CG_h9laurent_promoter_n_RM_12_91_18	2	0.25	2.74E-04	CBX8, MECP2	heterochromatin [CC]
CG_h9laurent_promoter_n_RM_14_191_9	1	0.25	3.85E-04	LINGO1, TNK2	epidermal growth factor receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_505_17	2	0.25	2.45E-04	PRDX3	alkyl hydroperoxide reductase activity [MF]
CG_h9laurent_promoter_n_RM_14_82_10	2	0.25	3.22E-04	ARHGEF11, WNT11, PLA2G6, IQSEC1	actin cytoskeleton organization [BP], positive regulation of protein kinase C signaling cascade [BP]
CG_h9laurent_promoter_n_RM_12_530_18	3	0.25	2.51E-04	KLF10, NRN1, CCDC88A, CAMK2B, CAPRIN2, SATB2, CRMP1, CITED1, WNT7A, SHANK1, BMP7	cellular response to transforming growth factor beta stimulus [BP], somatic stem cell maintenance [BP], embryonic pattern specification [BP], dendritic spine morphogenesis [BP], positive regulation of dendritic spine development [BP], regulation of dendritic spine development [BP], response to transforming growth factor beta stimulus [BP], positive regulation of dendritic spine morphogenesis [BP], regulation of neuron projection development [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_118_31	4	0.75	2.84E-04	EIF2B3, AGO2, EIF4E3	translation initiation factor activity [MF], mRNA cap binding complex [CC], regulation of translation [BP]
CG_h9laurent_promoter_n_RM_12_6_26	3	0.5	3.34E-04	IRS2, INSL3	insulin receptor binding [MF]
CG_h9laurent_promoter_n_RM_14_203_4	2	0.25	2.60E-04	FOXP1, PDGFA, SDC1, HDGFRP3, FGF8, LGR4	ureteric bud development [BP], wound healing [BP], positive regulation of mesenchymal cell proliferation [BP], cell migration involved in mesendoderm migration [BP], branching involved in salivary gland morphogenesis [BP], organ morphogenesis [BP], lung development [BP], metanephros development [BP], canonical Wnt receptor signaling pathway [BP], growth factor activity [MF], male genitalia development [BP], lung morphogenesis [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_h9laurent_promoter_n_RM_14_152_8	3	0.25	3.62E-04	BAD, GPLD1, CEBPA, RFX3, STAT5B	positive regulation of B cell differentiation [BP], positive regulation of insulin secretion involved in cellular response to glucose stimulus [BP], cellular response to organic cyclic compound [BP], positive regulation of type B pancreatic cell development [BP]
CG_h9laurent_promoter_n_RM_14_232_12	2	0.5	2.80E-04	HOXA5, BMP4, JUP, FOXA1	epithelial-mesenchymal cell signaling [BP], lung epithelial cell differentiation [BP], internal side of plasma membrane [CC], bronchus development [BP], trachea development [BP], epithelial tube branching involved in lung morphogenesis [BP], lung morphogenesis [BP]
CG_h9laurent_promoter_n_RM_16_4_5	1	0.25	4.54E-04	PLCB2, PTK2, HDAC4, EXT1, CHRDL2, CHRNA4, CDC42BPA, JAG2, DBN1, GABBR2, MEX3D, HEY1, ELAVL1	AU-rich element binding [MF], synaptic transmission [BP], regulation of osteoblast differentiation [BP], osteoblast development [BP], ossification [BP], actomyosin [CC], establishment of nucleus localization [BP], skeletal system development [BP]
CG_h9laurent_promoter_n_RM_12_116_14	2	0.5	2.21E-04	QDPR, FASN, CRABP2, WNT9A, TWIST1	embryonic forelimb morphogenesis [BP], NADPH binding [MF]
CG_h9laurent_promoter_n_RM_16_6_4	2	0.25	3.97E-04	ADCY3, MECP2, RAB3A, KCNB1, FGF3, TRIP12, APBA1	respiratory system process [BP], embryo development [BP], synaptic transmission [BP], cell-cell signaling [BP]
CG_h9laurent_promoter_n_RM_12_124_9	2	0.25	2.49E-04	YPEL1, FANCA, C1orf86	Fanconi anaemia nuclear complex [CC], regulation of myelination [BP]
CG_h9laurent_promoter_n_RM_14_249_4	3	0.25	4.54E-04	LYL1, DLG4, SP3	ADP-activated nucleotide receptor activity [MF], P2Y1 nucleotide receptor binding [MF], beta-1 adrenergic receptor binding [MF], definitive hemopoiesis [BP], B cell differentiation [BP]
CG_h9laurent_promoter_n_RM_16_16_4	1	0.25	4.31E-04	KRAS, CAMK2B	regulation of long-term neuronal synaptic plasticity [BP]
CG_h9laurent_promoter_n_RM_12_131_9	2	0.25	3.09E-04	PTCH1, GSK3A, FBXO31, AXIN1, STRN4	cyclin binding [MF], beta-catenin destruction complex [CC], armadillo repeat domain binding [MF]
CG_h9laurent_promoter_n_RM_14_248_21	3	0.25	3.37E-04	RGS11, HLA-C, HLA-B, AMBRA1, GNG7, GNG4, TP53INP1, GIT1, OSBPL7, NR3C1	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP], regulation of G-protein coupled receptor protein signaling pathway [BP], heterotrimeric G-protein complex [CC], steroid binding [MF], autophagic vacuole [CC]
CG_h9laurent_promoter_n_RM_12_192_11	1	0.25	3.37E-04	FBXO2, MGEA5	glycoprotein catabolic process [BP]
CG_h9laurent_promoter_n_RM_14_270_10	2	0.5	2.70E-04	DDAH1, MAFA	nitric oxide mediated signal transduction [BP]
CG_h9laurent_promoter_n_RM_12_481_13	5	0.75	3.18E-04	STIL, ROCK2, SCRIB, JUP, SALL1, SETD2, GCNT4	neural tube development [BP], neural tube closure [BP], morphogenesis of embryonic epithelium [BP], tissue morphogenesis [BP]
CG_h9laurent_promoter_n_RM_14_95_9	2	0.25	3.49E-04	KCTD1, TAF4, HR, DEAF1, PARP1, HOXB5, GRSF1, SATB2, NFIL3, HES2, NKX3-2, SOX21	DNA binding [MF], embryonic skeletal system development [BP], morphogenesis of embryonic epithelium [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], gene expression [BP], transcription factor complex [CC]
CG_h9laurent_promoter_n_RM_14_113_5	2	0.25	4.30E-04	RPS29, RPS2	viral transcription [BP]
CG_h9laurent_promoter_n_RM_12_301_28	3	0.75	2.25E-04	TADA1, TCF3, ABO, GATM	fucosylgalactoside 3-alpha-galactosyltransferase activity [MF], glycine amidinotransferase activity [MF], glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [MF], histone H3 acetylation [BP]
CG_h9laurent_promoter_n_RM_12_293_23	2	0.5	3.50E-04	SMAD7, THOC7, ALYREF, PARD3, SPRY2	negative regulation of peptidyl-threonine phosphorylation [BP], intronless viral mRNA export from host nucleus [BP], transcription export complex [CC], protein complex [CC]
CG_h9laurent_promoter_n_RM_14_368_6	2	0.25	3.67E-04	CSDA, B4GALT6, DAP, MCFD2, RPN1	cellular response to amino acid starvation [BP], post-translational protein modification [BP], positive regulation of cytoplasmic translation [BP], protein N-linked glycosylation via asparagine [BP]
CG_h9laurent_promoter_n_RM_12_59_16	6	0.75	2.97E-04	PAX5, NDRG2, GCLC, ELAVL3, HAGH	glutathione biosynthetic process [BP], cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_266_12	2	0.5	2.73E-04	TLN1, ELOVL2, FGF4, FGFR2, LAMTOR1, WNT11, ACSL1	linoleic acid metabolic process [BP], cranial suture morphogenesis [BP], synaptic vesicle transport [BP], mesenchymal cell proliferation [BP], bone morphogenesis [BP], lung-associated mesenchyme development [BP], branching morphogenesis of a nerve [BP], intracellular membrane-bounded organelle [CC]
CG_h9laurent_promoter_n_RM_12_494_13	3	0.75	2.36E-04	SLC9A3, IPMK, ATP5H, WNT5A, IP6K1, SLC9A7	sodium:hydrogen antiporter activity [MF], hydrogen ion transmembrane transporter activity [MF], genitalia development [BP], inositol-1,4,5-trisphosphate 3-kinase activity [MF]
CG_h9laurent_promoter_n_RM_14_201_8	2	0.25	3.04E-04	NOXO1, CTGF, INTS1, PREX1, GIPC1	reactive oxygen species metabolic process [BP], superoxide metabolic process [BP], dendritic shaft [CC], U2 snRNA 3'-end processing [BP]
CG_h9laurent_promoter_n_RM_14_150_2	1	0.25	3.52E-04	CHDH	choline dehydrogenase activity [MF]
CG_h9laurent_promoter_n_RM_12_317_24	4	0.75	4.82E-04	DRD2, PITX1	negative regulation of voltage-gated calcium channel activity [BP], pituitary gland development [BP]
CG_h9laurent_promoter_n_RM_14_102_10	2	0.25	4.11E-04	PTK2	establishment of nucleus localization [BP]
CG_h9laurent_promoter_n_RM_12_516_21	2	0.25	2.59E-04	PPP3CB, CFL1, PRKAR1B, DLG4, SHANK1	excitatory synapse [CC], ionotropic glutamate receptor binding [MF], learning or memory [BP], social behavior [BP], vocalization behavior [BP], protein localization to synapse [BP], establishment of cell polarity [BP], positive regulation of excitatory postsynaptic membrane potential [BP]
CG_h9laurent_promoter_n_RM_14_302_7	2	0.25	3.02E-04	IRS2, PHIP, KCNB1	insulin receptor binding [MF], regulation of insulin secretion [BP]
CG_h9laurent_promoter_n_RM_12_126_10	2	0.5	1.62E-04	NKX3-1, FOXN3, EPHA2	multicellular organismal development [BP], embryo development [BP]
CG_h9laurent_promoter_n_RM_14_354_14	6	0.75	2.58E-04	ABCB6, AXIN2, YBX2, CPT1A	mRNA stabilization [BP], integral to mitochondrial outer membrane [CC]
CG_h9laurent_promoter_n_RM_14_3_6	2	0.25	2.82E-04	CHDH, ANKH	choline dehydrogenase activity [MF], inorganic diphosphate transmembrane transporter activity [MF]
CG_h9laurent_promoter_n_RM_14_234_7	1	0.25	2.75E-04	HDAC4, SMAD2, MESP1	activating transcription factor binding [MF], negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cardiac atrium formation [BP], mesoderm formation [BP], lateral mesoderm development [BP], endoderm development [BP], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP]
CG_h9laurent_promoter_n_RM_18_2_32	5	0.25	4.35E-04	HECTD4, AHCTF1, GNPTAB, SYMPK, EPB41L4B, HNRPLL, CLSTN1, SMG1, LINGO1, FGFR2, CSNK1E, MYCBP2, LARP6, TONSL, BOLL, LSG1, THOC7, BRD1, PNCK, BARHL2, RFX7, TCF15, FRA10AC1, ST3GAL2, GLIS1, PHF21A, MLL3, GTF3C2, IMPAD1, RAD1, MNX1, CHD1, UBTD2, MAML3, SOX10, AFF3, SRP68, TOP2B, STK40, HSF2BP, UBA3, PAX3, CNTFR, CERS2, ICMT, GNAQ, RPS6KA6, AURKAIP1, ASCC2, ZNF503, CREBBP, ONECUT1, CBX4, MEX3D, NCOR1, FZD8, MAPK1, FOSL1, ELL2, BRWD1, SUGP2, SIAH1, PDS5A, SEPHS1, RXRG, TNKS1BP1, SATB1, TAPT1, ZNF521, TRPS1, APBA1, APBA3, SFRP5, LMO2, HOXA7, HOXA5, SMEK1, CDK5, CDK6, HIVEP3, USP4, EZH2, HAND2, CEBPA, HDGFRP3, KLF14, TWIST1, CALCOCO1, MLLT1, TTLL11, PPP1R13B, PDGFA, POU3F1, ZBTB4, ABR, EBF3, STK39, DACH1, SSBP3, MEX3B, MEX3C, PTPRS, SLC40A1, OAZ2, NOTCH2, GNA13, ACTL6B, PPP3CA, PTCH1, RYK	negative regulation of osteoblast differentiation [BP], brain development [BP], cardiac neural crest cell migration involved in outflow tract morphogenesis [BP], multicellular organismal development [BP], nucleus [CC], central nervous system neuron development [BP], limb morphogenesis [BP], regulation of transcription, DNA-dependent [BP], in utero embryonic development [BP], intracellular membrane-bounded organelle [CC], reflex [BP], anatomical structure morphogenesis [BP], embryonic digit morphogenesis [BP], negative regulation of cellular senescence [BP], extrinsic to membrane [CC], central nervous system development [BP], corpus callosum development [BP], regulation of transcription from RNA polymerase II promoter [BP], embryonic limb morphogenesis [BP], vasculature development [BP], suckling behavior [BP], cellular protein modification process [BP], forebrain development [BP], sequence-specific DNA binding [MF], regulation of gene expression [BP], embryo development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_355_18	3	0.5	2.13E-04	EIF2AK2, ZER1, PPA1, FOXA1	epithelial-mesenchymal signaling involved in prostate gland development [BP], vacuolar proton-transporting V-type ATPase, V1 domain [CC], evasion or tolerance by virus of host immune response [BP], diphosphate metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_129_9	3	0.25	2.53E-04	TMEM123, CCBL2, GCLM	glutamate-cysteine ligase catalytic subunit binding [MF], oncosis [BP], kynurenine-glyoxylate transaminase activity [MF], positive regulation of glutamate-cysteine ligase activity [BP]
CG_h9laurent_promoter_n_RM_12_517_20	2	0.5	1.79E-04	EZR	establishment or maintenance of apical/basal cell polarity [BP]
CG_h9laurent_promoter_n_RM_14_306_6	2	0.25	2.07E-04	CTBP1, NFIB	RNA polymerase II transcription corepressor activity [MF]
CG_h9laurent_promoter_n_RM_12_358_10	2	0.5	3.65E-04	CUEDC2, TRIM33, REXO1, FKBP5, CDK2AP1, RERE, NSMCE4A, BTG1, ZBTB14, SIX2, IRF2BP1, ZNF514, CCT6B, PPM1G, BEX2, EBF3, TPR, ADAMTS5, TAF4, HNRPDL, SFMBT1, ID3, CASP9, RUNX3, ZBTB45, MCMBP, HSP90AA1, KAT6A, CD2BP2	chaperone-mediated protein complex assembly [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_14_349_4	2	0.25	3.83E-04	FASN	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF]
CG_h9laurent_promoter_n_RM_12_211_14	2	0.5	2.27E-04	DNA2, NCKAP1, FGF8, POLG	mitochondrial DNA replication [BP], mesodermal cell migration [BP], gamma DNA polymerase complex [CC]
CG_h9laurent_promoter_n_RM_12_331_12	2	0.25	2.95E-04	BAD, ACSL1, FBXO31, CUL3, STAT5B	positive regulation of B cell differentiation [BP], response to interleukin-4 [BP], response to oleic acid [BP], cyclin catabolic process [BP]
CG_h9laurent_promoter_n_RM_18_1_11	5	0.25	5.56E-04	PPP1CA, PMEPA1, TTLL11, TTLL12, MNX1, SMURF1	negative regulation of transforming growth factor beta receptor signaling pathway [BP], spinal cord motor neuron cell fate specification [BP], tubulin-tyrosine ligase activity [MF]
CG_h9laurent_promoter_n_RM_14_243_7	4	0.5	2.89E-04	RGS19, RAP1GAP	GTPase activator activity [MF], GTP catabolic process [BP], regulation of Ras GTPase activity [BP]
CG_h9laurent_promoter_n_RM_12_76_11	3	0.5	2.26E-04	TRPT1, GRM4	tRNA 2'-phosphotransferase activity [MF], presynaptic active zone membrane [CC]
CG_h9laurent_promoter_n_RM_14_261_11	2	0.5	4.43E-04	GRM6, NPTX1, KCND3	synaptic transmission [BP]
CG_h9laurent_promoter_n_RM_18_19_3	1	0.25	5.05E-04	PTGR1	2-alkenal reductase [NAD(P)] activity [MF]
CG_h9laurent_promoter_n_RM_12_354_10	1	0.25	3.53E-04	TBL1XR1, RGS11, ZHX3, SF1, FEV, HIPK2, RGS7, NEUROD2	dendrite terminus [CC], transcription corepressor activity [MF]
CG_h9laurent_promoter_n_RM_14_29_19	2	0.25	3.29E-04	SYNCRIP, SMURF1, CELSR3, IRS1, GLRX2, ABHD14B, POGZ, PTBP3, ADAM12, ZBTB46, AMIGO1, PYCARD, CAPG, MEX3B, MPHOSPH9	axonal fasciculation [BP], nucleus [CC]
CG_h9laurent_promoter_n_RM_14_283_9	3	0.5	4.26E-04	AADAT, ITGB1	2-aminoadipate transaminase activity [MF], alpha3-beta1 integrin complex [CC], alpha9-beta1 integrin complex [CC]
CG_h9laurent_promoter_n_RM_12_340_4	2	0.25	2.61E-04	XYLT1, CHST15	chondroitin sulfate biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_12_467_11	2	0.5	1.80E-04	ERAP1, BTG1, TWIST1, LPHN1, PDE2A, BARX1, CITED2, NFIB	cardiac neural crest cell development involved in heart development [BP], embryonic camera-type eye morphogenesis [BP], axon [CC], positive regulation of angiogenesis [BP], spleen development [BP], RNA polymerase II transcription corepressor activity [MF], endocardial cushion development [BP]
CG_h9laurent_promoter_n_RM_12_174_13	4	0.5	2.60E-04	CATSPER1, DNAH17	ciliary or flagellar motility [BP]
CG_h9laurent_promoter_n_RM_12_496_17	6	0.75	2.66E-04	KCNMA1, WNT4, IPMK	embryonic epithelial tube formation [BP], regulation of aldosterone metabolic process [BP], neural tube formation [BP]
CG_h9laurent_promoter_n_RM_14_50_10	2	0.25	3.41E-04	TAPT1	embryonic skeletal system development [BP]
CG_h9laurent_promoter_n_RM_12_319_15	3	0.5	3.95E-04	ADCY9, IRS2, AKT1, DGKI, GNA12, FGG, SLC30A1, ATP7B, PPP1CA	energy reserve metabolic process [BP], positive regulation of glycogen biosynthetic process [BP], glycogen metabolic process [BP], regulation of glycogen biosynthetic process [BP], glycogen biosynthetic process [BP], negative regulation of plasma membrane long-chain fatty acid transport [BP], platelet activation [BP], cellular zinc ion homeostasis [BP]
CG_h9laurent_promoter_n_RM_12_62_21	4	0.75	2.52E-04	ABR, PTPRK, ROCK2, WNT11, DOCK4	Rac GTPase activator activity [MF], regulation of cell motility [BP], negative regulation of cell migration [BP]
CG_h9laurent_promoter_n_RM_14_342_15	2	0.25	3.32E-04	PTK2, PREX1, ERRFI1	positive regulation of Rho GTPase activity [BP], regulation of Rho GTPase activity [BP]
CG_h9laurent_promoter_n_RM_12_96_37	3	0.75	3.04E-04	CLASP1, PABPC4, CLIP1, COL1A1, FGFR2, PATL1, GNAQ	microtubule plus-end binding [MF], forebrain neuron development [BP], poly(U) RNA binding [MF], mesenchymal cell proliferation involved in lung development [BP], skeletal system development [BP]
CG_h9laurent_promoter_n_RM_16_23_1	1	0.25	2.14E-04	TJP1, LUZP1, NMUR1	neural fold bending [BP], neuromedin U receptor activity [MF], cell-cell signaling involved in cell-cell junction organization [BP], response to magnetism [BP]
CG_h9laurent_promoter_n_RM_14_71_5	2	0.25	2.98E-04	AKT1, RUNX1, DDAH1, HAND2, ZFAT	peripheral nervous system neuron development [BP], hematopoietic progenitor cell differentiation [BP], glycogen cell differentiation involved in embryonic placenta development [BP], positive regulation of progesterone secretion [BP], positive regulation of nitric oxide biosynthetic process [BP], in utero embryonic development [BP], positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP], spongiotrophoblast layer development [BP], positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_117_4	1	0.25	2.65E-04	LBX1	regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_h9laurent_promoter_n_RM_12_503_9	4	0.75	2.62E-04	MLL2, CCBE1, SOX18	oogenesis [BP], lymphangiogenesis [BP]
CG_h9laurent_promoter_n_RM_12_448_10	2	0.25	2.25E-04	SMPD4, ECE1, CTSH	substance P catabolic process [BP], neuropeptide catabolic process [BP], sphingomyelin phosphodiesterase D activity [MF], bradykinin catabolic process [BP], calcitonin catabolic process [BP], endothelin maturation [BP], HLA-A specific activating MHC class I receptor activity [MF], intrinsic to endosome membrane [CC]
CG_h9laurent_promoter_n_RM_14_170_7	2	0.25	3.44E-04	TONSL, PURB	nuclear replication fork [CC], DNA replication factor A complex [CC]
CG_h9laurent_promoter_n_RM_16_63_10	5	0.5	4.53E-04	SMARCC2	nervous system development [BP]
CG_h9laurent_promoter_n_RM_14_304_8	6	0.5	3.80E-04	RPS6KA2, VIPR2, NAMPT, TOLLIP, FGF12	cell-cell signaling [BP], stress-activated MAPK cascade [BP]
CG_h9laurent_promoter_n_RM_14_99_3	2	0.25	2.96E-04	HID1	extrinsic to Golgi membrane [CC]
CG_h9laurent_promoter_n_RM_16_68_14	2	0.25	4.89E-04	SP3, PYGO1, MNX1, TLE1, RFX7, MAP3K9, ELMSAN1, DAPK3, AMER2, NKX6-2	Wnt receptor signaling pathway [BP], regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_n_RM_14_281_6	4	0.75	3.30E-04	KCNJ11, MAP6D1, P2RX1	response to ATP [BP], N-terminal peptidyl-L-cysteine N-palmitoylation [BP]
CG_h9laurent_promoter_n_RM_12_74_10	3	0.5	2.40E-04	NGF, PARD3, BARHL2, LRP4, PARN, PKD1, FAM132A, MAP3K7, NRP1, DLL1, MAPK1, PRKCQ, FLT4, FGFR2, CNOT6L, SNTA1, IGF2	poly(A)-specific ribonuclease activity [MF], axonogenesis [BP], neuromuscular junction development [BP], protein phosphorylation [BP], insulin receptor signaling pathway [BP], positive regulation of insulin receptor signaling pathway [BP], regulation of protein phosphorylation [BP], peptidyl-tyrosine phosphorylation [BP], activation of MAPKK activity [BP], loop of Henle development [BP], vascular endothelial growth factor-activated receptor activity [MF], regulation of axon extension [BP], mesonephric tubule development [BP], proximal tubule development [BP], regulation of axonogenesis [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], positive regulation of protein phosphorylation [BP]
CG_h9laurent_promoter_n_RM_16_56_7	3	0.5	5.18E-04	SMARCC2, RGPD8, RGPD1, SMARCC1	npBAF complex [CC], nBAF complex [CC], SWI/SNF complex [CC], protein targeting to Golgi [BP], nucleosome disassembly [BP]
CG_h9laurent_promoter_n_RM_12_119_17	2	0.5	3.22E-04	PLEKHA7, CENPJ, CLASP1, AGPAT2, DACT2	delta-catenin binding [MF], microtubule nucleation [BP], triglyceride biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_256_17	7	1.0	3.48E-04	POLR2I, POLR2D	DNA-directed RNA polymerase II, core complex [CC]
CG_h9laurent_promoter_n_RM_16_27_4	3	0.5	3.84E-04	PABPC1, ALYREF, TUT1, RHEB, YBX2, LARP4B	mRNA 3'-end processing [BP], mRNA stabilization [BP], translation regulator activity [MF], mRNA polyadenylation [BP], spliceosomal complex [CC], polysome [CC], cytoplasmic stress granule [CC], ribonucleoprotein complex [CC], mRNA 3'-UTR binding [MF]
CG_h9laurent_promoter_n_RM_14_325_4	2	0.25	3.76E-04	CD63, ANKFY1, ASPH, ABCA2, AP3D1, PKLR	response to ATP [BP], endosome membrane [CC]
CG_h9laurent_promoter_n_RM_12_67_29	4	0.75	3.44E-04	WNT7B	metanephros morphogenesis [BP], metanephric loop of Henle development [BP]
CG_h9laurent_promoter_n_RM_14_377_10	1	0.25	3.32E-04	TGFB1	negative regulation of ossification [BP]
CG_h9laurent_promoter_n_RM_18_21_3	1	0.25	6.13E-04	ARRDC3, CDC42BPA	positive regulation of adrenergic receptor signaling pathway [BP], negative regulation of heat generation [BP], negative regulation of locomotion involved in locomotory behavior [BP], actomyosin structure organization [BP], beta-3 adrenergic receptor binding [MF]
CG_h9laurent_promoter_n_RM_12_356_16	2	0.5	2.74E-04	PTK6	negative regulation of protein tyrosine kinase activity [BP]
CG_h9laurent_promoter_n_RM_12_470_15	3	0.75	3.48E-04	LRP6, FZD5, KCNJ4, ALG5, TFRC, DGKI, TBC1D10A, TNK2	positive regulation of bone resorption [BP], determination of left/right symmetry [BP], GTPase inhibitor activity [MF], Wnt-activated receptor activity [MF], Wnt receptor signaling pathway involved in dorsal/ventral axis specification [BP], PDZ domain binding [MF]
CG_h9laurent_promoter_n_RM_12_404_17	2	0.25	3.29E-04	DBN1, ELAVL3, EFNB2	cell communication by chemical coupling [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_14_178_3	1	0.25	4.58E-04	GCH1, CCBL1, GRIN2A, PLXNA2	glutamine-phenylpyruvate transaminase activity [MF], L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], dopamine metabolic process [BP], cerebellar granule cell precursor tangential migration [BP], L-glutamine:pyruvate aminotransferase activity [MF], GTP cyclohydrolase I activity [MF], 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_h9laurent_promoter_n_RM_14_307_12	2	0.5	3.38E-04	CAMK2B, ANAPC2	positive regulation of synapse maturation [BP]
CG_h9laurent_promoter_n_RM_20_1_3	2	0.25	4.74E-04	APBA1, EIF4G3, RXRG, BOLL, SRP68, SATB1, STC1, SMG1, PTCH1, MEX3B, EIF4A3, STAR	positive regulation of translation [BP], RNA binding [MF], reflex [BP], regulation of gene expression [BP], cellular response to glucocorticoid stimulus [BP], cholesterol binding [MF], gene expression [BP], cellular response to cAMP [BP]
CG_h9laurent_promoter_n_RM_14_228_13	3	0.5	3.38E-04	SLBP, SYNCRIP	histone pre-mRNA 3'end processing complex [CC]
CG_h9laurent_promoter_n_RM_14_344_9	2	0.25	4.86E-04	IRF2, SREBF1, WNT4, NACC2	positive regulation of aldosterone biosynthetic process [BP], negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of testosterone biosynthetic process [BP], negative regulation of testicular blood vessel morphogenesis [BP], negative regulation of transcription, DNA-dependent [BP], histone deacetylation [BP], sterol response element binding [MF], regulatory region DNA binding [MF], female sex determination [BP], negative regulation of gene expression [BP], positive regulation of cortisol biosynthetic process [BP], negative regulation of male gonad development [BP]
CG_h9laurent_promoter_n_RM_14_176_5	3	0.5	1.35E-04	SOD2	vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [BP], erythrophore differentiation [BP], age-dependent response to reactive oxygen species [BP]
CG_h9laurent_promoter_n_RM_12_277_29	2	0.5	3.26E-04	CTDSP2, SSU72	CTD phosphatase activity [MF]
CG_h9laurent_promoter_n_RM_12_58_20	3	0.75	3.47E-04	AQP4, EPHA4, TCF3, SEMA6A, NEUROD2	neuron development [BP], regulation of dendritic spine morphogenesis [BP], cell development [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_16_74_10	5	0.5	5.09E-04	SATB1, GRSF1	morphogenesis of embryonic epithelium [BP], reflex [BP]
CG_h9laurent_promoter_n_RM_14_60_15	2	0.25	2.83E-04	STRN, EPS8, HOMER2	postsynaptic density [CC]
CG_h9laurent_promoter_n_RM_12_556_20	3	0.5	3.39E-04	CHML, GNAQ, AXIN1, CKB, CHST9, GATM, GPC4, ANAPC2, ARL4C, RALGAPA2, NEUROD2	positive regulation of synapse maturation [BP], GTP catabolic process [BP], GTPase activator activity [MF], positive regulation of GTPase activity [BP], positive regulation of synaptic plasticity [BP], chondroitin sulfate metabolic process [BP], creatine metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_593_9	2	0.25	3.92E-04	HEG1	lymph circulation [BP]
CG_h9laurent_promoter_n_RM_14_153_2	2	0.25	2.62E-04	SIX2, NOTCH1, HAND2, DPYD, CDC42EP3	cardiac right ventricle formation [BP], negative regulation of osteoblast differentiation [BP], dihydropyrimidine dehydrogenase (NADP+) activity [MF], thymidine catabolic process [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], sprouting angiogenesis [BP], cytoskeletal regulatory protein binding [MF], cardiac chamber formation [BP], coronary artery morphogenesis [BP], regulation of extracellular matrix assembly [BP], heart looping [BP], positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP], venous endothelial cell differentiation [BP], positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP], regulation of secondary heart field cardioblast proliferation [BP], negative regulation of cell differentiation [BP]
CG_h9laurent_promoter_n_RM_14_267_3	2	0.25	1.81E-04	GPR143, CSAD, NRARP, GNA13, SEPT12, NR3C1	patterning of blood vessels [BP], L-DOPA binding [MF], sulfinoalanine decarboxylase activity [MF], L-DOPA receptor activity [MF], sperm annulus [CC], glucocorticoid receptor activity [MF], mammary gland duct morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_47_19	3	0.5	3.32E-04	TNFRSF10D, BRD3, TNFRSF10B	TRAIL binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_12_240_8	3	0.25	2.80E-04	WAPAL	negative regulation of DNA replication [BP]
CG_h9laurent_promoter_n_RM_14_190_16	5	0.5	3.70E-04	TP53BP2, AKT2, ANP32A, MESP1, SRSF4, MAP3K9, MAML3, ZHX3, DEAF1, CSRNP1, ZIC5, VEZF1, PHIP, CPT1A, PNKP, EVX2, BARX1, ZNF827, PAX3, SNAPC4, BRD1, SOX21, KLLN, TAF11, ZNF425, CDK5, MCMBP, GATAD2B, HSPA5	DNA binding [MF], fatty acid beta-oxidation [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], positive regulation of fatty acid beta-oxidation [BP], regulation of fatty acid oxidation [BP], nucleus [CC], transcription from RNA polymerase II promoter [BP], positive regulation of protein targeting to membrane [BP]
CG_h9laurent_promoter_n_RM_14_265_5	2	0.25	2.85E-04	CTNNBIP1, SIAH1	beta-catenin destruction complex [CC]
CG_h9laurent_promoter_n_RM_14_356_7	6	0.75	2.84E-04	DRD2, SGK1, LUC7L	positive regulation of G-protein coupled receptor protein signaling pathway [BP], potassium channel regulator activity [MF], negative regulation of striated muscle tissue development [BP], long-term memory [BP]
CG_h9laurent_promoter_n_RM_12_182_7	1	0.25	4.26E-05	UROS, TEFM	uroporphyrinogen III biosynthetic process [BP], cellular response to amine stimulus [BP], uroporphyrinogen-III synthase activity [MF], DNA polymerase processivity factor activity [MF]
CG_h9laurent_promoter_n_RM_12_585_16	3	0.5	2.84E-04	DDX58, GATA5, DICER1, PVRL1	enamel mineralization [BP], intestinal epithelial cell differentiation [BP], ATP-dependent helicase activity [MF]
CG_h9laurent_promoter_n_RM_14_226_4	3	0.5	3.18E-04	EZR, INTS6	actin cytoskeleton [CC]
CG_h9laurent_promoter_n_RM_12_60_7	2	0.5	3.05E-04	SSBP2, DICER1, RPS6KA5, SH3RF1, CBX4, MNX1, HIP1, MIER3, RPS6KA3, PIDD, POLG, BMP4, HES4, PHIP, APTX, RBM39, PRDX3	cell death [BP], regulation of odontogenesis of dentin-containing tooth [BP], regulation of apoptotic process [BP], negative regulation of apoptotic process [BP], regulation of transcription, DNA-dependent [BP], negative regulation of cell death [BP], DNA ligation [BP]
CG_h9laurent_promoter_n_RM_12_139_5	2	0.25	1.44E-04	GCNT4, MSRB1, NKX3-1, FGFR1, FASTK	MADS box domain binding [MF], salivary gland development [BP], inter-male aggressive behavior [BP], positive regulation of androgen secretion [BP], positive regulation of phosphatidylinositol 3-kinase cascade [BP], Fas-activated serine/threonine kinase activity [MF], methionine-R-sulfoxide reductase activity [MF]
CG_h9laurent_promoter_n_RM_12_507_9	3	0.5	3.08E-04	PMEPA1, LITAF	WW domain binding [MF]
CG_h9laurent_promoter_n_RM_12_219_16	2	0.25	2.97E-04	SOCS1, IGF2	insulin-like growth factor receptor binding [MF]
CG_h9laurent_promoter_n_RM_14_246_20	2	0.5	3.22E-04	ZCCHC6, TUT1	RNA uridylyltransferase activity [MF]
CG_h9laurent_promoter_n_RM_14_303_9	3	0.5	4.17E-04	CBX8, NCAPD3	methylated histone residue binding [MF]
CG_h9laurent_promoter_n_RM_12_35_15	3	0.5	4.84E-04	MYH11	smooth muscle contractile fiber [CC]
CG_h9laurent_promoter_n_RM_18_4_11	5	0.25	4.36E-04	MAP4K3, EIF2AK2, MAP4K5, RYK, SNX5, TRIM33, ONECUT1, MOK, EPB41L4B, DACH1, EZH2, HAND2, CBX4, MNX1, NCKAP1, STK40, CHD1, TCF15, CEBPA, THSD7A, SMG1, MAML3, SOX10, CALCOCO1, AFF3, MLLT1, XPO1, GNPTAB, CSNK1E, FOSL1, MYCBP2, MED16, JAG2, TOP2B, MAPK1, CDK5, PDGFA, POU3F1, TWIST1, SIAH1, ZBTB4, RXRG, BOLL, CAMK2B, ABR, EBF3, TAPT1, CNTFR, PTPRS, FGFR2, SHANK1, ZNF521, TRPS1, APBA1, ADRA1D, APBA3, SFRP5, LMO2, RFX7, NOTCH2, GJC1, SCRIB, FZD8, SRP68, CDK6, GNA13, ACTL6B, ASCC2, PTCH1, CREBBP, RPS6KA6	negative regulation of osteoblast differentiation [BP], ear development [BP], protein serine/threonine kinase activity [MF], brain development [BP], generation of neurons [BP], cardiac neural crest cell migration involved in outflow tract morphogenesis [BP], cell communication [BP], multicellular organismal development [BP], nervous system development [BP], vasculature development [BP], positive regulation of dendritic spine development [BP], limb morphogenesis [BP], regulation of transcription, DNA-dependent [BP], cell development [BP], regulation of skeletal muscle adaptation [BP], in utero embryonic development [BP], cell differentiation [BP], extrinsic to membrane [CC], anatomical structure morphogenesis [BP], negative regulation of cellular senescence [BP], transcription regulatory region DNA binding [MF], regulation of dendritic spine development [BP], central nervous system development [BP], corpus callosum development [BP], asymmetric protein localization [BP], regulation of transcription from RNA polymerase II promoter [BP], embryonic limb morphogenesis [BP], neural tube closure [BP], regulation of osteoblast differentiation [BP], dendritic spine morphogenesis [BP], suckling behavior [BP], morphogenesis of embryonic epithelium [BP], forebrain development [BP], regulation of gene expression [BP], embryo development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], regulation of dendritic spine morphogenesis [BP]
CG_h9laurent_promoter_n_RM_14_320_24	4	0.5	4.76E-04	HNRPLL, SAV1, REXO1, MAP3K9, CERS1, DEAF1, CBFA2T3, ZSWIM7, RELN, PIP4K2A, SP3, CAMK2B, BAZ1A, PER2, LDB1, NKX6-2, BRD1, STRBP, RFX7, GSK3A, UBTD2, FRA10AC1, PID1, MAPK1, LMO2, PHF21A, RAD1, MNX1, SMURF1, YPEL1, AMER2, UBXN7, TRDMT1, EPS15L1, ZNF777, ARGLU1, ZC3H8, PRKRIR, CREBBP, TLE1, MSRB1, ZFHX3, CBX5, CBX4, TRIP12, FZD8, ADAP1, AKAP8L, IRF2BP1, PHIP, ELMSAN1, MAPK9, SUGP2, PYGO1, SIAH2, TCFL5, TNKS1BP1, MEMO1, YTHDC1, ZNF521, SFRP5, FBXW4, LRP8, HOXA6, HOXA5, NKX3-1, HIVEP3, JHDM1D, FOXO1, ZMYND19, PRICKLE1, HDGFRP3, MED14, DAPK3, RRAGC, RAD21, RP9, EBF3, SCML2, MEX3D, MEX3C, FAM53A, BNC1, PPP1CA, PURB, PURG, ZBTB45, ZNF792, AHCTF1	positive regulation of apoptotic signaling pathway [BP], Wnt receptor signaling pathway [BP], negative regulation of erythrocyte differentiation [BP], reelin-mediated signaling pathway [BP], intracellular membrane-bounded organelle [CC], transcription factor binding [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], negative regulation of cell differentiation [BP], embryo development [BP], nucleus [CC], RNA metabolic process [BP], positive regulation of dendritic spine morphogenesis [BP]
CG_h9laurent_promoter_n_RM_12_224_4	2	0.5	3.16E-04	G6PD, BRD1, KAT6A	MOZ/MORF histone acetyltransferase complex [CC], histone H3 acetylation [BP], negative regulation of protein glutathionylation [BP]
CG_h9laurent_promoter_n_RM_12_259_11	3	0.5	3.78E-04	PLBD1, NOTCH3, PTCH1	cell proliferation involved in metanephros development [BP], hydrolase activity [MF], glomerular capillary formation [BP]
CG_h9laurent_promoter_n_RM_14_154_15	2	0.25	3.47E-04	DUSP8, DUSP16	MAP kinase tyrosine/serine/threonine phosphatase activity [MF]
CG_h9laurent_promoter_n_RM_14_225_24	4	0.75	3.03E-04	LAMA1, HMGB2, HMGB1, MYH9, MED24, RAPH1, FAT1, MYO1E, HES6, ITGB1	DNA ligation involved in DNA repair [BP], microfilament motor activity [MF], chemoattractant activity [MF], base-excision repair, DNA ligation [BP], transcription cofactor activity [MF], RAGE receptor binding [MF], cell migration [BP], cell-cell junction [CC], filopodium [CC], DNA topological change [BP], V(D)J recombination [BP]
CG_h9laurent_promoter_n_RM_14_227_12	2	0.25	4.49E-04	AGPAT2, DGAT1, DGKQ, SOX10, DUSP8, RNF19A, DUSP16, CREBBP, SIN3A, TBL1XR1	MAP kinase tyrosine/serine/threonine phosphatase activity [MF], inactivation of MAPK activity [BP], activating transcription factor binding [MF], transcription factor binding [MF], cellular lipid metabolic process [BP], transferase activity, transferring acyl groups [MF], RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF]
CG_h9laurent_promoter_n_RM_14_308_8	4	0.5	2.77E-04	DGKQ, ADCY9, GNB2L1, GPLD1, PRKAR1B, CBX4, RBM39, SRCIN1, PIAS2	negative regulation of protein tyrosine kinase activity [BP], activation of protein kinase A activity [BP], nuclear speck [CC], transepithelial transport [BP]
CG_h9laurent_promoter_n_RM_12_398_13	2	0.25	1.85E-04	CSNK1D, SLC17A7, GCLC, TRMT112	peptidyl-glutamine methylation [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP], sodium:inorganic phosphate symporter activity [MF], sequestering of neurotransmitter [BP]
CG_h9laurent_promoter_n_RM_12_487_22	3	0.5	3.45E-04	SNX3, PARD3, SH3PXD2B	phosphatidylinositol-3-phosphate binding [MF]
CG_h9laurent_promoter_n_RM_16_67_5	4	0.25	5.87E-04	IRS2	lipid homeostasis [BP]
CG_h9laurent_promoter_n_RM_12_473_8	4	0.75	2.40E-04	BFSP1, FGFR2	lens fiber cell development [BP]
CG_h9laurent_promoter_n_RM_12_170_16	3	0.5	1.05E-04	TBX15, FGF8, EEA1	cell migration involved in mesendoderm migration [BP], synaptic vesicle to endosome fusion [BP], serine-pyruvate aminotransferase complex [CC], Tle3-Aes complex [CC]
CG_h9laurent_promoter_n_RM_14_268_3	2	0.25	3.10E-04	EGR2	rhombomere 3 formation [BP], rhombomere 5 formation [BP]
CG_h9laurent_promoter_n_RM_12_587_17	1	0.25	4.07E-04	HECTD1, HAGH, ZIC5, SALL1, NKX2-2, OPLAH, FGFR1, PLXNB2	positive regulation of neuron differentiation [BP], outer ear morphogenesis [BP], glutathione biosynthetic process [BP], neural tube closure [BP]
CG_h9laurent_promoter_n_RM_12_514_18	1	0.25	2.31E-04	CREBBP, ACD, PTCH1	embryonic limb morphogenesis [BP], RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription [MF]
CG_h9laurent_promoter_n_RM_14_289_8	2	0.5	3.70E-04	HIP1, TNNT2, CAMK2B, PTK2	actin binding [MF]
CG_h9laurent_promoter_n_RM_14_24_7	2	0.5	3.01E-04	PPM1K, PPP2CB	protein dephosphorylation [BP]
CG_h9laurent_promoter_n_RM_12_135_14	1	0.25	3.09E-04	IFT172, DPF1, HOXA2, OTX2, CNTFR	dorsal/ventral pattern formation [BP], smoothened signaling pathway [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_164_8	3	0.5	3.48E-04	ARHGAP21, ANKLE2, SLC23A1	mitotic nuclear envelope reassembly [BP], organelle transport along microtubule [BP], dehydroascorbic acid transport [BP]
CG_h9laurent_promoter_n_RM_16_21_3	2	0.5	1.97E-04	CSPG5, PIP5K1C, WNT9A, RHOC, PLXND1, PIP4K2A, CSNK2A2, FZD5	axonogenesis [BP], 1-phosphatidylinositol-4-phosphate 5-kinase activity [MF], axon guidance [BP], neuron differentiation [BP], multicellular organismal development [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_14_366_3	2	0.25	4.52E-04	C14orf39, DONSON, RECQL4	multicellular organismal development [BP]
CG_h9laurent_promoter_n_RM_14_167_9	2	0.25	4.21E-04	CLIP1, SIN3A, CTBP1	transcriptional repressor complex [CC], RNA polymerase II transcription corepressor activity [MF], regulation of transcription by chromatin organization [BP], repressing transcription factor binding [MF], response to methylglyoxal [BP], negative regulation of histone acetylation [BP], protein deacetylation [BP], macropinosome [CC], negative regulation of histone H3-K27 acetylation [BP]
CG_h9laurent_promoter_n_RM_12_273_12	2	0.5	2.79E-04	ROCK2, PABPC1	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP], positive regulation of centrosome duplication [BP]
CG_h9laurent_promoter_n_RM_12_401_32	2	0.5	3.60E-04	DOK2, CEBPA, SMAD7, PTPRS, FEZF1, TBX20, NR2F6, NRARP, HOXA7, SALL1, PAWR, NSMAF, SCN3B, HDAC4, NCOA2	negative regulation of transcription from RNA polymerase II promoter [BP], cerebellum development [BP], regulation of ventricular cardiac muscle cell membrane depolarization [BP], receptor signaling protein activity [MF]
CG_h9laurent_promoter_n_RM_12_312_15	2	0.5	2.93E-04	ALYREF, THOC7	intronless viral mRNA export from host nucleus [BP], transcription export complex [CC]
CG_h9laurent_promoter_n_RM_12_590_29	3	0.5	3.62E-04	EXT1, B3GNT9, IRS2, BHLHE23, LARGE, AKT1, PKP2, SLC27A5, B3GAT2, NES, BCL2, ZC3H8	glycoprotein biosynthetic process [BP], protein glycosylation [BP], T cell homeostasis [BP], intermediate filament binding [MF], negative regulation of plasma membrane long-chain fatty acid transport [BP], negative regulation of retinal cell programmed cell death [BP], plasma membrane long-chain fatty acid transport [BP]
CG_h9laurent_promoter_n_RM_12_523_11	3	0.5	2.81E-04	SCUBE1, JAG1	apical part of cell [CC], endocardial cushion cell development [BP], endothelial cell differentiation [BP]
CG_h9laurent_promoter_n_RM_12_423_15	3	0.5	3.25E-04	HDAC4, PRKDC, RAPGEF5, CTNND2, CNR1, MTHFSD, CCSAP, APBB1, ZIC5, MAPK9, SPOCK1, MTHFS, TONSL, OSR1, DLL1, BARX1, EBF3, SAV1, GPR161, SCRIB, PURB, CDK5, CDK6, SH3PXD2B, MYO5A, WNT7B, RECQL4	neurogenesis [BP], positive regulation of apoptotic process [BP], axonogenesis [BP], neuron projection [CC], neuron projection development [BP], Ras guanyl-nucleotide exchange factor activity [MF], cell projection [CC], generation of neurons [BP], 5-formyltetrahydrofolate cyclo-ligase activity [MF], neuron differentiation [BP], DNA replication factor A complex [CC], multicellular organismal development [BP], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_n_RM_12_21_9	4	0.25	2.89E-04	MYO1D, CYB5A, SLC23A2, GDNF, YBX2, MYO10, MYO1E	actin-dependent ATPase activity [MF], myosin complex [CC], mRNA stabilization [BP], L-ascorbic acid metabolic process [BP], microfilament motor activity [MF]
CG_h9laurent_promoter_n_RM_14_322_6	2	0.5	4.11E-04	RPS6KA3, HYAL2, TCF15, INSR, TNNT2, PITX2, IGF2	positive regulation of glycogen biosynthetic process [BP], insulin-like growth factor receptor binding [MF], transformation of host cell by virus [BP], positive regulation of mitosis [BP], muscle organ morphogenesis [BP], atrial cardiac muscle tissue morphogenesis [BP], skeletal system development [BP]
CG_h9laurent_promoter_n_RM_12_160_7	2	0.5	2.56E-04	MGAT1	alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_h9laurent_promoter_n_RM_12_61_22	2	0.25	2.50E-04	ARFGAP3, ARFGAP2	regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF]
CG_h9laurent_promoter_n_RM_12_364_9	2	0.5	2.28E-04	ZIC5, CELSR1, PLXNB2	neural tube closure [BP]
CG_h9laurent_promoter_n_RM_14_312_13	5	0.75	2.94E-04	GSK3B, GSK3A	negative regulation of type B pancreatic cell development [BP], beta-catenin destruction complex [CC], negative regulation of glycogen (starch) synthase activity [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], protein kinase A catalytic subunit binding [MF], negative regulation of glycogen biosynthetic process [BP], tau-protein kinase activity [MF]
CG_h9laurent_promoter_n_RM_14_93_10	4	0.5	3.42E-04	ELAVL1, CDKN1C, USP7, ERF, RPS2, PYCR1, RB1CC1, UBTD2, POLDIP3, NAP1L4, APBB2, LARP4B, BCAT2, SSBP3, PNCK, UBE2N, WNT3, ROCK2, PSMD12, PRDM4, TOX3, ZNF423, HES2, ZNF395, MAD2L2	positive regulation of translation [BP], gene expression [BP], nucleus [CC], midbrain-hindbrain boundary development [BP], cellular nitrogen compound metabolic process [BP]
CG_h9laurent_promoter_n_RM_16_41_2	2	0.5	1.66E-04	CLIP1	macropinosome [CC]
CG_h9laurent_promoter_n_RM_16_62_5	5	0.5	4.75E-04	SIX5, LMO2, MIER3, SOX15, FOXO1, MBD2, SH3PXD2B, BRD3, FGFR2, WNT7B, SP3	lens fiber cell development [BP], eye development [BP], embryonic placenta morphogenesis [BP], chromatin binding [MF], lung-associated mesenchyme development [BP], lens development in camera-type eye [BP]
CG_h9laurent_promoter_n_RM_14_211_5	2	0.5	3.73E-04	INTS1	U2 snRNA 3'-end processing [BP]
CG_h9laurent_promoter_n_RM_12_509_12	3	0.5	3.14E-04	CSTB, ITSN2, IRS2, PLA2G7, AGAP2, FERMT1, LPAR1, HIP1, GOLPH3	phospholipid binding [MF], lipid binding [MF], regulation of apoptotic process [BP]
CG_h9laurent_promoter_n_RM_12_389_10	1	0.25	2.93E-04	BBC3, BCAP31	reduction of endoplasmic reticulum calcium ion concentration [BP], positive regulation of intrinsic apoptotic signaling pathway [BP]
CG_h9laurent_promoter_n_RM_12_66_21	2	0.5	2.84E-04	MFAP2, SFRP2	fibronectin binding [MF]
CG_h9laurent_promoter_n_RM_16_43_4	2	0.5	4.11E-04	TCF3, FOXP1	immunoglobulin V(D)J recombination [BP]
CG_h9laurent_promoter_n_RM_12_594_13	5	0.75	3.02E-04	SFRP5, FZD8, CDK5, MED16, SLC30A1, SLC39A6, NCOA2	zinc ion transmembrane import [BP], embryo development [BP], cellular zinc ion homeostasis [BP], thyroid hormone receptor coactivator activity [MF]
CG_h9laurent_promoter_n_RM_12_185_14	3	0.25	3.07E-04	RALGDS, SMAD7, IRS1, AKT1, NACC2, XRCC1, APTX, RASGRP1	single strand break repair [BP], Ras protein signal transduction [BP], cellular protein complex localization [BP], positive regulation of glucose metabolic process [BP]
CG_h9laurent_promoter_n_RM_12_244_11	4	0.75	4.02E-04	DLG4, LRP4, LIFR, PHIP, FLNA, SHANK1, LIF	receptor clustering [BP], protein import into nucleus [BP], leukemia inhibitory factor signaling pathway [BP], vocalization behavior [BP]
CG_h9laurent_promoter_n_RM_12_567_10	4	0.5	3.06E-04	LTBP3, EFEMP1	negative regulation of chondrocyte differentiation [BP]
CG_h9laurent_promoter_n_RM_14_200_24	4	0.5	4.89E-04	TBC1D2B, NCBP2, SOX10, FOXD4, ASCL2, DEK, CDC42BPB, AGAP7, CHD1	peripheral nervous system development [BP], transcription from RNA polymerase II promoter [BP], mRNA 3'-end processing [BP], phospholipid binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_n_RM_16_60_2	2	0.5	1.44E-04	TFAP4, SMUG1	transcriptional repressor complex [CC], single-strand selective uracil DNA N-glycosylase activity [MF]
CG_h9laurent_promoter_n_RM_14_137_7	2	0.25	3.96E-04	BMP4	negative regulation of mitosis [BP]
CG_h9laurent_promoter_n_RM_12_243_17	4	0.75	4.47E-04	TTLL1, RAD1, TTLL12, ARPP19, FOXO1, TTLL11, NKX3-1, SMEK2, VPS53, FAM126B, VPS54, ANKLE2	GARP complex [CC], intracellular [CC], positive regulation of gluconeogenesis [BP], tubulin-tyrosine ligase activity [MF], intracellular membrane-bounded organelle [CC], protein phosphatase 2A binding [MF]